beatandraise : SEC Filings Research with AI

beatandraise.com

0000078003 2009-12-31 0000078003 2008-12-31 0000078003 2009-01-01 2009-12-31 0000078003 2007-01-01 2007-12-31 0000078003 2008-01-01 2008-12-31 0000078003 2007-12-31 0000078003 2006-12-31 0000078003 2010-02-18 0000078003 2009-06-26 0000078003 us-gaap:ParentMember 2007-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2007-12-31 0000078003 us-gaap:PreferredStockMember 2007-12-31 0000078003 us-gaap:CommonStockMember 2007-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2007-12-31 0000078003 us-gaap:TrustForBenefitOfEmployeesMember 2007-12-31 0000078003 us-gaap:TreasuryStockMember 2007-12-31 0000078003 us-gaap:RetainedEarningsMember 2007-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2007-12-31 0000078003 us-gaap:ParentMember 2008-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2008-12-31 0000078003 us-gaap:PreferredStockMember 2008-12-31 0000078003 us-gaap:CommonStockMember 2008-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2008-12-31 0000078003 us-gaap:TrustForBenefitOfEmployeesMember 2008-12-31 0000078003 us-gaap:TreasuryStockMember 2008-12-31 0000078003 us-gaap:RetainedEarningsMember 2008-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2008-12-31 0000078003 us-gaap:ParentMember 2009-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2009-12-31 0000078003 us-gaap:PreferredStockMember 2009-12-31 0000078003 us-gaap:CommonStockMember 2009-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2009-12-31 0000078003 us-gaap:TrustForBenefitOfEmployeesMember 2009-12-31 0000078003 us-gaap:TreasuryStockMember 2009-12-31 0000078003 us-gaap:RetainedEarningsMember 2009-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-12-31 0000078003 us-gaap:ParentMember 2007-01-01 2007-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2007-01-01 2007-12-31 0000078003 us-gaap:PreferredStockMember 2007-01-01 2007-12-31 0000078003 us-gaap:CommonStockMember 2007-01-01 2007-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2007-01-01 2007-12-31 0000078003 us-gaap:TrustForBenefitOfEmployeesMember 2007-01-01 2007-12-31 0000078003 us-gaap:TreasuryStockMember 2007-01-01 2007-12-31 0000078003 us-gaap:RetainedEarningsMember 2007-01-01 2007-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2007-01-01 2007-12-31 0000078003 us-gaap:ParentMember 2008-01-01 2008-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2008-01-01 2008-12-31 0000078003 us-gaap:PreferredStockMember 2008-01-01 2008-12-31 0000078003 us-gaap:CommonStockMember 2008-01-01 2008-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2008-01-01 2008-12-31 0000078003 us-gaap:TrustForBenefitOfEmployeesMember 2008-01-01 2008-12-31 0000078003 us-gaap:TreasuryStockMember 2008-01-01 2008-12-31 0000078003 us-gaap:RetainedEarningsMember 2008-01-01 2008-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2008-01-01 2008-12-31 0000078003 us-gaap:ParentMember 2009-01-01 2009-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2009-01-01 2009-12-31 0000078003 us-gaap:PreferredStockMember 2009-01-01 2009-12-31 0000078003 us-gaap:CommonStockMember 2009-01-01 2009-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2009-01-01 2009-12-31 0000078003 us-gaap:TrustForBenefitOfEmployeesMember 2009-01-01 2009-12-31 0000078003 us-gaap:TreasuryStockMember 2009-01-01 2009-12-31 0000078003 us-gaap:RetainedEarningsMember 2009-01-01 2009-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2009-01-01 2009-12-31 0000078003 us-gaap:ParentMember 2006-12-31 0000078003 us-gaap:NoncontrollingInterestMember 2006-12-31 0000078003 us-gaap:PreferredStockMember 2006-12-31 0000078003 us-gaap:CommonStockMember 2006-12-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2006-12-31 0000078003 us-gaap:TrustForBenefitOfEmployeesMember 2006-12-31 0000078003 us-gaap:TreasuryStockMember 2006-12-31 0000078003 us-gaap:RetainedEarningsMember 2006-12-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2006-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

73000000

443000000

70283000000

-425000000

57391000000

49142000000

-4569000000

57556000000

184000000

57740000000

111148000000

9320000000

1751000000

2159000000

656000000

1667000000

11456000000

27009000000

7963000000

4235000000

1604000000

2959000000

6568000000

3070000000

53408000000

2122000000

21609000000

8958000000

824000000

4381000000

5034000000

148000000

43076000000

11478000000

13287000000

21464000000

17721000000

4122000000

111148000000

10-K false 2009-12-31 PFIZER INC 0000078003 --12-31 Yes No Yes Large Accelerated Filer

3406000000

1827000000

8070372772 102000000000

50009000000

48296000000

48418000000

8888000000

8112000000

11239000000

14875000000

14537000000

15626000000

7845000000

7945000000

8089000000

2877000000

2668000000

3128000000

68000000

633000000

4337000000 2675000000 2534000000 292000000 2032000000 -1759000000

10827000000

9694000000

9278000000

2197000000

1645000000

1023000000

8630000000

8049000000

8255000000

14000000

78000000

-69000000

8644000000

8127000000

8186000000

9000000

23000000

42000000

8635000000

8104000000

8144000000

1.23

1.19

0.01

-0.01

1.23

1.20

1.18

1.23

1.19

1.18

0.01

-0.01

1.23

1.20

1.17

7007000000

6727000000

6917000000

7045000000

6750000000

6939000000

1978000000

23991000000

14645000000

1195000000

12403000000

6962000000

496000000

61670000000

13122000000

22780000000

42376000000

68015000000

4986000000

212949000000

5469000000

4370000000

1454000000

10107000000

2242000000

13583000000

37225000000

43193000000

6392000000

3243000000

17839000000

9000000000

5611000000

122503000000

61000000

443000000

70497000000

-333000000

21632000000

40426000000

552000000

90014000000

432000000

90446000000

212949000000

2302

93000000

8850000000

442000000

69913000000

-24000000

-550000000

-2089000000

-56847000000

49660000000

2299000000

65010000000

114000000

65124000000

8144000000

42000000

2768000000

6000000

2774000000

10960000000

48000000

10912000000

11000000

8156000000

8000000

23000000

1000000

738000000

121000000

5000000

-7000000

853000000

9994000000

-395000000

-49000000 1000000 117000000 68000000 -68000000 5000000 1000000 -25000000 -1195 -48000000 8000000

-145000000

111000000

-34000000

8000000

-26000000

1804

73000000

8863000000

443000000

70283000000

-24000000

-425000000

-2117000000

-57391000000

49142000000

-4569000000

57556000000

184000000

23000000

8104000000

-6833000000

35000000

-6868000000

1236000000

58000000

1294000000

8617000000

5000000

239000000

32000000

1000000

207000000

-26000000

500000000

93000000 -1000000 -113000000 -498 -20000000 -7000000 2000000 -25000000 -25000000

-250000000

-12000000

-238000000

46000000

-2000000

-283000000

-1000000

13000000

432000000

90014000000

552000000

40426000000

-21632000000

-799000000

-19000000

-333000000

70497000000

443000000

8869000000

1511

61000000

9000000

8635000000

5121000000

5000000

5126000000

13770000000

14000000

13756000000

-12430000000

23303000000

330000000

23633000000

35733000000

1319000000

4916000000

5000000

130000000

139000000

-61000000 7000000 111000000 50000000 50000000 -293 -12000000 -1000000 3000000 -10000000 -10000000

66000000

102000000

168000000

-218000000

-11000000

-207000000

-23000000

-1000000

28000000

-2000000

-212000000

3497

8819000000

-30000000

-1695000000

141000000

441000000

69104000000

-788000000

-46740000000

49669000000

-469000000

71358000000

74000000

71432000000

4757000000

5090000000

349000000

384000000

670000000 14000000

-9582000000

-1331000000

504000000

496000000

472000000

-195000000

-1631000000

-294000000

867000000

538000000

1695000000

3797000000

9454000000

647000000

1076000000

464000000

16587000000

18238000000

1205000000

1701000000

35331000000

35705000000

42364000000 27883000000

6888000000

9357000000

6504000000 1009000000

43123000000

1184000000

-632000000

1693000000

-31272000000

-12835000000

32033000000 40119000000 34969000000 37264000000

24023000000

605000000

967000000

1053000000

500000000

5548000000

8541000000

-91000000

74000000

14481000000

-6560000000

60000000

-127000000

-144000000

-1284000000

23303000000

2300000000

2252000000

935000000

782000000

176000000

190000000

27000000

937000000

27000000

1511

1804

.05

12000000000

8863000000

8869000000

799000000

2117000000

9000000

6000000

5200000000

437000000

283000000

2220000000

326000000

-168000000

-2788000000

773000000

320000000

-720000000

647000000

1509000000

-2002000000

-60000000

13353000000

1880000000

25426000000

23053000000

1635000000

172000000

464000000

260000000

795000000

3155000000 764000000

2573000000

64000000

9994000000

7975000000

459000000

-12610000000

41000000

1579000000

5617000000

643000000

853000000

500000000

68000000 -68000000

9994000000

-20000000

1. Significant Accounting Policies A. Consolidation and Basis of Presentation The consolidated financial statements include our parent company and all subsidiaries, including those operating outside the United States (U.S.) and are prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The decision whether or not to consolidate an entity requires consideration of majority voting interests, as well as effective economic or other control over the entity. Typically, we do not seek control by means other than voting interests and we do not have significant interests in non-consolidated entities. For subsidiaries operating outside the U.S., the financial information is included as of and for the year ended November 30 for each year presented. Substantially all unremitted earnings of international subsidiaries are free of legal and contractual restrictions. All significant transactions among our businesses have been eliminat ed. We made certain reclassifications to prior-period amounts to conform to the December 31, 2009 presentations related to the presentation of noncontrolling interests as a result of adopting a new accounting standard. Subsequent events have been evaluated through the time of our filing on February 26, 2010. On October 15, 2009, we completed our acquisition of Wyeth in a cash-and-stock transaction valued at approximately $68 billion. Commencing from the acquisition date, our financial statements reflect the assets, liabilities and operating results of Wyeth. In accordance with our domestic and international fiscal year-ends, approximately two-and-a-half months of the fourth calendar quarter of 2009 in the case of Wyeth’s U.S. operations and approximately one-and-a-half months of the fourth calendar quarter of 2009 in the case of Wyeth’s international operations are included in our consolidated financial statements for the year ended December 31, 2009. For additional information, see Note 2. Acquisition of Wyeth. B. New Accounting Standards As of January 1, 2009, we adopted a new accounting standard that retains the purchase method of accounting for acquisitions but requires a number of changes to that method, including changes in the way assets and liabilities are recognized in purchase accounting. Specifically, they require the capitalization of in-process research and development costs at fair value and require the expensing of transaction costs as incurred. The adoption of these provisions did not have a significant impact on our consolidated financial statements upon adoption, but they did significantly impact our accounting for the acquisition of Wyeth in 2009. For additional information, see Note 2. Acquisition of Wyeth. As of January 1, 2009, we adopted a new accounting standard that provides guidance for the accounting, reporting and disclosure of noncontrolling interests, previously referred to as minority interests. A noncontrolling interest represents the portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to a parent. The adoption of these provisions resulted in a number of changes to the presentation of our consolidated financial statements, but the amounts associated with noncontrolling interests are not significant. In addition, throughout 2009, we adopted several other new accounting standards, none of which had a significant impact on our consolidated financial statements upon adoption. Among other things, these standards:   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Require us to deconsolidate a subsidiary when we cease to have a controlling financial interest in the subsidiary and to recognize a gain or loss on the transaction and measure any retained investment in the subsidiary at fair value (as of September 28, 2009). </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Provide qualifying criteria and guidance on using the net asset value per share provided by the investee to measure the fair value of alternative investments (as of September 28, 2009). </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Provide additional guidance on measuring the fair value of liabilities in the absence of observable market information, transfer restrictions and non-performance risk assessment (as of July 1, 2009). </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Amend the guidance for evaluating and measuring “other-than-temporary” impairments for available-for-sale or held-to-maturity debt securities (as of March 30, 2009). </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Provide additional guidance for estimating fair value in inactive markets and the identification of disorderly transactions (as of March 30, 2009). </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Expand the use of fair value and related disclosure requirements and specify a hierarchy of valuation techniques used to develop the fair value measures (as of January 1, 2009). We applied these provisions in our accounting for the acquisition of Wyeth in 2009. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Provide guidance on the accounting for collaborative arrangements, as defined, such as: how costs incurred and revenues generated on sales to third parties should be reported in the income statement; how an entity should characterize payments on the income statement; and what participants should disclose in the notes to the financial statements about a collaborative arrangement (as of January 1, 2009). We provided additional disclosures in Note 5. Collaborative Arrangements. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Clarify how to account for certain transactions involving equity method investments in areas such as: how to determine the initial carrying value of the investment; how to allocate the difference between the investor’s carrying value and the investor’s share of the underlying equity of the investment; how to perform an impairment assessment of underlying intangibles held by the investee; how to account for the investee’s issuance of additional shares; and how to account for an investment on the cost method when it previously had been accounted for under the equity method (as of January 1, 2009). We applied these provisions in our accounting for our new equity method investment, ViiV Healthcare Limited (see Note 3A. Other Significant Transactions and Events: Formation of ViiV, an Equity-Method Investment). </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Clarify the accounting for certain separately identifiable assets, which an acquirer does not intend to actively use but intends to hold to prevent its competitors from obtaining access to them. These provisions require an acquirer to account for a defensive intangible asset as a separate unit of accounting, which should be amortized to expense over the period the asset diminishes in value (as of January 1, 2009). We applied these provisions in our accounting for the acquisition of Wyeth in 2009. </td></tr></table> C. Estimates and Assumptions In preparing the consolidated financial statements, we use certain estimates and assumptions that affect reported amounts and disclosures, including amounts recorded in connection with acquisitions, such as our acquisition of Wyeth on October 15, 2009. These estimates and underlying assumptions can impact all elements of our financial statements. For example, in the consolidated statements of income, estimates are used when accounting for deductions from revenues (such as rebates, chargebacks, sales returns and sales allowances), determining cost of sales, allocating cost in the form of depreciation and amortization, and estimating restructuring charges and the impact of contingencies. On the consolidated balance sheets, estimates are used in determining the valuation and recoverability of assets, such as accounts receivables, investments, inventories, fixed assets and intangible assets (including ac quired in-process research & development (IPR&D) assets, beginning in 2009, and goodwill), and estimates are used in determining the reported amounts of liabilities, such as taxes payable, benefit obligations, the impact of contingencies, rebates, chargebacks, sales returns and sales allowances, and restructuring reserves, all of which also will impact the consolidated statements of income. We regularly evaluate our estimates and assumptions using historical experience and other factors, including the economic environment. Our estimates often are based on complex judgments, probabilities and assumptions that we believe to be reasonable but that are inherently uncertain and unpredictable. As future events and their effects cannot be determined with precision, our estimates and assumptions may prove to be incomplete or inaccurate, or unanticipated events and circumstances may occur that might cause us to change those estimates and assumptions. Market conditions, such as illiquid credit markets, volatile equity markets, dramatic fluctuations in foreign currency rates and economic downturn, can increase the uncertainty already inherent in our estimates and assumptions. We adjust our estimates and assumptions when facts and circumstances indicate the need for change. Those changes generally will be reflected in our financial statements on a prospective basis unless they are required to be treated retrospectively under the relevant accounting standard. It is possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alt ernative estimated amounts. We also are subject to other risks and uncertainties that may cause actual results to differ from estimated amounts, such as changes in the healthcare environment, competition, litigation, legislation and regulations. These and other risks and uncertainties are discussed in the accompanying Financial Review, which is unaudited, under the headings “Our Operating Environment, Strategy and Response to Key Opportunities and Challenges” and “Forward-Looking Information and Factors That May Affect Future Results” and in our 2009 Annual Report on Form 10-K under the caption, Part 1 Item 1A. “Risk Factors.” D. Contingencies We and certain of our subsidiaries are involved in various patent, product liability, consumer, commercial, securities, environmental and tax litigations and claims; government investigations; and other legal proceedings that arise from time to time in the ordinary course of our business. Except for income tax contingencies, we record accruals for contingencies to the extent that we conclude their occurrence is probable and that the related liabilities are estimable, and we record anticipated recoveries under existing insurance contracts when assured of recovery. For tax matters, we record accruals for income tax contingencies to the extent that we conclude that a tax position is not sustainable under a “more-likely-than-not” standard, and we record our estimate of the potential tax benefits in one tax jurisdiction that could result from the payment of income taxes in another tax jurisdict ion when we conclude that the potential recovery is more likely than not (see Note 7D. Taxes on Income: Tax Contingencies). We consider many factors in making these assessments. Because litigation and other contingencies are inherently unpredictable and excessive verdicts do occur, these assessments can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions (see Note 1C. Significant Accounting Policies: Estimates and Assumptions). E. Acquisitions Our consolidated financial statements include the operations of an acquired business after the completion of the acquisition. We account for acquired businesses using the acquisition method of accounting. The acquisition method of accounting for acquired businesses requires, among other things, that most assets acquired and liabilities assumed be recognized at their estimated fair values as of the acquisition date and that the fair value of acquired IPR&D be recorded on the balance sheet. Also, transaction costs are expensed as incurred. Any excess of the purchase price over the assigned values of the net assets acquired is recorded as goodwill. For acquisitions consummated prior to January 1, 2009, amounts allocated to IPR&D were expensed at the date of acquisition. When we have acquired net assets that do not constitute a business under U.S. GAAP, no goodwill has been recognized. &l t;/font> F. Fair Value We often are required to measure certain assets and liabilities at fair value, either upon initial measurement or for subsequent accounting or reporting. For example, we use fair value extensively in the initial measurement of net assets acquired in a business combination and when accounting for and reporting on certain financial instruments. We estimate fair value using an exit price approach, which requires, among other things, that we determine the price that would be received to sell an asset or paid to transfer a liability in an orderly market. The determination of an exit price is considered from the perspective of market participants, considering the highest and best use of assets and, for liabilities, assuming the risk of non-performance will be the same before and after the transfer. A single estimate of fair value results from a complex series of judgments about future events and uncertainties and r elies heavily on estimates and assumptions. When estimating fair value, depending on the nature and complexity of the asset or liability, we may use one or all of the following approaches:   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Cost approach, which is based on the cost to acquire or construct comparable assets less an allowance for functional and/or economic obsolescence. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Income approach, which is based on the present value of a future stream of net cash flows. </td></tr></table> These fair value methodologies depend on the following types of inputs:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Quoted prices for identical assets or liabilities in active markets (called Level 1 inputs). </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Quoted prices for similar assets or liabilities in active markets or quoted prices for identical or similar assets or liabilities in markets that are not active or are directly or indirectly observable (called Level 2 inputs). </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Unobservable inputs that reflect estimates and assumptions (called Level 3 inputs). </td></tr></table> G. Foreign Currency Translation For most of our international operations, local currencies have been determined to be the functional currencies. We translate functional currency assets and liabilities to their U.S. dollar equivalents at rates in effect at the balance sheet date and record these translation adjustments in Shareholders’ equity—Accumulated other comprehensive income/(expense). We translate functional currency statement of income amounts to their U.S. dollar equivalents at average rates for the period. The effects of converting non-functional currency assets and liabilities into the functional currency are recorded in Other (income)/deductions—net. For operations in highly inflationary economies, we translate monetary items at rates in effect at the balance sheet date, with translation adjustments recorded in Other (income)/deductions—net, and non-monetary items at historical rates. H. Revenues Revenue Recognition—We record revenues from product sales when the goods are shipped and title passes to the customer. At the time of sale, we also record estimates for a variety of sales deductions, such as sales rebates, discounts and incentives, and product returns. When we cannot reasonably estimate the amount of future product returns, we record revenues when the risk of product return has been substantially eliminated. We record sales of certain of our vaccines to the U.S. government as part of the Pediatric Vaccine Stockpile program; these rules require that for fixed commitments made by the U.S. government, we record revenues when risk of ownership for the completed product has been passed to the U.S. government. There are no specific performance obligations associated with products sold under this program. Deductions from Revenues—As is typical in the biopharmaceutical industry, our gross product sales are subject to a variety of deductions that generally are estimated and recorded in the same period that the revenues are recognized and primarily represent rebates and discounts to government agencies, wholesalers, distributors and managed care organizations with respect to our pharmaceutical products. These deductions represent estimates of the related obligation and, as such, judgment and knowledge of market conditions and practices are required when estimating the impact of these sales deductions on gross sales for a reporting period. Specifically:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> In the U.S., we record provisions for pharmaceutical Medicaid, Medicare and contract rebates based upon our experience ratio of rebates paid and actual prescriptions written during prior quarters. We apply the experience ratio to the respective period’s sales to determine the rebate accrual and related expense. This experience ratio is evaluated regularly to ensure that the historical trends are as current as practicable. As appropriate, we will adjust the ratio to better match our current experience or our expected future experience. In assessing this ratio, we consider current contract terms, such as changes in formulary status and discount rates. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Outside the U.S., the majority of our pharmaceutical rebates, discounts and price reductions are contractual or legislatively mandated, and our estimates are based on actual invoiced sales within each period; both of these elements help to reduce the risk of variations in the estimation process. Some European countries base their rebates on the government’s unbudgeted pharmaceutical spending, and we use an estimated allocation factor (based on historical payments) and total revenues by country against our actual invoiced sales to project the expected level of reimbursement. We obtain third-party information that helps us to monitor the adequacy of these accruals. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Provisions for pharmaceutical chargebacks (primarily reimbursements to wholesalers for honoring contracted prices to third parties) closely approximate actual as we settle these deductions generally within two to five weeks of incurring the liability.</td></tr></table> <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Provisions for pharmaceutical returns are based on a calculation at each market that incorporates the following, as appropriate: local returns policies and practices; returns as a percentage of sales; an understanding of the reasons for past returns; estimated shelf life by product; an estimate of the amount of time between shipment and return or lag time; and any other factors that could impact the estimate of future returns, such as loss of exclusivity, product recalls or a changing competitive environment. Generally, returned products are destroyed, and customers are refunded the sales price in the form of a credit. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> We record sales incentives as a reduction of revenues at the time the related revenues are recorded or when the incentive is offered, whichever is later. We estimate the cost of our sales incentives based on our historical experience with similar incentives programs. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Our accruals for Medicaid rebates, Medicare rebates, performance-based contract rebates and chargebacks were $2.1 billion as of December 31, 2009, and $1.5 billion as of December 31, 2008, and substantially all are included in Current deferred tax liabilities and other current liabilities. </td></tr></table> Taxes collected from customers relating to product sales and remitted to governmental authorities are presented on a net basis; that is, they are excluded from Revenues. Collaborative Arrangements––Payments to and from our collaboration partners are presented in the statement of income based on the nature of the arrangement (including its contractual terms), the nature of the payments and applicable accounting guidance. Under co-promotion agreements, we record the amounts received from our partners as alliance revenues, a component of Revenues, when our co-promotion partners are the principal in the transaction and we receive a share of their net sales or profits. Alliance revenues are recorded when our co-promotion partners ship the product and title passes to their customers. The related expenses for selling and marketing these products are included in Selling, informational and administrative expenses. In collaborative arrangements where we manufacture a product for our partner, we record revenue s when our partner sells the product and title passes to its customer. All royalty payments to collaboration partners are recorded as part of Cost of sales. I. Cost of Sales and Inventories We value inventories at lower of cost or market. The cost of finished goods, work in process and raw materials is determined using average actual cost. J. Selling, Informational and Administrative Expenses Selling, informational and administrative costs are expensed as incurred. Among other things, these expenses include the costs of marketing, advertising, shipping and handling, information technology and the associated employee compensation. Advertising expenses relating to production costs are expensed as incurred, and the costs of radio time, television time and space in publications are expensed when the related advertising occurs. Advertising expenses totaled approximately $2.9 billion in 2009, $2.6 billion in 2008 and $2.7 billion in 2007. K. Research and Development Expenses and Acquisition-Related In-Process Research and Development Charges Prior to January 1, 2009, when recording acquisitions, we expensed amounts related to acquired IPR&D in Acquisition-related in-process research and development charges. IPR&D acquired after January 1, 2009, as part of a business combination, is capitalized as Identifiable intangible assets. IPR&D acquired as part of an asset acquisition is expensed as incurred. Research and development (R&D) costs are expensed as incurred. These expenses include the costs of our proprietary R&D efforts, as well as costs incurred in connection with certain licensing arrangements. Before a compound receives regulatory approval, we record upfront and milestone payments made by us to third parties under licensing arrangements as expense. Upfront payments are recorded when incurred, and milestone payments are recorded when the specific milestone has been achieved. Once a compound receives regulatory approval, we record any milestone payments in Identifiable intangible assets, less accumulated amortization and, unless the assets are determined to have an indefinite life, we amortize them evenly over the remaining agreement term or the expected product life cycle, whichever is shorter. L. Amortization of Intangible Assets, Depreciation and Certain Long-Lived Assets Long-lived assets include:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Goodwill—Goodwill represents the excess of the consideration transferred for an acquired business over the assigned values of its net assets. Goodwill is not amortized. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Identifiable intangible assets, less accumulated amortization—These acquired assets are recorded at our cost. Intangible assets with finite lives are amortized evenly over their estimated useful lives. Intangible assets with indefinite lives that are associated with marketed products are not amortized until a useful life can be determined. Intangible assets associated with IPR&D projects are not amortized until approval is obtained in a major market, typically either the U.S. or the European Union (EU), or in a series of other countries, subject to certain specified conditions and management judgment. The useful life of an amortizing asset generally is determined by identifying the period in which substantially all of the cash flows are expected to be generated.</td></tr></table>   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Property, plant and equipment, less accumulated depreciation—These assets are recorded at our original cost and are increased by the cost of any significant improvements after purchase. Property, plant and equipment assets, other than land and construction in progress, are depreciated evenly over the estimated useful life of the individual assets. Depreciation begins when the asset is ready for its intended use. For tax purposes, accelerated depreciation methods are used as allowed by tax laws. </td></tr></table> Amortization expense related to finite-lived acquired intangible assets that contribute to our ability to sell, manufacture, research, market and distribute products, compounds and intellectual property are included in Amortization of intangible assets as they benefit multiple business functions. Amortization expense related to intangible assets that are associated with a single function and depreciation of property, plant and equipment are included in Cost of sales, Selling, informational and administrative expenses and Research and development expenses, as appropriate. We review all of our long-lived assets for impairment indicators throughout the year and we perform detailed testing whenever impairment indicators are present. In addition, we perform detailed impairment testing for goodwill and indefinite-lived assets at least annually. When necessary, we record charges for impairments. Specifically:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> For finite-lived intangible assets, such as developed technology rights, and for other long-lived assets, such as property, plant and equipment, whenever impairment indicators are present, we perform a review for impairment. We calculate the undiscounted value of the projected cash flows associated with the asset, or asset group, and compare this estimated amount to the carrying amount. If the carrying amount is found to be greater, we record an impairment loss for the excess of book value over fair value. In addition, in all cases of an impairment review, we re-evaluate the remaining useful lives of the assets and modify them, as appropriate. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> For indefinite-lived intangible assets, such as brands and IPR&D assets, each year and whenever impairment indicators are present, we determine the fair value of the asset and record an impairment loss for the excess of book value over fair value, if any. In addition, in all cases of an impairment review other than for IPR&D assets, we reevaluate whether continuing to characterize the asset as indefinite-lived is appropriate. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> For goodwill, annually and whenever impairment indicators are present, we calculate the fair value of each reporting unit and compare the fair value to its book value. If the carrying amount is found to be greater, we then determine the implied fair value of goodwill by subtracting the fair value of all the identifiable net assets other than goodwill from the fair value of the reporting unit and record an impairment loss for the excess, if any, of book value of goodwill over the implied fair value. </td></tr></table> M. Restructuring Charges and Certain Acquisition-Related Costs We may incur restructuring charges in connection with acquisitions when we implement plans to restructure and integrate the acquired operations or in connection with cost-reduction initiatives that are initiated from time to time. Included in Restructuring charges and certain acquisition-related costs are all restructuring charges and certain costs associated with integrating an acquired business (if the restructuring action results in a change in the estimated useful life of an asset, that incremental impact is classified in Cost of sales, Selling, informational and administrative expenses and Research and development expenses, as appropriate). Termination costs are a significant component of our restructuring charges and are generally recorded when the actions are probable and estimable. Also, beginning in 2009, transaction costs, such as banking, leg al, accounting and other costs incurred in connection with an acquisition are expensed as incurred and included in Restructuring charges and certain acquisition-related costs. N. Cash Equivalents and Statement of Cash Flows Cash equivalents include items almost as liquid as cash, such as certificates of deposit and time deposits with maturity periods of three months or less when purchased. If items meeting this definition are part of a larger investment pool, we classify them as Short-term investments. Cash flows associated with financial instruments designated as fair value or cash flow hedges may be included in operating, investing or financing activities, depending on the classification of the items being hedged. Cash flows associated with financial instruments designated as net investment hedges are classified according to the nature of the hedge instrument. Cash flows associated with financial instruments that do not qualify for hedge accounting treatment are classified according to their purpose and accounting nature. O. Investments, Loans and Derivative Financial Instruments Many, but not all, of our financial instruments are carried at fair value. For example, substantially all of our cash equivalents, short-term investments and long-term investments are classified as available-for-sale securities and are carried at fair value, with changes in unrealized gains and losses, net of tax, reported in Other comprehensive income/(expense). Derivative financial instruments are carried at fair value in various balance sheet categories (see Note 9A. Financial Instruments: Selected Financial Assets and Liabilities), with changes in fair value reported in current earnings or deferred for qualifying hedging relationships. Virtually all of our valuation measurements for investments, loans and derivative financial instruments are based on the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instrument s in markets that are not active or are directly or indirectly observable. Realized gains or losses on sales of investments are determined by using the specific identification cost method. P. Income Tax Contingencies We account for income tax contingencies using a benefit recognition model. If we consider that a tax position is more likely than not to be sustained upon audit, based solely on the technical merits of the position, we recognize the benefit. We measure the benefit by determining the amount that is greater than 50% likely of being realized upon settlement, presuming that the tax position is examined by the appropriate taxing authority that has full knowledge of all relevant information. Under the benefit recognition model, if our initial assessment fails to result in the recognition of a tax benefit, we regularly monitor our position and subsequently recognize the tax benefit: (i) if there are changes in tax law, analogous case law or there is new information that sufficiently raise the likelihood of prevailing on the technical merits of the position to more likely than not; (ii) if the statu te of limitations expires; or (iii) if there is a completion of an audit resulting in a favorable settlement of that tax year with the appropriate agency. We regularly re-evaluate our tax positions based on the results of audits of federal, state and foreign income tax filings, statute of limitations expirations, changes in tax law or receipt of new information that would either increase or decrease the technical merits of a position relative to the “more-likely-than-not” standard. Liabilities associated with uncertain tax positions are classified as current only when we expect to pay cash within the next 12 months. Interest and penalties, if any, are recorded in Provision for taxes on income and are classified on our consolidated balance sheet with the related tax liability. We are subject to income tax in many jurisdictions and a certain degree of estimation is required in recording the assets and liabilities related to income taxes. All of our tax positions are subject to audit by the local taxing authorities in each tax jurisdiction. Tax audits can involve complex issues and the resolution of issues may span multiple years, particularly if subject to negotiation or litigation. Q. Pension and Postretirement Benefit Plans We provide defined benefit pension plans for the majority of employees worldwide. In the U.S., we have both qualified and supplemental (non-qualified) defined benefit plans, as well as other postretirement benefit plans, consisting primarily of healthcare and life insurance for retirees. We recognize the overfunded or underfunded status of each of our defined benefit plans as an asset or liability on our consolidated balance sheet. The obligations generally are measured at the actuarial present value of all benefits attributable to employee service rendered, as provided by the applicable benefit formula. Our pension and other postretirement obligations may include assumptions such as long-term rate of return on plan assets, expected employee turnover and participant mortality. For our pension plans, the obligation may also include assumptions as to future compensation levels. For our other postretirement bene fit plans, the obligation may include assumptions as to the expected cost of providing the healthcare and life insurance benefits, as well as the extent to which those costs are shared with the employee or others (such as governmental programs). Plan assets are measured at fair value. Net periodic benefit costs are recognized, as required, into Cost of sales, Selling, informational and administrative expenses and Research and development expenses, as appropriate. R. Share-Based Payments Our compensation programs can include share-based payments. All grants under share-based payment programs are accounted for at fair value and these fair values generally are amortized on an even basis over the vesting terms into Cost of sales, Selling, informational and administrative expenses, and Research and development expenses, as appropriate.

2. Acquisition of Wyeth A. Description of the Transaction On October 15, 2009 (the acquisition date), we acquired all of the outstanding equity of Wyeth in a cash-and-stock transaction, valued at approximately $68 billion, in which each share of Wyeth common stock outstanding, with certain limited exceptions, was canceled and converted into the right to receive $33.00 in cash without interest and 0.985 of a share of Pfizer common stock. The stock component was valued at $17.40 per share of Wyeth common stock based on the closing market price of Pfizer’s common stock on the acquisition date, resulting in a total merger consideration value of $50.40 per share of Wyeth common stock. While Wyeth now is a wholly owned subsidiary of Pfizer, the merger of local Pfizer and Wyeth entities may be pending or delayed in various jurisdictions and integration in these jurisdictions is subject to completion of various local legal and regulatory obligations. Wyeth’s core business was the discovery, development, manufacture and sale of prescription pharmaceutical products, including vaccines, for humans. Other operations of Wyeth included the discovery, development, manufacture and sale of consumer healthcare products (over-the-counter products), nutritionals and animal health products. Our acquisition of Wyeth has made us a more diversified health care company, with product offerings in human, animal, and consumer health, including vaccines, biologics, small molecules and nutrition, across developed and emerging markets. The acquisition of Wyeth also added to our pipeline of biopharmaceutical development projects endeavoring to develop medicines to help patients in critical areas, including oncology, pain, inflammation, Alzheimer’s disease, psychoses and diabetes. In connection with the regulatory approval process, we are required to divest certain animal health assets. Certain of these assets were sold in 2009, while others, classified as Assets held for sale, are pending disposition. B. Fair Value of Consideration Transferred The table below details the consideration transferred to acquire Wyeth:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="69%"/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="7%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(IN MILLIONS, EXCEPT PER SHARE AMOUNTS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">CONVERSION CALCULATION</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">FAIR VALUE</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center">FORM OF CONSIDERATION</td></tr> <tr> <td valign="top"> Wyeth common stock outstanding as of the acquisition date</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,339.6</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Multiplied by Pfizer’s stock price as of the acquisition date multiplied by the exchange ratio of 0.985 ($17.66(a) x 0.985)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">17.40</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,303</td> <td valign="bottom">  </td> <td valign="bottom" align="center">Pfizer common stock(a),(b)</td></tr> <tr> <td valign="top"> Wyeth common stock outstanding as of the acquisition date</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,339.6</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Multiplied by cash consideration per common share outstanding</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">33.00</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">44,208</td> <td valign="bottom">  </td> <td valign="bottom" align="right">Cash</td></tr> <tr> <td valign="top"> Wyeth stock options canceled for a cash payment(c)</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">405</td> <td valign="bottom">  </td> <td valign="bottom" align="right">Cash</td></tr> <tr> <td valign="top"> Wyeth restricted stock/restricted stock units and other equity-based awards canceled for a cash payment</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">320</td> <td valign="bottom">  </td> <td valign="bottom" align="right">Cash</td></tr> <tr> <td valign="top"> Total fair value of consideration transferred</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">68,236</td> <td valign="bottom">  </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="9"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> The fair value of Pfizer’s common stock used in the conversion calculation represents the closing market price of Pfizer’s common stock on the acquisition date. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Approximately 1.3 billion shares of Pfizer common stock, previously held as Pfizer treasury stock, were issued to former Wyeth shareholders. The excess of the average cost of Pfizer treasury stock issued over the fair value of the stock portion of the consideration transferred to acquire Wyeth was recorded as a reduction to Retained earnings. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> Each Wyeth stock option, whether or not vested and exercisable on the acquisition date, was canceled for a cash payment equal to the excess of the per share value of the merger consideration (calculated on the basis of the volume-weighted average of the per share price of Pfizer common stock on the New York Stock Exchange Transaction Reporting System for the five consecutive trading days ending two days prior to the acquisition date) over the per share exercise price of the Wyeth stock option. </td></tr></table> Certain amounts may reflect rounding adjustments. C. Recording of Assets Acquired and Liabilities Assumed The transaction has been accounted for using the acquisition method of accounting which requires, among other things, that most assets acquired and liabilities assumed be recognized at their fair values as of the acquisition date and that the fair value of acquired IPR&D be recorded on the balance sheet. The following table summarizes the provisional amounts recognized for assets acquired and liabilities assumed as of the acquisition date. Certain estimated values are not yet finalized (see below) and are subject to change, which could be significant. We will finalize the amounts recognized as we obtain the information necessary to complete the analyses. We expect to finalize these amounts as soon as possible but no later than one year from the acquisition date. The following table summarizes the provisional recording of assets acquired and liabilities assumed as of the acquisition date:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="83%"/> <td valign="bottom" width="12%"/> <td/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2"> AMOUNTS RECOGNIZED AS OF ACQUISITION DATE</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Working capital, excluding inventories(a)</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,342</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Inventories</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,388</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Property, plant and equipment</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,054</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Identifiable intangible assets, excluding in-process research and development</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">37,595</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> In-process research and development</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,918</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Other noncurrent assets</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,394</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Long-term debt</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(11,187</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Benefit obligations</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,211</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Net tax accounts(b)</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(24,773</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other noncurrent liabilities</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(1,908</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Total identifiable net assets</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">48,612</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Goodwill</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">19,954</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Net assets acquired</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">68,566</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Less: Amounts attributable to noncontrolling interests</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(330</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="top"> Total consideration transferred</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right">68,236</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="4"> </td> <td> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Includes cash and cash equivalents, short-term investments, accounts receivable, other current assets, assets held for sale, accounts payable and other current liabilities. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> As of the acquisition date, included in Current deferred tax assets and other current assets ($1.2 billion), Noncurrent deferred tax assets and other noncurrent assets ($2.7 billion), Income taxes payable ($0.6 billion), Current deferred tax liabilities and other current liabilities ($11.1 billion), Noncurrent deferred tax liabilities ($14.9 billion) and Other taxes payable ($2.1 billion, including accrued interest of $300 million). </td></tr></table> As of the acquisition date, the fair value of accounts receivable approximated book value acquired. The gross contractual amount receivable was $4.2 billion, of which $140 million was not expected to be collected. In the ordinary course of business, Wyeth incurs liabilities for environmental, legal and tax matters, as well as guarantees and indemnifications. These matters can include contingencies. Except as specifically excluded by the relevant accounting standard, contingencies are required to be measured at fair value as of the acquisition date, if the acquisition-date fair value of the asset or liability arising from a contingency can be determined. If the acquisition-date fair value of the asset or liability cannot be determined, the asset or liability would be recognized at the acquisition date if both of the following criteria were met: (i) it is probable that an asset existed or that a liability had been incurred at the acquisition date, and (ii) the amount of the asset or liability can be reasonably estimated.   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Environmental Matters—In the ordinary course of business, Wyeth incurs liabilities for environmental matters such as remediation work, asset retirement obligations and environmental guarantees and indemnifications. Virtually all liabilities for environmental matters, including contingencies, have been measured at fair value and approximate $550 million as of the acquisition date. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Legal Matters—Wyeth is involved in various legal proceedings, including product liability, patent, commercial, environmental, antitrust matters and government investigations, of a nature considered normal to its business (see Note 19. Legal Proceedings and Contingencies). Due to the uncertainty of the variables and assumptions involved in assessing the possible outcomes of events related to these items, an estimate of fair value is not determinable. As such, these contingencies have been measured under the same “probable and estimable” standard previously used by Wyeth. Liabilities for legal contingencies approximate $650 million as of the acquisition date, which includes the recording of additional adjustments of approximately $150 million for legal matters that we intend to resolve in a manner different from what Wyeth had planned or intended. See below for items pending finalization. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Tax Matters—In the ordinary course of business, Wyeth incurs liabilities for income taxes. Income taxes are exceptions to both the recognition and fair value measurement principles associated with the accounting for business combinations. Reserves for income tax contingencies continue to be measured under the benefit recognition model as previously used by Wyeth (see Note 1P. Significant Accounting Policies: Income Tax Contingencies). Net liabilities for income taxes approximate $24.8 billion as of the acquisition date, which includes $1.8 billion for uncertain tax positions. The net tax liability includes the recording of additional adjustments of approximately $15.0 billion for the tax impact of fair value adjustments and $10.6 billion for income tax matters that we intend to resolve in a manner different from what Wyeth had planned or intended. For example, because we plan to repa triate certain overseas funds, we provided deferred taxes on Wyeth’s unremitted earnings, as well as on certain book/tax basis differentials related to investments in certain foreign subsidiaries for which no taxes have been previously provided by Wyeth as it was Wyeth’s intention to permanently reinvest those earnings and investments. See below for items pending finalization. </td></tr></table> Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Specifically, the goodwill recorded as part of the acquisition of Wyeth includes the following:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> the expected synergies and other benefits that we believe will result from combining the operations of Wyeth with the operations of Pfizer, </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> any intangible assets that do not qualify for separate recognition, as well as future, as yet unidentified projects and products, and </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> the value of the going-concern element of Wyeth’s existing businesses (the higher rate of return on the assembled collection of net assets versus if Pfizer had acquired all of the net assets separately). </td></tr></table> Goodwill is not amortized and is not deductible for tax purposes. While the allocation of goodwill among reporting units is not complete, we expect the majority of the goodwill will be related to our Biopharmaceutical segment (see Note 12. Goodwill and Other Intangible Assets for additional information). The recorded amounts are provisional and subject to change. The following items still are subject to change:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Amounts for intangibles, inventory and PP&E, pending finalization of valuation efforts for acquired intangible assets as well as the completion of certain physical inventory counts and the confirmation of the physical existence and condition of certain property, plant and equipment assets. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Amounts for legal contingencies, pending the finalization of our examination and valuation of the portfolio of filed cases. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Amounts for income tax assets, receivables and liabilities pending the filing of Wyeth pre-acquisition tax returns and the receipt of information from taxing authorities which may change certain estimates and assumptions used. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> The allocation of goodwill among reporting units. </td></tr></table> A single estimate of fair value results from a complex series of judgments about future events and uncertainties and relies heavily on estimates and assumptions. Our judgments used to determine the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact our results of operations. D. Actual and Pro Forma Impact of Acquisition The following table presents information for Wyeth that is included in Pfizer’s consolidated statements of income from the acquisition date, October 15, 2009, through Pfizer’s domestic and international year-ends in 2009:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="77%"/> <td valign="bottom" width="19%"/> <td/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">WYETH’S OPERATIONS INCLUDED IN PFIZER’S 2009 RESULTS </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Revenues</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3,303</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Loss from continuing operations attributable to Pfizer Inc. common shareholders(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,191</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="4"> </td> <td> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Includes purchase accounting charges related to the fair value adjustments for acquisition-date inventory that has been sold ($904 million pre-tax), amortization of identifiable intangible assets acquired from Wyeth ($512 million pre-tax), and restructuring charges and additional depreciation—asset restructuring ($2.1 billion pre-tax). </td></tr></table> The following table presents supplemental pro forma information as if the acquisition of Wyeth had occurred on January 1, 2009 for the year ended December 31, 2009 and January 1, 2008 for the year ended December 31, 2008:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="81%"/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="5">UNAUDITED PRO FORMA CONSOLIDATED RESULTS</td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="5">YEAR ENDED DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS, EXCEPT PER SHARE DATA)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td></tr> <tr> <td valign="top"> Revenues</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">68,599</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">71,130</td></tr> <tr> <td valign="top"> Income from continuing operations attributable to Pfizer Inc. common shareholders</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">11,537</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,917</td></tr> <tr> <td valign="top"> Diluted earnings per common share attributable to Pfizer Inc. common shareholders</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1.43</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.11</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="7"> </td></tr></table> The unaudited pro forma consolidated results were prepared using the acquisition method of accounting and are based on the historical financial information of Pfizer and Wyeth, reflecting both in 2009 and 2008 Pfizer and Wyeth results of operations for a 12-month period. The historical financial information has been adjusted to give effect to the pro forma events that are: (i) directly attributable to the acquisition, (ii) factually supportable and (iii) expected to have a continuing impact on the combined results. The unaudited pro forma consolidated results are not necessarily indicative of what our consolidated results of operations actually would have been had we completed the acquisition on January 1, 2009 and on January 1, 2008. In addition, the unaudited pro forma consolidated results do not purport to project the future results of operations of the combined company nor do they reflect the expected realization of any cost savings associated with the acquisition. The unaudited pro forma consolidated results reflect primarily the following pro forma pre-tax adjustments:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Elimination of Wyeth’s historical intangible asset amortization expense (approximately $88 million in the pre-acquisition period in 2009 and $79 million in 2008). </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Additional amortization expense (approximately $2.4 billion in 2009 and $2.9 billion in 2008) related to the fair value of identifiable intangible assets acquired. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Additional depreciation expense (approximately $200 million in 2009 and $266 million in 2008) related to the fair value adjustment to property, plant and equipment acquired. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Additional interest expense (approximately $316 million in 2009 and $1.2 billion in 2008) associated with the incremental debt we issued in 2009 to partially finance the acquisition and a reduction of interest income (approximately $320 million in 2009 and $857 million in 2008) associated with short-term investments under the assumption that a portion of these investments would have been used to partially fund the acquisition. In addition, a reduction in interest expense (approximately $129 million in 2009 and $163 million in 2008) related to the fair value adjustment of Wyeth debt. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Elimination of $904 million incurred in 2009 related to the fair value adjustments to acquisition-date inventory that has been sold, which is considered non-recurring. There is no long-term continuing impact of the fair value adjustments to acquisition-date inventory, and, as such, the impact of those adjustments is not reflected in the unaudited pro forma operating results for 2009 and 2008. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Elimination of $834 million of costs incurred in 2009, which are directly attributable to the acquisition, and which do not have a continuing impact on the combined company’s operating results. Included in these costs are advisory, legal and regulatory costs incurred by both legacy Pfizer and legacy Wyeth and costs related to a bridge term loan credit agreement with certain financial institutions that has been terminated. </td></tr></table> In addition, all of the above adjustments were adjusted for the applicable tax impact. The taxes associated with the fair value adjustments for acquired intangible assets, property, plant and equipment and legacy Wyeth debt, as well as the elimination of the impact of the fair value step-up of acquired inventory reflect the statutory tax rates in the various jurisdictions where the fair value adjustments occurred. The taxes associated with incremental debt to partially finance the acquisition reflect a 38.3% tax rate since the debt is an obligation of a U.S. entity and is taxed at the combined effective U.S. federal statutory and state rate. The taxes associated with the elimination of the costs directly attributable to the acquisition reflect a 28.4% effective tax rate since the costs were incurred in the U.S. and were either taxed at the combined effective U.S. federal statutory and state rate or n ot deductible for tax purposes depending on the type of expenditure.

3. Other Significant Transactions and Events A. Formation of ViiV, an Equity-Method Investment In the fourth quarter of 2009, we completed a previously announced transaction, where we and GlaxoSmithKline plc (GSK) created a new company, ViiV Healthcare Limited (ViiV), which is focused solely on research, development and commercialization of human immunodeficiency virus (HIV) medicines. We recognized a gain of approximately $482 million in connection with the formation, which is recorded in Other (income)/deductions—net. Under the agreement, we and GSK have contributed certain existing HIV- related products, pipeline assets and research assets to ViiV and will perform R&D and manufacturing services. We initially hold a 15% equity interest and GSK holds an 85% equity interest in ViiV. The equity interests will be adjusted in the event that specified sales and regulatory milestones are achieved. Our equity interest in ViiV could vary from 9% to 30.5%, and GSK&#8217 ;s equity interest could vary from 69.5% to 91%, depending upon the milestones achieved with respect to the original assets contributed by us and by GSK to ViiV. Each company also may be entitled to preferential dividend payments to the extent that specific sales thresholds are met in respect of the marketed products and pipeline assets originally contributed. We are accounting for our interest in ViiV as an equity method investment due to the significant influence we have over the operations of ViiV through our board representation and minority veto rights. Our investment in ViiV is reported as a private equity investment in Long-term investments and loans. B. Prior-Period Acquisitions During the years ended December 31, 2008 and 2007, we completed the following acquisitions in support of our commitment to capitalizing on new growth opportunities:   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> In the fourth quarter of 2008, we completed the acquisition of a number of animal health product lines from Schering-Plough Corporation (Schering-Plough) for approximately $170 million. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> In the second quarter of 2008, we acquired Encysive Pharmaceuticals Inc. (Encysive), a biopharmaceutical company, through a tender offer, for approximately $200 million, including transaction costs. In addition, in the second quarter of 2008, we acquired Serenex, Inc. (Serenex), a privately held biotechnology company. In connection with these acquisitions, we recorded approximately $170 million in Acquisition-related in-process research and development charges and approximately $450 million in intangible assets. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> In the first quarter of 2008, we acquired CovX, a privately held biotherapeutics company, and we acquired all the outstanding shares of Coley Pharmaceutical Group, Inc. (Coley), a biopharmaceutical company. In connection with these and two smaller acquisitions related to Animal Health, we recorded approximately $440 million in Acquisition-related in-process research and development charges in 2008. In 2009, we resolved certain contingencies associated with CovX and recorded $68 million in Acquisition-related in-process research and development charges. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> In the first quarter of 2007, we acquired BioRexis Pharmaceutical Corp., a privately held biopharmaceutical company, and Embrex, Inc., an animal health company. In connection with these and other smaller acquisitions, we recorded $283 million in Acquisition-related in-process research and development charges. </td></tr></table> C. Bextra and Certain Other Investigations In January 2009, we entered into an agreement-in-principle with the U.S. Department of Justice (DOJ) to resolve previously reported investigations regarding past off-label promotional practices concerning Bextra, as well as certain other investigations. In connection with these actions, in the fourth quarter of 2008, we recorded a charge of $2.3 billion, pre-tax and after-tax, in Other (income)/deductions—net and such amount is included in Current deferred tax liabilities and other current liabilities in 2008. (see Note 19D. Legal Proceedings and Contingencies: Government Investigations). In the third quarter of 2009, we reached final resolution of this matter and no additional charge was recorded. The entire $2.3 billion was paid in 2009. We did record a tax benefit of $174 million in the third quarter of 2009 as such resolution resulted in t he receipt of information that raised our assessment of the likelihood of prevailing on the technical merits of our tax position. In addition, in September 2009, we settled state civil consumer protection allegations related to our past promotional practices concerning Geodon and recorded a charge of $33 million. D. Certain Product Litigation––Celebrex and Bextra In October 2008, we reached agreements-in-principle to resolve the pending U.S. consumer fraud purported class action cases and more than 90% of the known U.S. personal injury claims involving Celebrex and Bextra, and we reached agreements to resolve substantially all of the claims of state attorneys general primarily relating to alleged Bextra promotional practices. In connection with these actions, in the third quarter of 2008, we recorded pre-tax charges of approximately:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> $745 million applicable to all known U.S. personal injury claims; </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> $89 million applicable to the pending U.S. consumer fraud purported class action cases; and </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> $60 million applicable to agreements to resolve civil claims brought by 33 states and the District of Columbia, primarily relating to alleged Bextra promotional practices. Under these agreements, we made a payment of $60 million to the states and have adopted compliance measures that complement policies and procedures previously established by us. </td></tr></table> These litigation-related charges were recorded in 2008 in Other (income)/deductions—net. Virtually all of this amount was paid in 2009. During 2009, we recorded approximately $170 million in insurance recoveries in Selling, informational and administrative expenses. We believe that the charges of approximately $745 million will be sufficient to resolve all known U.S. personal injury claims, including those not yet settled. However, additional charges may have to be taken in the future in connection with certain pending claims and unknown claims relating to Celebrex and Bextra (see Note 19B. Legal Proceedings and Contingencies: Product Litigation). E. Adjustment of Prior Years’ Liabilities for Product Returns Revenues in 2008 include a reduction of $217 million, pre-tax, to adjust our prior years’ liabilities for product returns. After a detailed review in 2008 of our returns experience, we determined that our previous accounting methodology for product returns needed to be revised as the lag time between product sale and return was longer than we previously had assumed. Although fully recorded in 2008, virtually all of the adjustment relates back several years. F. Exubera In the third quarter of 2007, after an assessment of the financial performance of Exubera, an inhalable form of insulin for the treatment of diabetes, as well as its lack of acceptance by patients, physicians and payers, we decided to exit the product. In connection with these actions, we recorded total pre-tax charges of $2.8 billion, virtually all of which were recorded in the third quarter of 2007. These charges were included primarily in Cost of sales ($2.6 billion), Selling, informational and administrative expenses ($85 million), and Research and development expenses ($100 million). The charges included asset write-offs of $2.2 billion (intangibles, inventory and fixed assets) and other exit costs, primarily severance, contract and other termination costs. The exit costs resulted in cash expenditures in 2009, 2008 and 2007. As of December&#160 ;31, 2009, the remaining accrual for other exit costs is approximately $55 million and is primarily recorded in Current deferred tax liabilities and other current liabilities.

5. Collaborative Arrangements In the normal course of business, we enter into collaborative arrangements with respect to in-line medicines, as well as medicines in development, that require completion of research and regulatory approval. Collaborative arrangements are contractual agreements with third parties that involve a joint operating activity, typically a research and/or commercialization effort, where both we and our partner are active participants in the activity and are exposed to the significant risks and rewards of the activity. Our rights and obligations under our collaborative arrangements vary. For example, we have agreements to co-promote pharmaceutical products discovered by us or other companies, and we have agreements where we partner to co-develop and/or participate together in commercializing, marketing, promoting, manufacturing and/or distributing a drug product. The amounts and classifications in our consolidated statements of income of payments (income/(expense)) between us and our collaboration partners follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="82%"/> <td valign="bottom" width="4%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom"> Revenues—Revenues(a)</td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" bgcolor="#cccccc">$</td> <td valign="bottom" align="right" bgcolor="#cccccc">593</td> <td valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">473</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Revenues—Alliance revenues(b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2,925</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,251</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,789</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Total revenues from collaborative arrangements</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">3,518</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,739</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,262</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="bottom"> Cost of sales(c)</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(166</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(147</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(166</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="bottom"> Selling, informational and administrative expenses(d) </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">10</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">75</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">94</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="bottom"> Research and development expenses(e)</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(361</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(476</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(444</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="12"> </td> <td> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Represents sales to our partners of products manufactured by us. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Substantially all relate to amounts earned from our partners under co-promotion agreements. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> Primarily relates to royalties earned by our partners and cost of sales associated with inventory purchased from our partners. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d)</td> <td valign="top" align="left"> Represents net reimbursements from our partners for selling, informational and administrative expenses incurred. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(e)</td> <td valign="top" align="left"> Primarily related to net reimbursements, as well as upfront payments and milestone payments earned by our partners. The upfront and milestone payments were as follows: $150 million in 2009, $300 million in 2008 and $330 million in 2007. </td></tr></table> The amounts disclosed in the above table do not include transactions with third parties other than our collaboration partners, or other costs associated with the products under the collaborative arrangements. In 2009, Other (income)/deductions––net includes income of $20 million paid to us for the termination of a collaboration agreement and income of $17 million paid to us as our share of profit from a collaboration partner. In 2007, we capitalized $68 million of milestone payments associated with approved products.

6. Other (Income)/Deductions—Net The components of Other (income)/deductions—net follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="73%"/> <td valign="bottom" width="4%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td/> <td valign="bottom" width="3%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Interest income</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(746</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,288</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,496</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Interest expense</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">1,233</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">516</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">397</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Net interest (income)/expense(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">487</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(772</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,099</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Royalty-related income(b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(243</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(673</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(224</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Net gain on asset disposals(c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(188</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(14</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(326</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Legal matters, net(d)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">234</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,300</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Gain related to ViiV(e)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(482</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Asset impairment and other associated charges(f)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">417</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">143</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">28</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other, net</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">67</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">48</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(184</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Other (income)/deductions—net</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">292</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,032</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,759</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="15"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Net interest expense was $487 million in 2009 compared to net interest income of $772 million in 2008. Interest expense increased in 2009 due to our issuance of $13.5 billion of senior unsecured notes on March 24, 2009 and approximately $10.5 billion of senior unsecured notes on June 3, 2009, of which virtually all of the proceeds were used to partially finance the Wyeth acquisition (see Note 2. Acquisition of Wyeth). Interest income decreased in 2009 due to lower interest rates, partially offset by higher average cash balances. The decrease in net interest income in 2008 compared to 2007 was due primarily to lower net financial assets and lower interest rates during 2008 compared to 2007. Capitalized interest expense totaled $34 million in 2009, $46 million in 2008 and $43 million in 2007. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> In 2008, includes $425 million related to the sale of certain royalty rights. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> In 2009, primarily represents gains on sales of certain equity investments. In 2007, included a gain of $211 million related to the sale of a building in Korea. Net gains also include realized gains and losses on sales of available-for-sale securities: In 2009, 2008 and 2007, gross realized gains were $186 million, $20 million and $8 million, respectively. In 2009, gross realized losses were $43 million and none in both 2008 and 2007. Proceeds from the sale of available-for-sale securities were $27.0 billion in 2009, $2.2 billion in 2008 and $663 million in 2007. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d)</td> <td valign="top" align="left"> In 2008, primarily includes charges of $2.3 billion related to the resolution of certain investigations concerning Bextra and various other products, and charges of $900 million related to our agreements and our agreements-in-principle to resolve certain litigation and claims involving our non-steroidal anti-inflammatory (NSAID) pain medicines (see Note 3C. Other Significant Transactions and Events: Bextra and Certain Other Investigations, and Note 3D. Other Significant Transactions and Events: Certain Product Litigation—Celebrex and Bextra). </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(e)</td> <td valign="top" align="left"> Represents a gain related to ViiV, a new equity method investment, which is focused solely on research, development and commercialization of HIV medicines (see Note 3A. Other Significant Transactions and Events: Formation of ViiV, an Equity-Method Investment). </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(f)</td> <td valign="top" align="left"> 2009 amounts primarily represent asset impairment charges associated with certain materials used in our research and development activities that are no longer considered recoverable. 2008 amounts primarily represent charges related to impairment of certain equity investments and the exit of our Exubera product (see Note 12. Goodwill and Other Intangible Assets). </td></tr></table>

8. Other Comprehensive Income/(Expense) Changes, net of tax, in accumulated other comprehensive income/(expense) and the components of comprehensive income follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="35%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10"> NET UNREALIZED GAINS /(LOSSES)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">BENEFIT PLANS</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" rowspan="2" valign="bottom" align="right" colspan="2"> ACCUMULATED OTHER COMPREHENSIVE INCOME/(EXPENSE)</td> <td style="BORDER-TOP: #000000 1px solid" rowspan="2" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2"> CURRENCY TRANSLATION ADJUSTMENT AND OTHER</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">DERIVATIVE FINANCIAL INSTRUMENTS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">AVAILABLE FOR-SALE SECURITIES</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2"> ACTUARIAL GAINS/ (LOSSES)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">PRIOR SERVICE (COSTS)/ CREDITS AND OTHER</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Balance, January 1, 2007</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,227</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(26</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">96</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,739</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(27</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(469</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Other comprehensive income/(expense)—Pfizer Inc(a):</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Foreign currency translation adjustments</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,422</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,422</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Unrealized holding gains/(losses)</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(43</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(40</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Reclassification adjustments to income(b)</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(96</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(8</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(101</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Actuarial gains and other benefit plan items</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,374</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,385</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Amortization of actuarial losses and other benefit plan items</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">248</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">255</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Curtailments and settlements—net</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">268</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(5</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">263</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Other</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(62</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(6</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(62</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">313</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(12</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(656</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(8</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(354</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,768</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Balance, December 31, 2007</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,872</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(32</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">54</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,567</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(28</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,299</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Other comprehensive income/(expense)––Pfizer Inc.(a): </td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Foreign currency translation adjustments</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(5,898</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(5,898</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Unrealized holding gains/(losses)</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">69</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(193</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(124</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Reclassification adjustments to income(b) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(20</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(22</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Actuarial gains/(losses) and other benefit plan items</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,098</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">22</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,076</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Amortization of actuarial losses and other benefit plan items</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">130</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">133</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Curtailments and settlements—net</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">280</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">283</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Other</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">129</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">35</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">174</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">629</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(9</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">73</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">994</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(25</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,662</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(6,868</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Balance, December 31, 2008</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,389</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">28</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(86</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,132</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,569</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Other comprehensive income/(expense)—Pfizer Inc.(a):</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Foreign currency translation adjustments</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,978</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,978</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Unrealized holding gains/(losses)</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">291</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">576</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">867</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Reclassification adjustments to income(b) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(299</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(143</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(437</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Actuarial gains/(losses) and other benefit plan items</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(701</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">154</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(547</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Amortization of actuarial losses and other benefit plan items</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">291</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(6</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">285</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Curtailments and settlements—net</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">390</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(5</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">385</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Other</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(158</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(11</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(167</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Income taxes</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(46</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(14</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(78</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(57</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(48</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(243</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td> </td></tr> <tr> <td valign="top"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,121</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="top" nowrap="nowrap" bgcolor="#bfbfbf"> Balance, December 31, 2009</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">3,550</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">6</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">269</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(3,367</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">94</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">552</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> Amounts do not include foreign currency translation adjustments attributable to noncontrolling interests of $5 million in 2009, $35 million in 2008 and $6 million in 2007. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b) </td> <td valign="top" align="left"> The currency translation adjustments reclassified to income resulted from the sale of businesses. </td></tr></table> Income taxes are not provided for foreign currency translation relating to permanent investments in international subsidiaries. As of December 31, 2009, we estimate that we will reclassify into 2010 income the following pre-tax amounts currently held in Accumulated other comprehensive income/(expense): virtually none of the unrealized holding gains on derivative financial instruments; $253 million of actuarial losses related to benefit plan obligations and plan assets and other benefit plan items; and $(22) million of prior service credits related primarily to benefit plan amendments.

9. Financial Instruments A. Selected Financial Assets and Liabilities Information about certain of our financial assets and liabilities follows:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="81%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="6">AS OF DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td></tr> <tr> <td valign="top"> Selected financial assets measured at fair value on a recurring basis(a):</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Trading securities(b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">184</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">     </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">190</td></tr> <tr> <td valign="top"> Available-for-sale debt securities(c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">32,338</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">30,061</td></tr> <tr> <td valign="top"> Available-for-sale money market funds(d)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,569</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">398</td></tr> <tr> <td valign="top"> Available-for-sale equity securities, excluding money market funds(c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">281</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">319</td></tr> <tr> <td valign="top"> Derivative financial instruments in receivable positions(e):</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Foreign currency swaps</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">798</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">128</td></tr> <tr> <td valign="top"> Foreign currency forward-exchange contracts</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">502</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">399</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Interest rate swaps</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">276</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">732</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">36,948</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">32,227</td></tr> <tr> <td valign="top"> Other selected financial assets(f):</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Short-term loans, carried at cost</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,195</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">824</td></tr> <tr> <td valign="top"> Held-to-maturity debt securities, carried at amortized cost(c) </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">812</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,349</td></tr> <tr> <td valign="top"> Private equity securities, carried at cost</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">811</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">182</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Long-term loans, carried at cost</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">784</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,568</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">3,602</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">4,923</td></tr> <tr> <td valign="top"> Total selected financial assets</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">40,550</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">37,150</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="8"> </td></tr> <tr> <td valign="top"> Financial liabilities measured at fair value on a recurring basis(a):</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Derivative financial instruments in a liability position(g):</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Foreign currency swaps</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">528</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">153</td></tr> <tr> <td valign="top"> Foreign currency forward-exchange contracts</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">237</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,083</td></tr> <tr> <td valign="top"> Interest rate swaps</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">25</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="top"> Total</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">790</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,243</td></tr> <tr> <td valign="top"> Other financial liabilities(f),(h):</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Short-term borrowings, carried at historical proceeds, as adjusted(i)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5,469</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,320</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Long-term debt, carried at historical proceeds, as adjusted(j), (k)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">43,193</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">7,963</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">48,662</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">17,283</td></tr> <tr> <td valign="top"> Total selected financial liabilities</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">49,452</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">18,526</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="8"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> Fair values are determined based on valuation techniques categorized as follows: Level 1 means the use of quoted prices for identical instruments in active markets; Level 2 means the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable; Level 3 means the use of unobservable inputs. Virtually all of our financial assets and liabilities measured at fair value on a recurring basis use Level 2 inputs in the calculation of fair value, except that included in available-for-sale equity securities, excluding money market funds, are $77 million as of December 31, 2009 and $87 million as of December 31, 2008 of investments that use Level 1 inputs in the calculation of fair value. None of our financial assets and liabilities measured at fair value on a recurring basis is valued using Level 3 inputs at December 31, 2009 or 2008. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b) </td> <td valign="top" align="left"> Trading securities are held in trust for legacy Pharmacia severance benefits. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c) </td> <td valign="top" align="left"> Gross unrealized gains and losses are not significant. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d) </td> <td valign="top" align="left"> Includes approximately $1.2 billion of money market funds held in escrow to secure certain of Wyeth’s payment obligations under its 1999 Nationwide Class Action Settlement Agreement, which relates to litigation alleging that Wyeth’s former weight-loss products, Redux and Pondimin, caused valvular heart disease and other conditions. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(e) </td> <td valign="top" align="left"> Designated as hedging instruments, except for certain foreign currency contracts used as offsets; namely, foreign currency swaps with fair values of $106 million and foreign currency forward-exchange contracts with fair values of $100 million at December 31, 2009; and foreign currency swaps with fair values of $32 million and foreign currency forward-exchange contracts with fair values of $175 million at December 31, 2008. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(f) </td> <td valign="top" align="left"> The differences between the estimated fair values and carrying values of our financial assets and liabilities not measured at fair value on a recurring basis were not significant as of December 31, 2009 or December 31, 2008. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(g) </td> <td valign="top" align="left"> Designated as hedging instruments, except for certain foreign currency contracts used as offsets, namely, foreign currency forward-exchange contracts with fair values of $122 million and foreign currency swaps with fair values of $3 million at December 31, 2009; and foreign currency forward-exchange contracts with fair values of $836 million and foreign currency swaps with fair values of $76 million at December 31, 2008. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(h) </td> <td valign="top" align="left"> The carrying amounts may include adjustments for discount or premium amortization or for the effect of interest rate swaps designated as hedges. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(i) </td> <td valign="top" align="left"> Includes foreign currency borrowings with fair values of $1.1 billion at December 31, 2009 and $1.6 billion at December 31, 2008, which are used as hedging instruments.</td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(j) </td> <td valign="top" align="left"> Includes foreign currency debt with fair values of $2.1 billion at December 31, 2009 and December 31, 2008, which is used as a hedging instrument. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(k) </td> <td valign="top" align="left"> The fair value of our long-term debt is $46.2 billion at December 31, 2009 and $8.2 billion at December 31, 2008. </td></tr></table> The following methods and assumptions were used to estimate the fair value of our financial assets and liabilities:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Trading equity securities—quoted market prices. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Trading debt securities—observable market interest rates. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Available-for-sale debt securities—matrix-pricing model using observable market quotes and credit ratings. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Available-for-sale money market funds—observable prices. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Available-for-sale equity securities, excluding money market funds––pricing services that principally use a composite of observable prices. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Derivative financial instruments (assets and liabilities)––matrix-pricing model using observable market quotes and credit ratings. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Held-to-maturity debt securities—matrix-pricing model using observable market quotes and credit ratings. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Short-term and long-term loans—discounted future cash flows using current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Private equity securities—application of the implied volatility associated with an observable biotech index to the carrying amount of our portfolio and, to a lesser extent, performance multiples of comparable securities adjusted for company-specific information. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Short-term borrowings and long-term debt—matrix-pricing model using observable market quotes and our own credit rating. </td></tr></table> In addition, we have long-term receivables where the determination of fair value uses discounted future cash flows, using current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. These selected financial assets and liabilities are in the following captions in the consolidated balance sheets as follows:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="81%"/> <td valign="bottom" width="3%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="8">AS OF DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#ffffff">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#ffffff">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#ffffff"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#ffffff">  </td></tr> <tr> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Assets</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Cash and cash equivalents</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">666</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">     </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,980</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Short-term investments</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">23,991</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21,609</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Short-term loans</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,195</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">824</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Long-term investments and loans</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">13,122</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,478</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Current deferred tax assets and other current assets(a) </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">526</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">404</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Noncurrent deferred tax assets and other noncurrent assets(b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">1,050</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">855</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">40,550</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">37,150</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom">Liabilities</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Short-term borrowings</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5,469</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,320</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Current deferred tax liabilities and other current liabilities(c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">369</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,119</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Long-term debt</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">43,193</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,963</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other noncurrent liabilities(d)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">421</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">124</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">49,452</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">18,526</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="10"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> At December 31, 2009, derivative instruments at fair value include foreign currency forward-exchange contracts ($503 million) and foreign currency swaps ($23 million) and at December 31, 2008, includes foreign currency forward-exchange contracts ($398 million), interest rate swaps ($4 million) and foreign currency swaps ($2 million). </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b) </td> <td valign="top" align="left"> At December 31, 2009, derivative instruments at fair value include foreign currency swaps ($774 million) and interest rate swaps ($276 million) and at December 31, 2008, includes interest rate swaps ($729 million) and foreign currency swaps ($126 million). </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c) </td> <td valign="top" align="left"> At December 31, 2009, derivative instruments at fair value include foreign currency forward-exchange contracts ($237 million) and foreign currency swaps ($132 million) and at December 31, 2008, includes foreign currency forward-exchange contracts ($1.1 billion) and foreign currency swaps ($36 million). </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d) </td> <td valign="top" align="left"> At December 31, 2009, derivative instruments at fair value include foreign currency swaps ($396 million) and interest rate swaps ($25 million) and at December 31, 2008, includes foreign currency swaps ($117 million) and interest rate swaps ($7 million). </td></tr></table> We regularly evaluate all of our financial assets for impairment. For investments in debt and equity securities, when a decline in fair value, if any, is determined to be other-than-temporary, an impairment charge is recorded, and a new cost basis in the investment is established. For loans, an impairment charge is recorded if it is probable that we will not be able to collect all amounts due according to the loan agreement. There were no significant impairments recognized in 2009, 2008 or 2007. B. Investments in Debt and Equity Securities The contractual maturities of the available-for-sale and held-to-maturity debt securities as of December 31, 2009, follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="77%"/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="8">YEARS</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">WITHIN 1</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">OVER 1 TO 5</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">TOTAL</td></tr> <tr> <td valign="top"> Available-for-sale debt securities:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Western European and other government debt</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,612</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,494</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">19,106</td></tr> <tr> <td valign="top"> Western European and other government agency debt</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,578</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">595</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,173</td></tr> <tr> <td valign="top"> Federal Home Loan Mortgage Corporation and Federal National Mortgage Association</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">102</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,815</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,917</td></tr> <tr> <td valign="top"> Corporate debt</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,001</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,877</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,878</td></tr> <tr> <td valign="top"> U.S. government Federal Deposit Insurance Corporation guaranteed debt</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,753</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,753</td></tr> <tr> <td valign="top"> Supranational debt</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">968</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">335</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,303</td></tr> <tr> <td valign="top"> Reverse repurchase agreements(a)</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,018</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,018</td></tr> <tr> <td valign="top"> Other asset-backed securities</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">37</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">97</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">134</td></tr> <tr> <td valign="top"> Certificates of deposit</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">56</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">56</td></tr> <tr> <td valign="top"> Held-to-maturity debt securities:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Certificates of deposit and other</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">806</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">6</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">812</td></tr> <tr> <td valign="top"> Total debt securities</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,178</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,972</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">33,150</td></tr> <tr> <td valign="top"> Trading securities</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">184</td></tr> <tr> <td valign="top"> Available-for-sale money market funds(b)</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,569</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Available-for-sale equity securities, excluding money market funds</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">281</td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">36,184</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="10"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Involving U.S. government securities. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Consisting of securities issued by the U.S. government and its agencies or instrumentalities and reverse repurchase agreements involving the same investments held. </td></tr></table> C. Short-Term Borrowings Short-term borrowings include amounts for commercial paper of $3.9 billion as of December 31, 2009, and $7.8 billion as of December 31, 2008. The weighted-average effective interest rate on short-term borrowings outstanding was 0.7% as of December 31, 2009, and 1.9% as of December 31, 2008. As of December 31, 2009, we had access to $8.6 billion of lines of credit, of which $6.4 billion expire within one year. Of these lines of credit, $8.5 billion are unused, of which our lenders have committed to loan us $7.1 billion at our request. Also, $7.0 billion of our unused lines of credit, of which $5.0 billion expire in late 2010 and $2.0 billion expire in 2013, may be used to support our commercial paper borrowings. D. Long-Term Debt We issued long-term debt in the first and second quarters of 2009, virtually all of the proceeds of which were used to partially finance our acquisition of Wyeth on October 15, 2009. Also, our long-term debt increased due to the addition of an aggregate principal amount of $10.3 billion of legacy Wyeth debt. On October 30, 2009, Pfizer Inc. issued an unconditional and irrevocable guarantee of the prompt payment, when due, of any amounts owed in respect of an aggregate principal amount of $10.3 billion of such debt. The guarantee is an unsecured unsubordinated obligation of Pfizer Inc. The legacy Wyeth debt has a weighted-average maturity of approximately 11 years, ranging from 2011 through 2037. Additional information about our long-term debt, including legacy Wyeth debt follows:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="70%"/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" rowspan="2" valign="bottom" align="right"> MATURITY DATE</td> <td style="BORDER-TOP: #000000 1px solid" rowspan="2" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right" colspan="6">AS OF DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Senior unsecured notes:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Issued on March 24, 2009:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 4.45%(a)</td> <td valign="bottom">  </td> <td valign="bottom" align="right">March 2012</td> <td valign="bottom" nowrap="nowrap">     </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3,510</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">     </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 6.20%(a)</td> <td valign="bottom">  </td> <td valign="bottom" align="right">March 2019</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3,247</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 5.35%(a)</td> <td valign="bottom">  </td> <td valign="bottom" align="right">March 2015</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,997</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 7.20%(a)</td> <td valign="bottom">  </td> <td valign="bottom" align="right">March 2039</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,455</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Floating rate notes at the three-month London Interbank Offering Rate (LIBOR), plus 1.95%</td> <td valign="bottom">  </td> <td valign="bottom" align="right">March 2011</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,250</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Issued on June 3, 2009:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 4.75% euro(b)</td> <td valign="bottom">  </td> <td valign="bottom" align="right">June 2016</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,867</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 5.75% euro(b)</td> <td valign="bottom">  </td> <td valign="bottom" align="right">June 2021</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,865</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 3.625% euro(b)</td> <td valign="bottom">  </td> <td valign="bottom" align="right">June 2013</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,653</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 6.50% U.K. pound(b)</td> <td valign="bottom">  </td> <td valign="bottom" align="right">June 2038</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,408</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Legacy Wyeth debt:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 5.95%</td> <td valign="bottom">  </td> <td valign="bottom" align="right">April 2037</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,091</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 5.50%</td> <td valign="bottom">  </td> <td valign="bottom" align="right">February 2014</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,912</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 5.50%</td> <td valign="bottom">  </td> <td valign="bottom" align="right">March 2013</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,617</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 6.95%</td> <td valign="bottom">  </td> <td valign="bottom" align="right">March 2011</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,570</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 5.50%</td> <td valign="bottom">  </td> <td valign="bottom" align="right">February 2016</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,087</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Notes and other debt with a weighted-average interest rate of 6.21%(c)</td> <td valign="bottom">  </td> <td valign="bottom" align="right">2011–2036</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,869</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Other:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 4.55% euro</td> <td valign="bottom">  </td> <td valign="bottom" align="right">May 2017</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,391</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,312</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> 4.75% euro</td> <td valign="bottom">  </td> <td valign="bottom" align="right">December 2014</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,385</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,311</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Debentures, notes, borrowings and mortgages with a weighted-average interest rate of approximately 4.17%(d)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2011–2028</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">5,019</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">5,340</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total long-term debt</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">43,193</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">7,963</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Current portion not included above</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">27</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">937</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="13"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="2%">(a) </td> <td valign="top" align="left"> Instrument is callable by us at any time at the greater of 100% of the principal amount or the sum of the present values of the remaining scheduled payments of principal and interest discounted at the U.S. Treasury rate plus 0.50% plus, in each case, accrued and unpaid interest. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="2%">(b) </td> <td valign="top" align="left"> Instrument is callable by us at any time at the greater of 100% of the principal amount or the sum of the present values of the remaining scheduled payments of principal and interest discounted at a comparable government bond rate plus 0.20% plus accrued and unpaid interest. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="2%">(c) </td> <td valign="top" align="left"> The weighted-average maturity of all other debt issuances is approximately 17 years. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="2%">(d) </td> <td valign="top" align="left"> The weighted-average maturity of all other debt issuances is approximately 8 years. </td></tr></table> Long-term debt outstanding as of December 31, 2009 matures in the following years:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="61%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="1%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2011</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2012</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2013</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2014</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">AFTER 2014</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Maturities</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,137</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,522</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,278</td> <td valign="bottom">    </td> <td valign="bottom" align="right">$4,125</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">27,131</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="17"> </td></tr></table> In March 2007, we filed a securities registration statement with the U.S. Securities and Exchange Commission (SEC). The registration statement was filed under the automatic shelf registration process available to “well-known seasoned issuers” and expires in March 2010. We can issue securities of various types under that registration statement at any time, subject to approval by our Board of Directors in certain circumstances. On March 24, 2009, in order to partially finance our acquisition of Wyeth, we issued $13.5 billion of senior unsecured notes under this registration statement. On June 3, 2009, also in order to partially finance the Wyeth acquisition, we issued approximately $10.5 billion of senior unsecured notes in a private placement pursuant to Regulation S under the Securities Act of 1933, as amended (Securities Act of 1933). The notes have not been and will not be registered under the Securities Act of 1933 and, subject to certain exceptions, may not be sold, offered or delivered within the United States or to, or for, the account or benefit of U.S. persons. E. Derivative Financial Instruments and Hedging Activities Foreign Exchange Risk—A significant portion of our revenues, earnings and net investments in foreign affiliates is exposed to changes in foreign exchange rates. We seek to manage our foreign exchange risk, in part, through operational means, including managing expected same-currency revenues in relation to same-currency costs and same-currency assets in relation to same-currency liabilities. Depending on market conditions, foreign exchange risk also is managed through the use of derivative financial instruments and foreign currency debt. These financial instruments serve to protect net income and net investments against the impact of the translation into U.S. dollars of certain foreign exchange-denominated transactions. The aggregate notional amount of foreign exchange derivative financial instruments hedging or offsetting foreign currency exposures is $50 billion. The derivative financial instruments primarily hedge or offset exposures in euro, Japanese yen and U.K. pound. All derivative contracts used to manage foreign currency risk are measured at fair value and are reported as assets or liabilities on the consolidated balance sheet. Changes in fair value are reported in earnings or deferred, depending on the nature and purpose of the financial instrument (offset or hedge relationship) and the effectiveness of the hedge relationships, as follows:   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> We defer on the balance sheet the effective portion of the gains or losses on foreign currency forward-exchange contracts and foreign currency swaps that are designated as cash flow hedges and reclassify those amounts, as appropriate, into earnings in the same period or periods during which the hedged transaction affects earnings. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> We recognize the gains and losses on forward-exchange contracts and foreign currency swaps that are used to offset the same foreign currency assets or liabilities immediately into earnings along with the earnings impact of the items they generally offset. These contracts essentially take the opposite currency position of that reflected in the month-end balance sheet to counterbalance the effect of any currency movement. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> We recognize the gain and loss impact on foreign currency swaps designated as hedges of our net investments in earnings in three ways: over time––for the periodic net swap payments; immediately––to the extent of any change in the difference between the foreign exchange spot rate and forward rate; and upon sale or substantial liquidation of our net investments–to the extent of change in the foreign exchange spot rates. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> We defer on the balance sheet foreign exchange gains and losses related to foreign exchange-denominated debt designated as a hedge of our net investments in foreign subsidiaries and reclassify those amounts into earnings upon the sale or substantial liquidation of our net investments. </td></tr></table> Any ineffectiveness is recognized immediately into earnings. There was no significant ineffectiveness in 2009, 2008 or 2007. Interest Rate Risk—Our interest-bearing investments, loans and borrowings are subject to interest rate risk. We seek to invest and loan primarily on a short-term or variable-rate basis; however, in light of current market conditions, we currently borrow primarily on a long-term, fixed-rate basis. From time to time, depending on market conditions, we will change the profile of our outstanding debt by entering into derivative financial instruments like interest rate swaps. We entered into derivative financial instruments to hedge or offset the fixed interest rates on the hedged item, matching the amount and timing of the hedged item. The aggregate notional amount of interest rate derivative financial instruments is $6.2 billion. The derivative financial instruments hedge U.S. dollar, euro and U.K. pound fixed-rate debt. All derivative contracts used to manage interest rate risk are measured at fair value and reported as assets or liabilities on the consolidated balance sheet. Changes in fair value are reported in earnings, as follows: We recognize the gains and losses on interest rate swaps that are designated as fair value hedges in earnings upon the recognition of the change in fair value of the hedged risk. We recognize the offsetting earnings impact of fixed-rate debt attributable to the hedged risk also in earnings. Any ineffectiveness is recognized immediately into earnings. There was no significant ineffectiveness in 2009, 2008 or 2007. Information about gains/(losses) incurred to hedge or offset operational foreign exchange or interest rate risk is as follows:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="84%"/> <td valign="bottom" width="14%"/> <td/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">GAINS/(LOSSES)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">YEAR ENDED DECEMBER 31, 2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td></tr> <tr> <td valign="top"> Derivative Financial Instruments in Fair Value Hedge Relationships</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Interest rate swaps</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Recognized in OID(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(6</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td></tr> <tr> <td valign="top"> Foreign currency swaps</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Recognized in OID(a) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(3</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td></tr> <tr> <td valign="top"> Derivative Financial Instruments in Cash Flow Hedge Relationships</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> U.S. Treasury interest rate locks</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Recognized in OID(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(11</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td></tr> <tr> <td valign="top"> Recognized in OCI(a), (b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(16</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td></tr> <tr> <td valign="top"> Reclassified from OCI to OID(a), (b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Foreign currency swaps</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Recognized in OID(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Recognized in OCI(a), (b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">305</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Reclassified from OCI to OID(a), (b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">281</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Foreign currency forward exchange contracts</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Recognized in OID(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Recognized in OCI(a), (b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Reclassified from OCI to OID(a), (b) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">18</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Derivative Financial Instruments in Net Investment Hedge Relationships</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Foreign currency swaps</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Recognized in OID(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(1</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Recognized in OCI(a), (b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">17</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Derivative Financial Instruments Not Designated as Hedges</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Foreign currency swaps</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Recognized in OID(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">22</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Foreign currency forward-exchange contracts</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Recognized in OID(a) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(418</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td></tr> <tr> <td valign="top"> Non-Derivative Financial Instruments in Net Investment Hedge Relationships</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Foreign currency short-term borrowings</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Recognized in OID(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Recognized in OCI(a), (b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">54</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Foreign currency long-term debt</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr> <td valign="top"> Recognized in OID(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr> <td valign="top"> Recognized in OCI(a), (b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">52</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="4"> </td> <td> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="2%">(a) </td> <td valign="top" align="left"> OID = Other (income)/deductions––net. OCI = Other comprehensive income/(expense), a balance sheet account. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="2%">(b) </td> <td valign="top" align="left"> Amounts presented represent the effective portion of the gain or loss. For derivative financial instruments in cash flow hedge relationships, the effective portion is included in Other comprehensive income/(expense) – Net unrealized gains/(losses) on derivative financial instruments. For derivative financial instruments in net investment hedge relationships and for foreign currency debt designated as hedging instruments, the effective portion is included in Other comprehensive income/(expense)––Currency translation adjustment. </td></tr></table> For information about the fair value of our derivative financial instruments, and the impact on our consolidated balance sheet, see Note 9A. Financial Instruments: Selected Financial Assets and Liabilities. Certain of our derivative instruments are covered by associated credit-support agreements that have credit-risk-related contingent features designed to reduce our counterparties’ exposure to our risk of defaulting on amounts owed. The aggregate fair value of these derivative instruments that are in a liability position is $428 million, for which we have posted collateral of $309 million in the normal course of business. These features include the requirement to pay additional collateral in the event of a downgrade in our debt ratings. If there had been a downgrade to an A rating by Standard & Poor’s (S&P) or the equivalent rating by Moody& #8217;s Investors Service (Moody’s) on December 31, 2009, we would have been required to post an additional $20 million of collateral to our counterparties. If there had been a downgrade to below an A rating by S&P or the equivalent rating by Moody’s, on December 31, 2009, we would have been required to post an additional $108 million of collateral to our counterparties. The collateral advanced receivables are reported in Short-term loans. F. Credit Risk On an ongoing basis, we review the creditworthiness of counterparties to our foreign exchange and interest rate agreements and do not expect to incur a significant loss from failure of any counterparties to perform under the agreements. There are no significant concentrations of credit risk related to our financial instruments with any individual counterparty. As of December 31, 2009, we had $2 billion due from a well-diversified, highly rated group (S&P’s rating of mostly AA or better) of bank counterparties around the world. In general, there is no requirement for collateral from customers. However, derivative financial instruments are executed under master netting agreements with financial institutions. These agreements contain provisions that provide for the ability for collateral payments, depending on levels of exposure, our credit rating and the credit rating of the counterparty. As of December 31, 2009, we received cash collateral of $953 million against various counterparties. The collateral primarily supports the approximate fair value of our derivative contracts. The collateral received obligations are reported in Short-term borrowings, including current portion of long-term debt.

10. Inventories The components of inventories follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="79%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right" colspan="6">AS OF DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Finished goods</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5,249</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">     </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,024</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Work-in-process</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5,776</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,527</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Raw materials and supplies</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">1,378</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">830</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Total inventories(a),(b)</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">12,403</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,381</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="10"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> Increase primarily due to the acquisition of Wyeth inventories, which were recorded at fair value (see Note 2. Acquisition of Wyeth for additional detail). Wyeth inventories included pre-launch inventory associated with Prevnar/Prevenar 13 Infant which did not launch until 2010. Prevnar/Prevenar 13 Infant was approved by the EU member states in December 2009 and in the U.S. in February 2010. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b) </td> <td valign="top" align="left"> Certain amounts of inventories are in excess of one year’s supply, including the pre-launch inventory associated with Prevnar/Prevenar 13 Infant. These excess amounts are primarily attributable to biologics inventory acquired from Wyeth at fair value and the quantities are generally consistent with the normal operating cycle of such inventory. There are no recoverability issues associated with these quantities. </td></tr></table>

12. Goodwill and Other Intangible Assets A. Goodwill The changes in the carrying amount of goodwill for the years ended December 31, 2009 and 2008 follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="76%"/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="1%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap">BIOPHARMACEUTICAL</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap" colspan="2">DIVERSIFIED</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap" colspan="2">OTHER</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap" colspan="2">TOTAL</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Balance as of January 1, 2008</td> <td valign="bottom">    </td> <td valign="bottom" align="right">$21,256</td> <td valign="bottom" nowrap="nowrap">     </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">126</td> <td valign="bottom" nowrap="nowrap">     </td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,382</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Additions(a)</td> <td valign="bottom">    </td> <td valign="bottom" align="right">21</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">36</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">57</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other(b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">40</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(15</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">25</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Balance, December 31, 2008</td> <td valign="bottom">    </td> <td valign="bottom" align="right">21,317</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">147</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21,464</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Additions(a)</td> <td valign="bottom">    </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19,954</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19,954</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other(b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">848</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">26</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">84</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">958</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top" bgcolor="#bfbfbf"> Balance as of December 31, 2009</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">$22,165</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">173</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">20,038</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">42,376</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="16"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> In 2009, $20.0 billion relates to our acquisition of Wyeth and is subject to change upon completion of our allocation of the consideration transferred to the assets acquired and liabilities assumed from Wyeth (see Note 2. Acquisition of Wyeth). The allocation of goodwill among reporting units has not yet been completed but will be completed within one year from the Wyeth acquisition date, October 15, 2009. In 2008, primarily related to our acquisitions of Coley and a number of animal health product lines from Schering-Plough, as well as two smaller animal health acquisitions. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b) </td> <td valign="top" align="left"> In 2009, primarily relates to foreign exchange, partially offset by a reduction of approximately $150 million in Biopharmaceutical in connection with the formation of ViiV (see Note 3A. Other Significant Transactions and Events: Formation of ViiV, an Equity-Method Investment for additional information.) In 2008, primarily relates to tax adjustments and the impact of foreign exchange.</td></tr></table> B. Other Intangible Assets The components of identifiable intangible assets, primarily included in Biopharmaceutical follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="62%"/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="center" colspan="23">AS OF DECEMBER 31,</td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="9" bgcolor="#bfbfbf">2009</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="9">2008</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom"> GROSS CARRYING AMOUNT</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">ACCUMULATED AMORIZATION</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">IDENTIFIABLE INTANGIBLE ASSETS, LESS ACCUMULATED AMORTIZATION</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" valign="bottom">GROSS CARRYING AMOUNT</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" valign="bottom">ACCUMULATED AMORTIZATION</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" valign="bottom">IDENTIFIABLE INTANGIBLE ASSETS, LESS ACCUMULATED AMORTIZATION</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom">Finite-lived intangible assets:</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Developed technology rights</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">68,870</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">(21,223</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">) </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">47,647</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td align="right" valign="bottom">31,484</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td align="right" valign="bottom">(17,673</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td align="right" valign="bottom">13,811</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Brands</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">1,637</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">(535</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">) </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">1,102</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">1,016</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">(487</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">529</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> License agreements</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">622</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">(119</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">) </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">503</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">246</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">(78</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">168</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Trademarks</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">113</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">(73</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">) </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">40</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">118</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">(78</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">40</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Other(a)</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">488</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">(231</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">257</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">531</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">(291</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" valign="bottom">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">240</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Total amortized finite-lived intangible assets</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">71,730</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">(22,181</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">49,549</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">33,395</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">(18,607</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" valign="bottom">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">14,788</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom"> Indefinite-lived intangible assets:</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Brands</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">12,562</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">12,562</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">2,860</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">—</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">2,860</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> In-process research and development</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">5,834</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">5,834</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">—</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">—</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Trademarks</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">68</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">68</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">70</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">—</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td align="right" valign="bottom">70</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">2</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">2</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">3</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">3</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Total indefinite-lived intangible assets</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">18,466</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">18,466</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">2,933</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" valign="bottom">2,933</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom"> Total identifiable intangible assets</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">90,196</td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">(22,181</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">) </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">68,015</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">(b) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td align="right" valign="bottom">36,328</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td align="right" valign="bottom">(18,607</td> <td nowrap="nowrap" valign="bottom">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td align="right" valign="bottom">17,721</td> <td nowrap="nowrap" valign="bottom">(b) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" colspan="25" valign="bottom"> </td></tr></table>   <table cellspacing="0" style="BORDER-COLLAPSE: collapse" cellpadding="0" width="100%" border="0"> <tr> <td align="left" width="1%" valign="top">(a) </td> <td align="left" valign="top"> Includes patents, non-compete agreements and customer contracts. </td></tr></table> <table cellspacing="0" style="BORDER-COLLAPSE: collapse" cellpadding="0" width="100%" border="0"> <tr> <td align="left" width="1%" valign="top">(b) </td> <td align="left" valign="top"> Increase primarily relates to the acquisition of Wyeth’s identifiable intangible assets, which were recorded at fair value (see Note 2. Acquisition of Wyeth), partially offset by amortization. </td></tr></table> All of these assets are subject to our review for impairment, explained in Note 1L. Significant Accounting Policies: Amortization of Intangible Assets, Depreciation and Certain Long-Lived Assets. Developed Technology Rights Developed technology rights represent the amortized cost associated with developed technology, which has been acquired from third parties and which can include the right to develop, use, market, sell and/or offer for sale the product, compounds and intellectual property that we have acquired with respect to products, compounds and/or processes that have been completed. We possess a well-diversified portfolio of hundreds of developed technology rights across therapeutic categories, primarily representing the commercialized products included in our Biopharmaceutical segment. Virtually all of these assets were acquired in connection with our Wyeth acquisition in 2009 and our Pharmacia acquisition in 2003. The more significant components of developed technology rights are the following (in order of significance): Enbrel and Prevnar/Prevenar 13 Infant and, to a lesser extent, Celebrex, Premarin, Effexor, Pristiq, BeneFIX, BMP-2, Refacto, Genotropin, Tygacil, Detrol/Detrol LA, Xalatan, Prevnar/Prevenar 7 and Zyvox. Also included in this category are the post-approval milestone payments made under our alliance agreements for certain Biopharmaceutical products, such as Rebif and Spiriva. Brands Brands represent the amortized or unamortized cost associated with tradenames and know-how, as the products themselves no longer receive patent protection. Most of these assets are associated with our Diversified segment. Virtually all of these assets were acquired in connection with our Wyeth acquisition in 2009 and our Pharmacia acquisition in 2003. The more significant components of indefinite-lived brands are the following (in order of significance): Advil, 3rd Age Nutritionals, Xanax, 1st Age Nutritionals, Centrum, Medrol, 2nd Age Nutritionals, Robitussin, Caltrate, Preparation H and ChapStick. The more significant components of finite-lived brands are the following (in order of significance): Depo-Provera, Advil Cold and Sinus and Dimetapp. In-Process Research and Development IPR&D assets represent research and development assets that have not yet received regulatory approval and are required to be classified as indefinite-lived assets until the successful completion or the abandonment of the associated research and development effort. Accordingly, during the development period after the date of acquisition, these assets will not be amortized until approval is obtained in a major market, typically either the U.S. or the EU, or in a series of other countries, subject to certain specified conditions and management judgment. At that time, we will determine the useful life of the asset, reclassify the asset out of in-process research and development and begin amortization. In 2009, Prevnar/Prevenar 13 Infant received regulatory approval in a major market, and as a result, we reclassified the asset from IPR&D to Developed Technology Rights and began to amortize the asset. If the associated research and development effort is abandoned, the related IPR&D assets will likely be written off and we will record an impairment loss in our consolidated statements of income. All of these IPR&D assets were acquired in connection with our acquisition of Wyeth. The significant components of IPR&D are Prevnar/Prevenar 13 Adult and projects for the treatment of Alzheimer’s disease, cancer and leukemia, among others. Amortization and Impairments The weighted-average life of both our total finite-lived intangible assets and our developed technology rights is approximately 11 years. Total amortization expense for finite-lived intangible assets was $3.0 billion in 2009, $2.8 billion in 2008 and $3.2 billion in 2007. The annual amortization expense expected for the years 2010 through 2014 is as follows:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="45%"/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2010</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2011</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2012</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2013</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2014</td></tr> <tr> <td valign="top"> Amortization expense</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,884</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,842</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,737</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,309</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,317</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="16"> </td></tr></table> In 2009, we recorded an impairment charge of $298 million in Other (income)/deductions––net associated with certain materials used in our research and development activities that are no longer considered recoverable. We had no significant impairments in 2008, and, in 2007, we recorded charges of $1.1 billion in Cost of sales and Selling, informational and administrative expenses related to the impairment of Exubera (see Note 3F. Other Significant Transactions and Events: Exubera).

11. Property, Plant and Equipment The major categories of property, plant and equipment follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="80%"/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" rowspan="2" valign="bottom" align="right"> USEFUL LIVES (YEARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="7">AS OF DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom"> Land</td> <td valign="bottom"> </td> <td valign="bottom" align="right" nowrap="nowrap">—</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">937</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">616</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Buildings</td> <td valign="bottom"> </td> <td valign="bottom" align="right" nowrap="nowrap">33 1/3-50</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">14,186</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,775</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Machinery and equipment</td> <td valign="bottom"> </td> <td valign="bottom" align="right" nowrap="nowrap">8-20</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">12,236</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,583</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Furniture, fixtures and other</td> <td valign="bottom"> </td> <td valign="bottom" align="right" nowrap="nowrap">3-12 1/2</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,599</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,350</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Construction in progress</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">1,966</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,804</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">33,924</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">25,128</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Less: Accumulated depreciation</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">11,144</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">11,841</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom"> Total property, plant and equipment(a)</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">22,780</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,287</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="11"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> Increase primarily due to the acquisition of Wyeth property, plant and equipment, which was recorded at fair value (see Note 2. Acquisition of Wyeth for additional detail). </td></tr></table>

13. Pension and Postretirement Benefit Plans and Defined Contribution Plans We provide defined benefit pension plans and defined contribution plans for the majority of our employees worldwide. In the U.S., we have both qualified and supplemental (non-qualified) defined benefit plans. A qualified plan meets the requirements of certain sections of the Internal Revenue Code, and, generally, contributions to qualified plans are tax deductible. A qualified plan typically provides benefits to a broad group of employees and may not discriminate in favor of highly compensated employees in its coverage, benefits or contributions. A supplemental (non-qualified) plan provides additional benefits to certain employees. In addition, we provide medical and life insurance benefits to certain retirees and their eligible dependents through our postretirement plans. In 2009, we assumed all of Wyeth’s defined benefit obligations and related plan assets for qualified and non-qualified pension p lans and postretirement plans in connection with our acquisition of Wyeth (see Note 2. Acquisition of Wyeth). A. Components of Net Periodic Benefit Costs and Other Amounts Recognized in Other Comprehensive (Income)/Expense The annual cost and other amounts recognized in other comprehensive (income)/expense of the U.S. qualified, U.S. supplemental (non-qualified) and international pension plans and postretirement plans follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="44%"/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/> <td/> <td/> <td valign="bottom" width="1%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="55">YEAR ENDED DECEMBER 31,</td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="38">PENSION PLANS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">U.S. QUALIFIED</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" nowrap="nowrap" colspan="10">U.S. SUPPLEMENTAL (NON-QUALIFIED)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">INTERNATIONAL</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">POSTRETIREMENT PLANS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Service cost</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">252</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">236</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">282</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">24</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">27</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">188</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">249</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">292</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">39</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">39</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">42</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Interest cost</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">526</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">459</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">447</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">53</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">38</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">55</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">342</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">388</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">349</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">145</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">141</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">137</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Expected return on plan assets</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(527</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(646</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(693</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(375</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(437</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(381</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(26</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(35</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(36</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Amortization of:</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Actuarial losses</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">212</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">32</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">65</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">31</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">29</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">45</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">30</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">43</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">96</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">18</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">28</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">42</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Prior service costs/(credits)</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Curtailments and settlements—net</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">110</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">32</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">58</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">120</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(155</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Special termination benefits</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">61</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">137</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">25</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">29</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">24</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Less: Amounts included in discontinued operations</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(27</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Net periodic benefit costs </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">636</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">146</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">156</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">241</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">208</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">130</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">194</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">272</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">230</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">194</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">201</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">208</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other changes recognized in other comprehensive (income)/expense(a)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(783</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,273</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(582</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(23</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(52</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(134</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">806</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">415</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(808</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(122</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(140</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(311</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Total recognized in net periodic benefit costs and other comprehensive (income)/expense</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(147</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,419</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(426</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">218</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">156</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,000</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">687</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(578</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">72</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">61</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(103</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="57"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> For details, see Note 8. Other Comprehensive Income/(Expense). </td></tr></table> The increase in the 2009 U.S. qualified pension plans’ net periodic benefit costs compared to 2008 was largely driven by the securities market downturn during 2008 and by charges resulting from employee terminations associated with our cost-reduction initiatives. The securities market downturn during 2008 contributed to a lower plan asset base and higher actuarial losses recognized. The decrease in the 2008 U.S. qualified pension plans’ net periodic benefit costs compared to 2007 was largely driven by the increase in the discount rate and the impact of our cost-reduction initiatives. The increase in the 2009 U.S. supplemental (non-qualified) plans’ net periodic benefit costs compared to 2008 was largely driven by the impact of special termination benefits recognized for certain executives as part of Wyeth-related restructuring initiatives. The increase in the 2008 U.S. supplemental (non-qualified) plans’ net periodic benefit costs compared to 2007 was largely driven by settlement charges recognized due to lump sum benefit payments made to certain former executives in 2008. The decrease in the 2009 international plans’ net periodic benefit costs compared to 2008 was largely driven by an increase in interest rates set at the beginning of the year and ongoing restructuring and certain acquisition-related activities, which was partially offset by lower expected returns on plan assets. The increase in the 2008 international plans’ net periodic benefit costs compared to 2007 was attributable to a settlement gain of $106 million resulting from a transfer of pension obligations, along with the respective plan assets, to the Japanese government in accordance with Japanese laws, which was partially offset by higher expected return on plan assets during 2008. The following table presents the amount in Accumulated other comprehensive income/(expense) expected to be amortized into 2010 net periodic benefit costs:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="57%"/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">PENSION PLANS</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">U.S. QUALIFIED</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">U.S. SUPPLEMENTAL (NON-QUALIFIED)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">INTERNATIONAL</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">POSTRETIREMENT PLANS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Actuarial losses</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(153</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(29</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(70</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Prior service (costs)/credits and other</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(2</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">4</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">18</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(155</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(27</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(66</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="19"> </td></tr></table> B. Actuarial Assumptions The following table provides the weighted-average actuarial assumptions:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="77%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="1%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(PERCENTAGES)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2009</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2008</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2007</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Weighted-average assumptions used to determine benefit obligations:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Discount rate:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> U.S. qualified pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.4</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.5</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> U.S. non-qualified pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.2</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.4</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> International pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5.1</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">5.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">5.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Postretirement plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.0</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.4</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Rate of compensation increase:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> U.S. qualified pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4.0</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> U.S. non-qualified pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4.0</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> International pension plans</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">3.6</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">3.2</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">3.3</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Weighted-average assumptions used to determine net periodic benefit cost:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Discount rate:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> U.S. qualified pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.4</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">5.9</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> U.S. non-qualified pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.4</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">5.9</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> International pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5.6</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">5.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.4</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Postretirement plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.4</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">5.9</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Expected return on plan assets:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> U.S. qualified pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8.5</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">8.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">9.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> International pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.7</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">7.2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">6.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Postretirement plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8.5</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">8.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">9.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Rate of compensation increase:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> U.S. qualified pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4.3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> U.S. non-qualified pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4.3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> International pension plans</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3.2</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">3.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">3.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="12"> </td></tr></table> The assumptions above are used to develop the benefit obligations at fiscal year-end and to develop the net periodic benefit cost for the subsequent fiscal year. Therefore, the assumptions used to determine net periodic benefit cost for each year are established at the end of each previous year, while the assumptions used to determine benefit obligations were established at each year-end. The net periodic benefit cost and the benefit obligations are based on actuarial assumptions that are reviewed on an annual basis. We revise these assumptions based on an annual evaluation of long-term trends, as well as market conditions that may have an impact on the cost of providing retirement benefits. The expected rates of return on plan assets for our U.S. qualified, international and postretirement plans represent our long-term assessment of return expectations, which we may change based on shifts in economic and financial market conditions. The 2009 expected rates of return for these plans reflect our long-term outlook for a globally diversified portfolio, which is influenced by a combination of return expectations for individual asset classes, actual historical experience and our diversified investment strategy. The historical returns are one of the inputs used to provide context for the development of our expectations for future returns. Using this information, we develop ranges of returns for each asset class and a weighted-average expected return for our targeted portfolio, which includes the impact of portfolio diversification and active portfolio management. The healthcare cost trend rate assumptions for our U.S. postretirement benefit plans are as follows:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="83%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(PERCENTAGES)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2009</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2008</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Healthcare cost trend rate assumed for next year</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8.6</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">9.0</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Rate to which the cost trend rate is assumed to decline</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">5.0</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">5.0</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Year that the rate reaches the ultimate trend rate</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2018</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">2018</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="9"> </td></tr></table> A one-percentage-point increase or decrease in the healthcare cost trend rate assumed for postretirement benefits would have the following effects as of December 31, 2009:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="87%"/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">INCREASE</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">DECREASE</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Effect on total service and interest cost components</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(14</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Effect on postretirement benefit obligation</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">360</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(307</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="10"> </td></tr></table> C. Obligations and Funded Status The following table presents an analysis of the changes in 2009 and 2008 in the benefit obligations, plan assets and accounting funded status of our U.S. qualified, U.S. supplemental (non-qualified) and international pension plans and our postretirement plans:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="45%"/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="39">YEAR ENDED DECEMBER 31,</td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="26">PENSION PLANS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">U.S. QUALIFIED</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">U.S. SUPPLEMENTAL (NON-QUALIFIED)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">INTERNATIONAL</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">POSTRETIREMENT PLANS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Change in benefit obligation:</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Benefit obligation at beginning of year</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">7,783</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,456</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">876</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">973</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5,851</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,839</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,966</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,178</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Service cost</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">252</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">236</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">24</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">23</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">188</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">249</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">39</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">39</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Interest cost</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">526</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">459</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">53</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">38</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">342</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">388</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">145</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">141</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Employee contributions</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">12</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">49</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">39</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Plan amendments</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(1</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(6</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">18</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(151</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(33</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Increases/(decreases) arising primarily from changes in actuarial assumptions</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">9</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">172</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">33</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">102</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,136</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,005</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">108</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(221</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Foreign exchange impact</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">844</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,234</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">10</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(11</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Acquisitions(a)</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,785</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">364</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,062</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,798</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Curtailments</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(196</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(48</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(29</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(6</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(25</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(74</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(26</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Settlements</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(325</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(212</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(32</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(202</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(53</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(58</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Special termination benefits</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">61</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">137</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">25</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">24</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Benefits paid</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(316</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(304</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(58</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(51</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(301</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(325</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(229</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(194</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Benefit obligation at end of year(a),(b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">12,578</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">7,783</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">1,368</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">876</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">9,062</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">5,851</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">3,733</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,966</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Change in plan assets:</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Fair value of plan assets at beginning of year</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5,897</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,989</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,394</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,579</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">303</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">413</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Actual gain/(loss) on plan assets</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">800</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,576</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">646</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,249</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">67</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(107</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Company contributions</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">90</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">253</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">448</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">471</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">180</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">152</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Employee contributions</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">12</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">49</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">39</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Foreign exchange impact</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">574</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,048</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Acquisitions(a)</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3,919</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">804</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Settlements</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(325</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(212</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(32</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(202</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(53</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(58</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Benefits paid</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(316</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(304</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(58</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(51</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(301</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(325</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(229</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(194</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Fair value of plan assets at end of year(a)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">9,977</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">5,897</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">6,524</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">4,394</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">370</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">303</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Funded status (plan assets less than the benefit obligation) at end of year(a)</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,601</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,886</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(1,368</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(876</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,538</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,457</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(3,363</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,663</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="41"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> Increase in 2009 primarily due to acquisition of Wyeth (see Note 2. Acquisition for Wyeth, for additional information). </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b) </td> <td valign="top" align="left"> For the U.S. and international pension plans, the benefit obligation is the projected benefit obligation. For the postretirement plans, the benefit obligation is the accumulated postretirement benefit obligation. </td></tr></table> The unfavorable change in our U.S. qualified plans’ projected benefit obligations funded status from $1.9 billion underfunded in the aggregate as of December 31, 2008, to $2.6 billion underfunded in the aggregate as of December 31, 2009, was largely driven by the acquisition of the Wyeth U.S. qualified pension plans and the 0.1 percentage-point reduction in discount rate, which was partially offset by the increase in plan assets due to investment gains earned from the securities market recovery during 2009. In 2009, contributions to our U.S. qualified plans were $2 million. In 2008, contributions to our U.S. qualified plans were not significant. In the aggregate, the U.S. qualified pension plans are underfunded on a projected benefit measurement basis and on an accumulated benefit obligation measurement basis as of December 31, 2009 and 2008. The unfavorable change in our U.S. supplemental (non-qualified) pension plans’ projected benefit obligations funded status from $876 million underfunded in the aggregate as of December 31, 2008 to $1.4 billion underfunded in the aggregate as of December 31, 2009, was largely driven by the acquisition of the Wyeth U.S. supplemental (non-qualified) pension plans and recognition of special termination benefits for certain executives as part of Wyeth-related restructuring initiatives. The U.S. supplemental (non-qualified) pension plans are not generally funded, as there is no tax or other incentives that exist, and these obligations, which are substantially greater than the annual cash outlay for these liabilities, are paid from cash generated from operations. The unfavorable change in our international plans’ projected benefit obligations funded status from $1.5 billion underfunded in the aggregate as of December 31, 2008, to $2.5 billion underfunded in the aggregate as of December 31, 2009, was largely driven by the acquisition of the Wyeth international pension plans, a 0.4 percentage-point increase in the average rate of compensation increases and weakening of the U.S. dollar against the U.K. pound, euro and Japanese yen, somewhat offset by the increase in plan assets due to investment gains earned from the securities market recovery during 2009. Outside the U.S., in general, we fund our defined benefit plans to the extent that tax or other incentives exist and we have accrued liabilities on our consolidated balance sheet to reflect those plans that are not fully funded. The unfavorable change in our postretirement plans’ accumulated benefit obligations (ABO) funded status from $1.7 billion underfunded in the aggregate as of December 31, 2008, to $3.4 billion underfunded in the aggregate as of December 31, 2009, was largely driven by the acquisition of the Wyeth postretirement plans. The ABO for all of our U.S. qualified pension plans were $11.4 billion in 2009 and $7.0 billion in 2008. The ABO for our U.S. supplemental (non-qualified) pension plans was $1.2 billion in 2009 and $762 million in 2008. The ABO for our international pension plans was $8.0 billion in 2009 and $5.3 billion in 2008. The U.S. qualified pension plans loan securities to other companies. Such securities may be onward loaned, sold or pledged by the other companies, but they may be required to be returned in a short period of time. We also require cash collateral from these companies and a maintenance margin of 103% of the fair value of the collateral relative to the fair value of the loaned securities. As of December 31, 2009, the fair value of collateral received was $722 million and as of December 31, 2008, the fair value of collateral received was $572 million. The securities loaned continue to be included in the table above in Fair value of plan assets at end of year. Amounts recognized in our consolidated balance sheet follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="48%"/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="39">AS OF DECEMBER 31,</td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="26">PENSION PLANS</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">U.S. QUALIFIED</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">U.S. SUPPLEMENTAL (NON-QUALIFIED)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">INTERNATIONAL</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">POSTRETIREMENT PLANS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Noncurrent assets(a)</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">146</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">160</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Current liabilities(b)</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(203</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(107</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(58</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(37</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(120</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(59</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Noncurrent liabilities(c)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(2,601</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(1,886</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(1,165</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(769</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(2,626</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(1,580</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(3,243</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(1,604</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Funded status</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,601</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,886</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(1,368</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(876</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,538</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,457</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(3,363</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,663</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="41"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> Included primarily in Noncurrent deferred tax assets and other noncurrent assets. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b) </td> <td valign="top" align="left"> Included in Current deferred tax liabilities and other current liabilities. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c) </td> <td valign="top" align="left"> Included in Pension benefit obligations and Postretirement benefit obligations, as appropriate. </td></tr></table> Amounts recognized in Accumulated other comprehensive income/(expense) follow:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="48%"/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="39">AS OF DECEMBER 31,</td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="26">PENSION PLANS</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">U.S. QUALIFIED</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">U.S. SUPPLEMENTAL (NON-QUALIFIED)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">INTERNATIONAL</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">POSTRETIREMENT PLANS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Actuarial losses</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,391</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,173</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(405</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(433</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,231</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,231</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(226</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(204</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Prior service (costs)/credits and other</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">15</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">14</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">18</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">23</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(23</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(23</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">173</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">29</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,376</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,159</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(387</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(410</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,254</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,254</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(53</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(175</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="41"> </td></tr></table> The actuarial losses primarily represent the cumulative difference between the actuarial assumptions and actual return on plan assets, changes in discount rates and plan experience. These actuarial losses are recognized in Accumulated other comprehensive income/(expense) and are amortized into net periodic pension costs over an average period of 10.6 years for our U.S. qualified plans, an average period of 9.8 years for our U.S. supplemental (non-qualified) plans and an average period of 14.6 years for our international plans. Information related to the U.S. qualified, U.S. supplemental (non-qualified) and international pension plans follows:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="58%"/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="21">AS OF DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="21">PENSION PLANS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="5">U.S. QUALIFIED</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="5">U.S. SUPPLEMENTAL (NON-QUALIFIED)</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="5">INTERNATIONAL</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Pension plans with an accumulated benefit obligation in excess of plan assets:</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Fair value of plan assets</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">9,792</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,897</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,796</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,574</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Accumulated benefit obligation</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">11,218</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,011</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,246</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">762</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3,725</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,961</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Pension plans with a projected benefit obligation in excess of plan assets:</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Fair value of plan assets</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">9,977</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,897</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5,332</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,943</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Projected benefit obligation</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">12,578</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,783</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,368</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">876</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8,016</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,560</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="25"> </td></tr></table> All of our U.S. plans are underfunded as of December 31, 2009. D. Plan Assets Information about plan assets follows:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="52%"/> <td valign="bottom" width="8%"/> <td/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="8">FAIR VALUE(a)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom"> </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">AS OF DECEMBER 31,</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">LEVEL 1</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">LEVEL 2</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">LEVEL 3</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> U.S. qualified pension plans(a):</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Cash and cash equivalents</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">605</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">     </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">605</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Equity securities:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Global equity securities</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3,034</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,009</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Equity commingled funds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,670</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,670</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Debt securities:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Fixed income commingled funds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">791</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">791</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Government bonds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">526</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">500</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Corporate debt securities</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,054</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,039</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Other investments:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Private equity funds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">843</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">843</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">454</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">454</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">9,977</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">3,009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">5,621</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,347</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> International pension plans(a):</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Cash and cash equivalents</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">402</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">402</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Equity securities:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Global equity securities</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,570</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,430</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">107</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Equity commingled funds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,682</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,662</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">20</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Debt securities:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Fixed income commingled funds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,081</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,081</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Government bonds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">977</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">977</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Corporate debt securities</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">149</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">144</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Other investments:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Private equity funds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">39</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">34</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Insurance contracts</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">411</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">65</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">346</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">213</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">86</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">127</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">6,524</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,430</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">4,529</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">565</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> U.S. postretirement plans(a),(b):</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Cash and cash equivalents</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">35</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">35</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Equity securities:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Global equity securities</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">25</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">25</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Equity commingled funds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">163</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">163</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Debt securities:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Fixed income commingled funds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">99</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">99</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Government bonds</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">7</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Corporate debt securities</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">26</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other investments</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">15</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">15</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">370</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">25</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">345</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="16"> </td></tr></table> <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Fair values are determined based on valuation techniques categorized as follows: Level 1 means the use of quoted prices for identical instruments in active markets; Level 2 means the use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable; Level 3 means the use of unobservable inputs. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Reflects postretirement plan assets, which support a portion of our U.S. retiree medical plans. </td></tr></table> The following table presents an analysis of changes during 2009 in Level 3 plan assets, by plan asset category, for our U.S. qualified pension plans and international pension plans using significant unobservable inputs to measure fair value:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="35%"/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">ACTUAL RETURN ON PLAN ASSETS</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">FAIR VALUE, BEGINNING OF YEAR</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">ASSETS HELD, END OF YEAR</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">ASSETS SOLD DURING THE PERIOD</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">PURCHASES, SALES AND SETTLEMENTS, NET</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">TRANSFER INTO/(OUT OF) LEVEL 3</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">EXCHANGE RATE CHANGES</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">FAIR VALUE, END OF YEAR</td></tr> <tr> <td valign="top"> U.S. qualified pension plans:</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Equity securities:</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Global equity securities</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9</td></tr> <tr> <td valign="top"> Debt securities:</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Government bonds</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">27</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td></tr> <tr> <td valign="top"> Corporate debt securities</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(11</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td></tr> <tr> <td valign="top"> Other investments:</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Private equity funds</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">821</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(44</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">47</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">843</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">356</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(21</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">3</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">116</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">454</td></tr> <tr bgcolor="#bfbfbf"> <td valign="top"> Total Level 3 plan assets</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,234</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(61</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">19</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">155</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,347</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="25"> </td></tr> <tr> <td valign="top"> International pension plans:</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Equity securities:</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Global equity securities</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">72</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(25</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(32</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">33</td></tr> <tr> <td valign="top"> Equity commingled funds</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">29</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(5</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(6</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">20</td></tr> <tr> <td valign="top"> Debt securities:</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Corporate debt securities</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5</td></tr> <tr> <td valign="top"> Other investments:</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Private equity funds</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">34</td></tr> <tr> <td valign="top"> Insurance contracts</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">309</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(30</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">50</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">346</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">122</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(10</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">4</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">11</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">127</td></tr> <tr bgcolor="#bfbfbf"> <td valign="top"> Total Level 3 plan assets</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">562</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(25</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(61</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">70</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">565</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="25"> </td></tr></table> As of December 31, 2009, the following methods and assumptions were used to estimate the fair value of our pension and postretirement plans’ assets:   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Cash and cash equivalents, Equity commingled funds, Fixed-income commingled funds—observable prices. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Global equity securities—quoted market prices. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Government bonds, Corporate debt securities—observable market prices. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Other investments—principally unobservable prices adjusted by cash contributions and distributions.</td></tr></table> The following table presents the weighted-average long-term target asset allocations and the percentage of the fair value of plan assets for our U.S. qualified and international pension plans and postretirement plans by major investment category:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="63%"/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="9%"/> <td/> <td valign="bottom" width="12%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">AS OF DECEMBER 31,</td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">TARGET ALLOCATION PERCENTAGE</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="3">PERCENTAGE OF PLAN ASSETS</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> (PERCENTAGES)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">     </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2008</td></tr> <tr> <td valign="top"> U.S. qualified pension plans:</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Cash and cash equivalents</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.1</td> <td valign="bottom">    </td> <td valign="bottom" align="right">2.3</td></tr> <tr> <td valign="top"> Equity securities</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">48</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">47.1</td> <td valign="bottom">    </td> <td valign="bottom" align="right">40.6</td></tr> <tr> <td valign="top"> Debt securities</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">39</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">33.8</td> <td valign="bottom">    </td> <td valign="bottom" align="right">41.2</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Real estate and other investments</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">10</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">13.0</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">15.9</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">100</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">100.0</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">100.0</td></tr> <tr> <td valign="top"> International pension plans:</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Cash and cash equivalents</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.1</td> <td valign="bottom">    </td> <td valign="bottom" align="right">8.7</td></tr> <tr> <td valign="top"> Equity securities</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">54</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">49.9</td> <td valign="bottom">    </td> <td valign="bottom" align="right">48.5</td></tr> <tr> <td valign="top"> Debt securities</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">32</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">33.8</td> <td valign="bottom">    </td> <td valign="bottom" align="right">31.6</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Real estate and other investments</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">14</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">10.2</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">11.2</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">100</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">100.0</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">100.0</td></tr> <tr> <td valign="top"> U.S. postretirement plans:</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Cash and cash equivalents</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">9</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">9.4</td> <td valign="bottom">    </td> <td valign="bottom" align="right">0.6</td></tr> <tr> <td valign="top"> Equity securities</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">54</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">50.9</td> <td valign="bottom">    </td> <td valign="bottom" align="right">57.9</td></tr> <tr> <td valign="top"> Debt securities</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">34</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">35.6</td> <td valign="bottom">    </td> <td valign="bottom" align="right">37.0</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Real estate and other investments</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">3</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">4.1</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">4.5</td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">100</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">100.0</td> <td valign="bottom">    </td> <td valign="bottom" align="right">100.0</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="8"> </td></tr></table> We utilize long-term asset allocation ranges in the management of our plans’ invested assets. The weighted-average target allocation percentages in the preceding table represent our current target within the allocation range for each class of assets in our portfolio. Our long-term return expectations are developed based on a diversified, global investment strategy that takes into account historical experience, as well as the impact of portfolio diversification, active portfolio management, and our view of current and future economic and financial market conditions. As market conditions and other factors change, we may adjust our targets accordingly and our asset allocations may vary from the target allocations outlined above. Our long-term asset allocation ranges reflect our asset class return expectations and tolerance for investment risk within the context of the respective plans’ long-term benefit obligations. These ranges are supported by analysis that incorporates historical and expected returns by asset class, as well as volatilities and correlations across asset classes and our liability profile. This analysis, referred to as an asset-liability analysis, also provides an estimate of expected returns on plan assets, as well as a forecast of potential future asset and liability balances. The plans’ assets are managed with the objectives of minimizing pension expense and cash contributions over the long term. Asset liability studies are performed periodically in order to support asset allocations. Assets include equity and fixed income securities, as well as investments in private real estate, private debt and private equity. The investment managers of each separately managed account are prohibited from investing in derivative securities except for currency risk management activities, which are permitted within the plans’ non-U.S. asset classes and derivatives to manage duration risk in the fixed income accounts. Investment performance is reviewed on a monthly basis in total, as well as by asset class and individual manager, relative to one or more benchmarks. Investment performance and detailed statistical analysis of both investment performance and portfolio holdings are conducted, a large portion of which is presented to senior management on a quarterly basis. Periodic formal meetings are held with each investment manager to review the investments. E. Cash Flows It is our practice to fund amounts for our qualified pension plans that are at least sufficient to meet the minimum requirements set forth in applicable employee benefit laws and local tax laws. The following table presents expected future cash flow information as of December 31, 2009:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="56%"/> <td valign="bottom" width="8%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" rowspan="2" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="8">PENSION PLANS</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" rowspan="2" valign="bottom" align="right" colspan="2"> POST RETIREMENT PLANS</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2"> U.S. QUALIFIED</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2"> U.S. SUPPLEMENTAL (NON-QUALIFIED)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">INTERNATIONAL</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Expected employer contributions:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> 2010</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">7</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">203</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">445</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">259</td></tr> <tr> <td valign="top"> Expected benefit payments:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> 2010</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">837</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">203</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">383</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">291</td></tr> <tr> <td valign="top"> 2011</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">702</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">119</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">386</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">301</td></tr> <tr> <td valign="top"> 2012</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">737</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">126</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">407</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">308</td></tr> <tr> <td valign="top"> 2013</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">777</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">126</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">423</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">321</td></tr> <tr> <td valign="top"> 2014</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">816</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">134</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">441</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">334</td></tr> <tr> <td valign="top"> 2015–2019</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,818</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">754</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,527</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,775</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="13"> </td></tr></table> The table reflects the total U.S. and international plan benefits projected to be paid from the plans or from our general assets under the current actuarial assumptions used for the calculation of the benefit obligation and, therefore, actual benefit payments may differ from projected benefit payments. F. Defined Contribution Plans We have savings and investment plans in several countries, including the U.S., Japan, Spain and the Netherlands. For the U.S. plans, employees may contribute a portion of their salaries and bonuses to the plans, and we match, largely in company stock or company stock units, a portion of the employee contributions. In the U.S., the matching contributions in company stock are sourced from an internal stock trust as well as through open market purchases. Employees are permitted to subsequently diversify all or any portion of their company match contribution. The contribution match for certain legacy Pfizer U.S. participants is held in an employee stock ownership plan. We recorded charges related to our plans of $191 million in 2009, $198 million in 2008 and $203 million in 2007.

14. Equity A. Common Stock In connection with our acquisition of Wyeth on October 15, 2009, we issued approximately 1.3 billion shares of common stock, which were previously held as Pfizer treasury stock, to former Wyeth shareholders to partially fund the acquisition (see Note 2. Acquisition of Wyeth for additional details). The excess of the average cost of Pfizer treasury stock issued over the fair value of the stock portion of the consideration transferred to acquire Wyeth was recorded as a reduction to Retained Earnings. We purchase our common stock via privately negotiated transactions or in open market purchases as circumstances and prices warrant. Purchased shares under each of the share-purchase programs, which are authorized by our Board of Directors, are available for general corporate purposes. On June 23, 2005, we announced that the Board of Directors authorized a $5 billion share-purchase plan (the 2005 Stock Purchase Plan). On June 26, 2006, we announced that the Board of Directors increased the authorized amount of shares to be purchased under the 2005 Stock Purchase Plan from $5 billion to $18 billion. On January 23, 2008, we announced that the Board of Directors had authorized a new $5 billion share-purchase plan, to be funded by operating cash flows, that may be utilized from time to time. In total, under the 2005 Stock Purchase Plan, through December 31, 2009, we purchased approximately 710 million shares for approximately $18.0 billion. We did not purchase any shares of our common stock in 2009. During 2008, we purchased 26 million shares of our common stock at an average price per share of $18.96, and during 2007, we purchased 395&# 160;million shares of our common stock at an average price per share of $25.27. B. Preferred Stock The Series A convertible perpetual preferred stock is held by an Employee Stock Ownership Plan (Preferred ESOP) Trust and provides dividends at the rate of 6.25%, which are accumulated and paid quarterly. The per share stated value is $40,300 and the preferred stock ranks senior to our common stock as to dividends and liquidation rights. Each share is convertible, at the holder’s option, into 2,574.87 shares of our common stock with equal voting rights. The conversion option is indexed to our common stock and requires share settlement, and, therefore, is reported at the fair value at the date of issuance. We may redeem the preferred stock at any time or upon termination of the Preferred ESOP, at our option, in cash, in shares of common stock or, a combination of both at a price of $40,300 per share. C. Employee Stock Ownership Plans We have two employee stock ownership plans (collectively, the ESOPs), the Preferred ESOP and another that holds common stock of the company (Common ESOP). As of January 1, 2008, the legacy Pharmacia U.S. savings plan was merged with the Pfizer Savings Plan. Prior to the merger, a portion of the matching contributions for legacy Pharmacia U.S. savings plan participants was funded through the ESOPs. In January 2007, we paid the remaining balance of financing, which was outstanding prior to our acquisition of Pharmacia in 2003, relating to the Preferred ESOP. Compensation expense related to the ESOPs totaled approximately $35 million in 2007. Allocated shares held by the Common ESOP are considered outstanding for the earnings per share (EPS) calculations and the eventual conversion of allocated preferred shares held by the Preferred ESOP is assumed in the diluted EPS calculation. As of December 31, 2009, the Preferred ESOP held preferred shares with a stated value of approximately $61 million, convertible into approximately 4 million shares of our common stock. As of December 31, 2009, the Common ESOP held approximately 5 million shares of our common stock. As of December 31, 2009, all preferred and common shares held by the ESOPs have been allocated to the Pharmacia U.S. and certain Puerto Rico savings plan participants. D. Employee Benefit Trust The Pfizer Inc. Employee Benefit Trust (EBT) was established in 1999 to fund our employee benefit plans through the use of its holdings of Pfizer Inc. stock. Our consolidated balance sheets reflect the fair value of the shares owned by the EBT as a reduction of Shareholders’ equity.

15. Share-Based Payments Our compensation programs can include share-based payments. In 2009, 2008 and 2007, the primary share-based awards and their general terms and conditions are as follows:   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Stock options, which, when vested, entitle the holder to purchase a specified number of shares of Pfizer common stock at a price per share equal to the market price of Pfizer common stock on the date of grant. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Restricted stock units (RSUs), which, when vested, entitle the holder to receive a specified number of shares of Pfizer common stock, including shares resulting from dividend equivalents paid on such RSUs. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Performance share awards (PSAs) and performance-contingent share awards (PCSAs), which, when vested, entitle the holder to receive a number of shares of Pfizer common stock, within a range of shares from zero to a specified maximum, calculated using a non-discretionary formula that measures Pfizer’s performance relative to an industry peer group. Dividend equivalents accumulate on PSAs and are paid at the end of the vesting term in respect of any shares that are paid. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Short-term incentive awards, which entitle the holder to receive a specified dollar value on the first anniversary of the grant date, based upon performance. At the election of the holder, such specified dollar value is paid: (i) in the case of senior management, all in RSUs, or half in RSUs and half in cash; and (ii) in the case of all other holders, all in RSUs, all in cash, or half in RSUs and half in cash. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Stock appreciation rights (SARs), also referred to as Total Shareholder Return Units (TSRUs), which entitle the holder to receive, two years after the end of the vesting term, a number of shares of Pfizer common stock with a value equal to the difference between the defined settlement price and the closing market price of Pfizer common stock on the date of grant, plus accumulated dividend equivalents through the payment date. </td></tr></table> The Company’s shareholders approved the amendment and restatement of the 2004 Stock Plan at the Annual Meeting of Shareholders held on April 23, 2009. The primary purpose of the amendment was to increase the number of shares of common stock available for grants by 425 million shares. In addition, the amendment provided other changes including that the number of stock options, SARs or other performance-based awards that may be granted to any one individual during any 36-month period is limited to 8 million shares and that RSUs, PSAs and restricted stock grants count as two shares, while stock options and SARs count as one share, toward the maximums for the incremental 425 million shares. As of December 31, 2009, 499 million shares were available for award, which included 0.8 million shares available for award through February 13, 2010 under the Pharmacia Long-Term Incentive plan (the Pharmacia Plan). Such amounts do not include 41 million shares previously issuable but no longer available for award under the Pharmacia Plan, as amended and restated. The 2004 Stock Plan, as amended, is the only Pfizer plan under which equity-based compensation may currently be awarded to executives and other employees. The Company’s shareholders originally approved the 2004 Stock Plan at the Annual Meeting of Shareholders held on April 22, 2004, and, effective upon that approval, new stock option and other share-based awards could be granted only under the originally approved 2004 Stock Plan. As originally approved, the 2004 Stock Plan allowed a maximum of 3 million shares to be awarded to any employee per year and 475 million shares in total. RSUs, PSAs, PCSAs and restricted stock grants counted as three shares, while stock options and SARs counted as one share, toward the maximums under the Plan. In the past, we had various employee stock and incentive plans under which stock options and other share-based awards were granted. Stock options and other share-based awards that were granted under prior plans and were outstanding on April 22, 2004, continue in accordance with the terms of the respective plans. Although not required to do so, we have used authorized and unissued shares and, to a lesser extent, shares held in our Employee Benefit Trust and treasury stock to satisfy our obligations under these programs. A. Impact on Net Income The components of share-based compensation expense and the associated tax benefit follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="72%"/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/> <td/> <td valign="bottom" width="3%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom">Stock option expense</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">165</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">194</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">286</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Restricted stock unit expense</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">183</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">169</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">160</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">PSA and PCSA (expense reduction)/expense</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(17</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">)   </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(9</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Short-term incentive award expense</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">TSRU expense</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">15</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">Directors’ compensation</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom">Share-based payment expense</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">349</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">384</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">437</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">Tax benefit for share-based compensation expense</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(99</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(114</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(141</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom">Share-based payment expense, net of tax</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">250</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">270</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">296</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="15"> </td></tr></table> Amounts capitalized as part of inventory cost were not significant. In 2009, 2008 and 2007, the impact of modifications under our cost-reduction initiatives to share-based awards was not significant. Generally, these modifications resulted in an acceleration of vesting, either in accordance with plan terms or at management’s discretion. B. Stock Options Stock options, which, when vested, entitle the holder to purchase a specified number of shares of Pfizer common stock at a price per share equal to the market price of Pfizer common stock on the date of grant, are accounted for using a fair-value-based method at the date of grant in the consolidated statements of income. The values determined through this fair-value-based method generally are amortized on an even basis over the vesting term into Cost of sales, Selling, informational and administrative expenses, and Research and development expenses, as appropriate. All employees may receive stock option grants. No stock options were awarded to senior and key management in 2009; however, stock options were awarded to certain other employees. Except for stock options awarded to two executive officers at the time they joined Pfizer, no stock options were awarded to senior and key management in 2008. In virtually all instances, stock options granted since 2005 vest after three years of continuous service from the grant date and have a contractual term of 10 years. In all cases, even for stock options that are subject to accelerated vesting upon voluntary retirement, stock options must be held for at least one year from the grant date before any vesting may occur. In the event of a divestiture or restructuring, options held by employees are immediately vested and are exercisable for a period from three months to their remaining term, depending on various conditions. </fon t> The fair-value-based method for valuing each stock option grant on the grant date uses, for virtually all grants, the Black-Scholes-Merton option-pricing model, which incorporates a number of valuation assumptions noted in the following table, shown at their weighted-average values:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="70%"/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="4%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="7">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom">Expected dividend yield(a)</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4.90</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">%   </td> <td valign="bottom">    </td> <td valign="bottom" align="right">5.54</td> <td valign="bottom" nowrap="nowrap">%   </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.49</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Risk-free interest rate(b)</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2.69</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">2.90</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.69</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Expected stock price volatility(c)</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">41.36</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">27.21</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">21.28</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Expected term(d) (years)</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6.0</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">5.75</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">5.75</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="12"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Determined using a constant dividend yield during the expected term of the option. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Determined using the interpolated yield on U.S. Treasury zero-coupon issues. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> Determined using implied volatility, after consideration of historical volatility. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d)</td> <td valign="top" align="left"> Determined using historical exercise and post-vesting termination patterns. </td></tr></table> The following table summarizes all stock option activity during 2009:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="46%"/> <td valign="bottom" width="10%"/> <td/> <td/> <td valign="bottom" width="10%"/> <td/> <td/> <td valign="bottom" width="10%"/> <td/> <td valign="bottom" width="10%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">SHARES (THOUSANDS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">WEIGHTED-AVERAGE EXERCISE PRICE PER SHARE</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">WEIGHTED-AVERAGE REMAINING CONTRACTUAL TERM (YEARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">AGGREGATE INTRINSIC VALUE(a) (MILLIONS)</td></tr> <tr> <td valign="top"> Outstanding, December 31, 2008</td> <td valign="bottom"> </td> <td valign="bottom" align="right">489,054</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">32.91</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Granted</td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,454</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12.74</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Exercised</td> <td valign="bottom"> </td> <td valign="bottom" align="right">(556</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12.70</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Forfeited</td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,988</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21.55</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Canceled</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(86,271</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">36.54</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom">Outstanding, December 31, 2009</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">447,693</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">30.11</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4.6</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">259</td></tr> <tr> <td valign="bottom"> Vested and expected to vest(b), December 31, 2009</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">441,480</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">30.26</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4.6</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">246</td></tr> <tr> <td valign="bottom">Exercisable, December 31, 2009</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">318,808</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">34.20</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3.2</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="12"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Market price of underlying Pfizer common stock less exercise price. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> The number of options expected to vest takes into account an estimate of expected forfeitures.</td></tr></table> The following table provides data related to all stock option activity:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="70%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="8">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS, EXCEPT PER STOCK OPTION AMOUNTS AND YEARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom">Weighted-average grant date fair value per stock option</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3.30</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.30</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.11</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Aggregate intrinsic value on exercise</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">173</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Cash received upon exercise</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">7</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">29</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">532</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Tax benefits realized related to exercise</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">54</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Total compensation cost related to nonvested stock options not yet recognized, pre-tax</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">147</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">159</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">216</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Weighted-average period in years over which stock option compensation cost is expected to be recognized</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1.2</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.1</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.2</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="12"> </td></tr></table> C. Restricted Stock Units (RSUs) RSUs, which, when vested, entitle the holder to receive a specified number of shares of Pfizer common stock, including shares resulting from dividend equivalents paid on such RSUs, are accounted for using a fair-value-based method at the date of grant. For RSUs granted in 2009, 2008 and 2007, in virtually all instances, the units vest after three years of continuous service from the grant date and the values determined using the fair-value-based method are amortized on an even basis over the vesting term into Cost of sales, Selling, informational and administrative expenses and Research and development expenses, as appropriate. The value of each RSU grant is estimated on the grant date. The fair-value-based method utilizes the closing price of Pfizer common stock on the date of grant. The following table summarizes all RSU activity during 2009:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="79%"/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="4%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">SHARES (THOUSANDS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">WEIGHTED- AVERAGE GRANT DATE FAIR VALUE PER SHARE</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Nonvested, December 31, 2008</td> <td valign="bottom">  </td> <td valign="bottom" align="right">28,964</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24.47</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Granted</td> <td valign="bottom">  </td> <td valign="bottom" align="right">15,152</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13.75</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Vested</td> <td valign="bottom">  </td> <td valign="bottom" align="right">(5,179</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">25.25</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Reinvested dividend equivalents</td> <td valign="bottom">  </td> <td valign="bottom" align="right">1,656</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15.39</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Forfeited</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(2,510</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21.53</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Nonvested, December 31, 2009</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">38,083</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">19.90</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="9"> </td></tr></table> The following table provides data related to all RSU activity:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="75%"/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS EXCEPT YEARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom">Total fair-value-based amount of shares vested</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">131</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">     </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">119</td> <td valign="bottom" nowrap="nowrap">     </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">146</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Total compensation cost related to nonvested RSU awards not yet recognized, pre-tax</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">198</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">257</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">254</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Weighted-average period in years over which RSU cost is expected to be recognized</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1.3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.5</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.1</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="14"> </td></tr></table> D. Performance Share Awards (PSAs) and Performance-Contingent Share Awards (PCSAs) PSAs and PCSAs are awarded to senior and key management. PSAs in 2009, 2008, 2007 and 2006, and PCSAs in earlier years entitle the holder to receive, at the end of a vesting term, a number of shares of our common stock within a specified range of shares, calculated using a non-discretionary formula that measures our performance relative to an industry peer group. PSAs are accounted for using a fair-value-based method at the date of grant in the consolidated statements of income beginning with grants in 2006. Further, PSAs generally are amortized on an even basis over the vesting term into Cost of sales, Selling, informational and administrative expenses and Research and development expenses, as appropriate. PCSAs, which have not been awarded since 2005, are accounted for using the intrinsic value method in the consolidated statements of income. Senior and other key member s of management may receive PSA grants and were eligible to receive PCSA grants. In most instances, PSA grants vest after three years, and PCSA grants vest after five years of continuous service from the grant date. In certain instances, PCSA grants vest over two to four years of continuous service from the grant date. The vesting terms are equal to the contractual terms. PSA grants made in 2009, 2008, 2007 and 2006 vest and are paid based on a non-discretionary formula that measures our performance using relative total shareholder return over a performance period relative to an industry peer group. If our minimum performance in the measure is below the threshold level relative to the peer group, then no shares are paid. PCSA grants, which were all made prior to 2006, vest and are paid based on a non-discretionary formula that measures our performance using relative total shareholder return and relative change in diluted EPS over a performance period relative to an industry peer group. If our minimum performance is below the threshold level relative to the peer group, then no shares will be paid. We measure PSA grants using a fair-value-based amount, which is derived from a Monte Carlo simulation model, times the target number of shares. The target number of shares is determined by reference to the fair value of share-based awards to similar employees in the industry peer group. We measure PCSA grants at intrinsic value whereby the probable award is allocated over the term of the award, and then the resultant shares are adjusted to the fair value of our common stock at each accounting period until the date of payment. The weighted-average assumptions used in the valuation of PSAs are as follows:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="80%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="7">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom">Risk-free interest rate</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1.95</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">%   </td> <td valign="bottom">    </td> <td valign="bottom" align="right">2.05</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">4.68</td> <td valign="bottom" nowrap="nowrap">% </td></tr> <tr> <td valign="bottom">Expected Pfizer stock price volatility</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">40.40</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">27.21</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">21.28</td> <td valign="bottom" nowrap="nowrap">% </td></tr> <tr> <td valign="bottom">Average peer stock price volatility</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">36.30</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">32.13</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">18.85</td> <td valign="bottom" nowrap="nowrap">% </td></tr> <tr> <td valign="bottom">Contractual term in years</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">3</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="9"> </td> <td> </td></tr></table>   The following table summarizes all PSA and PCSA activity during 2009, with the shares granted representing the maximum award that could be achieved:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="78%"/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">SHARES (THOUSANDS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">WEIGHTED- AVERAGE GRANT DATE FAIR VALUE PER SHARE</td></tr> <tr> <td valign="bottom">Nonvested, December 31, 2008</td> <td valign="bottom">  </td> <td valign="bottom" align="right">7,892</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23.52</td></tr> <tr> <td valign="bottom"> Granted</td> <td valign="bottom">  </td> <td valign="bottom" align="right">2,388</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12.43</td></tr> <tr> <td valign="bottom"> Vested</td> <td valign="bottom">  </td> <td valign="bottom" align="right">(2,025</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">18.77</td></tr> <tr> <td valign="bottom"> Forfeited</td> <td valign="bottom">  </td> <td valign="bottom" align="right">(2,479</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19.09</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Modifications(a)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">342</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15.05</td></tr> <tr> <td valign="bottom">Nonvested, December 31, 2009</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6,118</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">23.07</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="7"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Modifications include pro-ration of the awards for service to the date of termination for 13 former employees in 2009. The modifications were made at the discretion of the Senior Vice President of Worldwide Human Resources, or her designee for 2009. There was no incremental cost related to the modifications. </td></tr></table> The following table provides data related to all PSA and PCSA activity:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="72%"/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="9%"/> <td/> <td/> <td valign="bottom" width="9%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="8">YEAR ENDED DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS, EXCEPT YEARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td></tr> <tr> <td valign="bottom">Total intrinsic value of vested PSA/PCSA shares</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">37</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">46</td></tr> <tr> <td valign="bottom">Total compensation cost related to nonvested PSA grants not yet recognized, pre-tax</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">17</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">20</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15</td></tr> <tr> <td valign="bottom">Weighted-average period in years over which PSA cost is expected to be recognized</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="10"> </td></tr></table> E. Total Shareholder Return Units (TSRUs) Total Shareholder Return Units (TSRUs) (formerly known as Stock Appreciation Rights (SARs)) are awarded to senior and key management. TSRUs entitle the holders to receive, two years after the end of a three-year vesting term, a number of shares of our common stock with a value equal to the difference between the defined settlement price and the grant price, plus the dividends accumulated during the five-year term. The settlement price is the average closing price of Pfizer common stock during the 20 trading days ending on the fifth anniversary of the grant; the grant price is the closing price of Pfizer common stock on the date of the grant. The TSRUs are automatically settled on the fifth anniversary of the grant but vest on the third anniversary of the grant, after which time there no longer is a risk of forfeiture. TSRUs are accounted for using a fair-value-based method at the date of grant in the consolidated statements of income and generally are amortized on an even basis over the vesting term into Cost of sales, Selling, informational and administrative expenses and Research and development expenses, as appropriate. The fair-value-based method for valuing the TSRUs uses the Monte Carlo simulation model. The model incorporates a number of valuation assumptions noted in the following table, shown at their weighted-average values:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="78%"/> <td valign="bottom" width="8%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" rowspan="2" valign="bottom" align="center" bgcolor="#bfbfbf"> TSRUs 2009</td> <td style="BORDER-TOP: #000000 1px solid" rowspan="2" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" rowspan="2" valign="bottom" align="center"> TSRUs 2008</td> <td style="BORDER-TOP: #000000 1px solid" rowspan="2" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom">Expected dividend yield(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4.55</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.54</td> <td valign="bottom" nowrap="nowrap">% </td></tr> <tr> <td valign="bottom">Risk-free interest rate(b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2.35</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.77</td> <td valign="bottom" nowrap="nowrap">% </td></tr> <tr> <td valign="bottom">Expected stock price volatility(c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">36.92</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom"> </td> <td valign="bottom" align="right">27.21</td> <td valign="bottom" nowrap="nowrap">% </td></tr> <tr> <td valign="bottom">Expected term(d) (years)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5.00</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.00</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="6"> </td> <td> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Determined using a constant dividend yield during the expected term of the TSRU. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Determined using the interpolated yield on U.S. Treasury zero-coupon issues. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> Determined using implied volatility, after consideration of historical volatility. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d)</td> <td valign="top" align="left"> Determined using the contractual term.</td></tr></table> The following summarizes all TSRU activity during 2009:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="74%"/> <td valign="bottom" width="9%"/> <td/> <td/> <td valign="bottom" width="9%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">SHARES (THOUSANDS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap" colspan="2">WEIGHTED- AVERAGE GRANT DATE VALUE PER SHARE</td></tr> <tr> <td valign="top"> Nonvested, December 31, 2008</td> <td valign="bottom">  </td> <td valign="bottom" align="right">2,756</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">22.49</td></tr> <tr> <td valign="top"> Granted</td> <td valign="bottom">  </td> <td valign="bottom" align="right">6,365</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14.62</td></tr> <tr> <td valign="top"> Vested</td> <td valign="bottom">  </td> <td valign="bottom" align="right">(47</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">18.02</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Forfeited</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(393</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">16.12</td></tr> <tr> <td valign="top"> Nonvested, December 31, 2009</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8,681</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">17.04</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="7"> </td></tr></table> The following table provides data related to all TSRU activity:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="79%"/> <td valign="bottom" width="7%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="5">YEAR ENDED DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS, EXCEPT PER TSRU AMOUNTS AND YEARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">2008</td></tr> <tr> <td valign="top"> Weighted-average grant date fair value per TSRU</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4.26</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5.54</td></tr> <tr> <td valign="top"> Total compensation cost related to nonvested TSRU grants not yet recognized, pre-tax</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">23</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9</td></tr> <tr> <td valign="top"> Weighted-average period in years over which TSRU cost is expected to be recognized</td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2.1</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.2</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="7"> </td></tr></table>

16. Earnings per Common Share Basic and diluted EPS were computed using the following common share data:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="71%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="8">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(IN MILLIONS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">    2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">    2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">    2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> EPS Numerator—Basic:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Income from continuing operations attributable to Pfizer Inc.</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8,621</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,026</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,213</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Less: Preferred stock dividends—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">3</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">4</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Income from continuing operations attributable to Pfizer Inc. common shareholders</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8,619</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,023</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,209</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Discontinued operations—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">14</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">78</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(69</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Net income attributable to Pfizer Inc. common shareholders</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">8,633</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">8,101</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">8,140</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> EPS Denominator—Basic:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Weighted-average number of common shares outstanding</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">7,007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">6,727</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">6,917</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> EPS Numerator—Diluted:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Income from continuing operations attributable to Pfizer Inc.</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8,621</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,026</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,213</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Less: ESOP contribution—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Income from continuing operations attributable to Pfizer Inc. common shareholders</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8,621</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,026</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,211</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Discontinued operations—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">14</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">78</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(69</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Net income attributable to Pfizer Inc. common shareholders</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">8,635</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">8,104</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">8,142</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> EPS Denominator—Diluted:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Weighted-average number of common shares outstanding</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">7,007</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,727</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,917</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Common-share equivalents—stock options, stock issuable under employee compensation plans and convertible preferred stock</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">38</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">23</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">22</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Weighted-average number of common shares outstanding and common-share equivalents</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">7,045</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">6,750</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">6,939</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans(a)</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">400</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">489</td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">514</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="10"> </td> <td> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> These common stock equivalents were outstanding during 2009, 2008 and 2007 but were not included in the computation of diluted EPS for those years because their inclusion would have had an anti-dilutive effect. </td></tr></table>

17. Lease Commitments We lease properties and equipment for use in our operations. In addition to rent, the leases may require us to pay directly for taxes, insurance, maintenance and other operating expenses or to pay higher rent when operating expenses increase. Rental expense, net of sublease income, was $364 million in 2009, $370 million in 2008 and $398 million in 2007. This table shows future minimum rental commitments under non-cancelable operating leases as of December 31 for the following years:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="47%"/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2010</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2011</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2012</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2013</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2014</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">AFTER 2014</td></tr> <tr> <td valign="top"> Lease commitments</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">266</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">183</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">144</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">119</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">97</td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">890</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="19"> </td></tr></table>

18. Insurance Our insurance coverage reflects market conditions (including cost and availability) existing at the time it is written, and our decision to obtain insurance coverage or to self-insure varies accordingly. Depending upon the cost and availability of insurance and the nature of the risk involved, the amount of self-insurance may be significant. The cost and availability of coverage have resulted in self-insuring certain exposures, including product liability. If we incur substantial liabilities that are not covered by insurance or substantially exceed insurance coverage and that are in excess of existing accruals, there could be a material adverse effect on our results of operations in any particular period (see Note 19. Legal Proceedings and Contingencies).

20. Segment, Geographic and Revenue Information Business Segments Effective with the acquisition of Wyeth, we operate in the following two distinct commercial organizations, which constitute our two business segments:   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Biopharmaceutical consists of the Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets customer-focused units and includes products that prevent and treat cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urogenital conditions, cancer, eye diseases and endocrine disorders, among others. Biopharmaceutical’s segment profit includes costs related to research and development, manufacturing, and sales and marketing activities that are associated with the products in our Biopharmaceutical segment. </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Diversified includes animal health products that prevent and treat diseases in livestock and companion animals including vaccines, parasiticides and anti-infectives; consumer healthcare products that include over-the-counter healthcare products such as pain management therapies (analgesics and heat wraps), cough/cold/allergy remedies, dietary supplements, hemorrhoidal care and personal care items; nutrition products such as infant and toddler nutritional products; and Capsugel, which represents our gelatin capsule products and services business. Diversified’s segment profit includes costs related to research and development, manufacturing, and sales and marketing activities that are associated with the products in our Diversified segment. </td></tr></table> Segment profit/(loss) is measured based on income from continuing operations before provision for taxes on income and income attributable to noncontrolling interests. Certain costs, such as significant impacts of purchase accounting for acquisitions, restructuring and acquisition-related costs, costs related to our cost-reduction initiatives and transition activity associated with our former consumer healthcare business, which was sold in 2006, are included in Corporate/Other only. This methodology is utilized by management to evaluate our businesses. Each segment is managed separately and offers different products requiring different marketing and distribution strategies. We sell our products primarily to customers in the wholesale sector. In 2009, sales to our three largest U.S. wholesaler customers represented approximately 17%, 11% and 10% of total revenues and, collectively, represented approximately 13% of accounts receivable as of December 31, 2009. In 2008, sales to our three largest U.S. wholesaler customers represented approximately 16%, 10% and 10% of total revenues and, collectively, represented approximately 19% of accounts receivable as of December 31, 2008. These sales and related accounts receivable were concentrated in the Biopharmaceutical segment. Revenues exceeded $500 million in each of 13 countries outside the U.S. in 2009 and in each of 14 countries outside the U.S. in 2008. The U.S. was the only country to contribute more than 10% of total revenues in each year. Segment Revenues and Profit(a) Segment revenues and profit are as follows:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="69%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="top">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom"> Revenues</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Biopharmaceutical</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">45,448</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">44,174</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">44,424</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Diversified</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,189</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,592</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,324</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Corporate/Other(b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">372</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">530</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">670</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Total revenues</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">50,009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">48,296</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">48,418</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom"> Segment profit/(loss)(c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Biopharmaceutical</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">21,939</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,786</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">20,740</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Diversified</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">935</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">972</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">790</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Corporate/Other(b), (d) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(12,047</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">)     </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(13,064</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(12,252</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom"> Total profit/(loss)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">10,827</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,694</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,278</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="15"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> Reflects legacy Wyeth products and operations commencing on the Wyeth acquisition date, October 15, 2009, in accordance with Pfizer’s domestic and international year-ends. Prior-period amounts for Capsugel, which were previously classified in Corporate/Other, are now classified in Diversified. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b) </td> <td valign="top" align="left"> Corporate/Other includes Pfizer Centersource, which includes contract manufacturing and bulk pharmaceutical chemical sales, and transition activity associated with our former consumer healthcare business (sold in December 2006). Corporate/Other under Segment profit/(loss) also includes interest income/(expense), corporate expenses (e.g., corporate administration costs), other income/(expense) (e.g., realized gains and losses attributable to our investments in debt and equity securities), certain performance-based and all share-based compensation expenses, significant impacts of purchase accounting for acquisitions, acquisition-related costs, intangible asset impairments and costs related to our cost-reduction initiatives. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c) </td> <td valign="top" align="left"> Segment profit/(loss) equals Income from continuing operations before provision for taxes on income and net income attributable to noncontrolling interests. Certain costs, such as significant impacts of purchase accounting for acquisitions, acquisition-related costs and costs related to our cost-reduction initiatives and transition activity associated with our former consumer healthcare business are included in Corporate/Other only. This methodology is utilized by management to evaluate our businesses. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d) </td> <td valign="top" align="left"> In 2009, Corporate/Other includes: (i) significant impacts of purchase accounting for acquisitions of $3.8 billion, including intangible asset amortization, charges related to fair value adjustments of acquisition-date inventory sold and other charges, primarily related to our acquisitions of Wyeth in 2009 and Pharmacia in 2003; (ii) restructuring and acquisition-related costs of $4.3 billion, primarily related to our acquisition of Wyeth; (iii) all share-based compensation expense; (iv) a gain of $482 million related to ViiV (see Note 3A. Other Significant Transactions and Events: Formation of ViiV, an Equity-Method Investment); (v) net interest expense of $487 million; and (vi) an impairment of $298 million associated with certain materials used in our research and development activities that are no longer considered recoverable. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">     </td> <td valign="top" align="left">In 2008, Corporate/Other includes: (i) restructuring charges and implementation costs associated with our cost-reduction initiatives of $4.2 billion; (ii) significant impacts of purchase accounting for acquisitions of $3.2 billion, including acquired in-process research and development, intangible asset amortization and other charges; (iii) charges of approximately $2.3 billion related to the resolution of certain investigations concerning Bextra and various other products, as well as certain other investigations, and charges of approximately $900 million associated with the resolution of certain litigation involving our NSAID pain medicines; (iv) all share-based compensation expense; (v) net interest income of $772 million; (vi) asset impairment charges of $213 million; and (vii) acquisition-related costs of $49 million. </td> ;</tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">     </td> <td valign="top" align="left">In 2007, Corporate/Other includes: (i) restructuring charges and implementation costs associated with our cost-reduction initiatives of $3.9 billion; (ii) significant impacts of purchase accounting for acquisitions of $3.4 billion, including acquired in-process research and development, intangible asset amortization and other charges; (iii) $2.8 billion of charges associated with Exubera; (iv) net interest income of $1.1 billion; (v) all share-based compensation expense; (vi) gain on disposal of assets and other of $174 million; and (vii) acquisition-related costs of $11 million.</td></tr></table> Segment Assets, Property, Plant and Equipment Additions, and Depreciation and Amortization(a) Additional details follow:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="75%"/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="8">YEAR ENDED/AS OF DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2009  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2007</td></tr> <tr> <td valign="top"> Identifiable assets</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Biopharmaceutical</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">120,789  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">60,591</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">67,431</td></tr> <tr> <td valign="top"> Diversified</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">16,684  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,808</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,738</td></tr> <tr> <td valign="top"> Discontinued operations/Held for sale</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">496  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">148</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">114</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Corporate/Other(b), (c)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">74,980  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">47,601</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">44,985</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total identifiable assets</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">212,949  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">111,148</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">115,268</td></tr> <tr> <td valign="top"> Property, plant and equipment additions(d)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Biopharmaceutical</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">985  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,351</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,608</td></tr> <tr> <td valign="top"> Diversified</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">147  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">265</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">146</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Corporate/Other(b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">73  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">85</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">126</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total property, plant and equipment additions</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">1,205  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,701</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,880</td></tr> <tr> <td valign="top"> Depreciation and amortization(d)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Biopharmaceutical</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,672  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,223</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,886</td></tr> <tr> <td valign="top"> Diversified</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">113  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">108</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">94</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Corporate/Other(b), (e)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2,972  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,759</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">3,220</td></tr> <tr> <td valign="top"> Total depreciation and amortization</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,757  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,090</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,200</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="10"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Reflects legacy Wyeth amounts in 2009 commencing on the Wyeth acquisition date, October 15, 2009. Prior-period amounts for Capsugel, which were previously classified in Corporate/Other, are now classified in Diversified. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Corporate/Other includes Pfizer Centersource, which includes contract manufacturing and bulk pharmaceutical chemical sales and transition activity associated with our former consumer healthcare business (sold in December 2006). </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> Assets included within Corporate/Other are primarily cash and cash equivalents, short-term investments, and long-term investments and loans. In 2009, also includes $20.0 billion of goodwill resulting from our acquisition of Wyeth (see Note 2. Acquisition of Wyeth for additional information). The allocation of goodwill among segments has not yet been completed but will be completed within one year from the acquisition date, October 15, 2009. Upon completion of the goodwill allocation, this goodwill will be reclassified to the appropriate segments. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d)</td> <td valign="top" align="left"> Certain production facilities are shared. Property, plant and equipment, as well as capital additions and depreciation, are allocated based on estimates of physical production. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(e)</td> <td valign="top" align="left"> Corporate/Other includes non-cash charges associated with purchase accounting related to intangible asset amortization of $2.7 billion in 2009, $2.5 billion in 2008 and $3.1 billion in 2007. </td></tr></table>   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="74%"/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top">Geographic(a)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top">Revenues and long-lived assets by geographic region are as follows:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="8">YEAR ENDED/AS OF DECEMBER 31,</td></tr> <tr> <td valign="top"/> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2009  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2007</td></tr> <tr> <td valign="top"> Revenues</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> United States(b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">21,749  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">20,401</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,153</td></tr> <tr> <td valign="top"> Europe</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">14,561  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,980</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13,647</td></tr> <tr> <td valign="top"> Japan/Other Asia</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">7,988  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,166</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,511</td></tr> <tr> <td valign="top"> Canada/Latin America/AFME(c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">5,711  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,749</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,107</td></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="top"> Consolidated</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">50,009  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">48,296</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">48,418</td></tr> <tr> <td valign="top"> Long-lived assets(d)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> United States(b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">50,901  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,296</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">19,145</td></tr> <tr> <td valign="top"> Europe</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">32,015  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,220</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15,416</td></tr> <tr> <td valign="top"> Japan/Other Asia</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,966  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,080</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,177</td></tr> <tr> <td valign="top"> Canada/Latin America/AFME(c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,913  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">412</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">494</td></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="top"> Consolidated</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">90,795  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right">31,008</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right">36,232</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="10"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Reflects legacy Wyeth amounts in 2009 commencing on the Wyeth acquisition date, October 15, 2009. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Includes operations in Puerto Rico. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> Includes Africa and the Middle East. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d)</td> <td valign="top" align="left"> Long-lived assets include identifiable intangible assets (excluding goodwill) and property, plant and equipment. </td></tr></table> <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td valign="top">Revenues by Product</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top">Significant product revenues are as follows:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="9">YEAR ENDED DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td></tr> <tr> <td valign="top"> Biopharmaceutical products:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Lipitor</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">11,434</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,401</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,675</td></tr> <tr> <td valign="top"> Lyrica</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,840</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,573</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,829</td></tr> <tr> <td valign="top"> Celebrex</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,383</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,489</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,290</td></tr> <tr> <td valign="top"> Norvasc</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,973</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,244</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,001</td></tr> <tr> <td valign="top"> Viagra</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,892</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,934</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,764</td></tr> <tr> <td valign="top"> Xalatan/Xalacom</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,737</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,745</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,604</td></tr> <tr> <td valign="top"> Detrol/Detrol LA</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,154</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,214</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,190</td></tr> <tr> <td valign="top"> Zyvox</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,141</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,115</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">944</td></tr> <tr> <td valign="top"> Geodon/Zeldox</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,002</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,007</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">854</td></tr> <tr> <td valign="top"> Sutent</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">964</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">847</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">581</td></tr> <tr> <td valign="top"> Genotropin</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">887</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">898</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">843</td></tr> <tr> <td valign="top"> Vfend</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">798</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">743</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">632</td></tr> <tr> <td valign="top"> Chantix/Champix</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">700</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">846</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">883</td></tr> <tr> <td valign="top"> Caduet</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">548</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">589</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">568</td></tr> <tr> <td valign="top"> Effexor(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">520</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td></tr> <tr> <td valign="top"> Zoloft</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">516</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">539</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">531</td></tr> <tr> <td valign="top"> Aromasin</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">483</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">465</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">401</td></tr> <tr> <td valign="top"> Cardura</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">457</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">499</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">506</td></tr> <tr> <td valign="top"> Revatio</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">450</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">336</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">201</td></tr> <tr> <td valign="top"> Aricept(b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">432</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">482</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">401</td></tr> <tr> <td valign="top"> Zithromax/Zmax</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">430</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">429</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">438</td></tr> <tr> <td valign="top"> Enbrel(a), (c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">378</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td></tr> <tr> <td valign="top"> Prevnar/Prevenar 7(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">287</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td></tr> <tr> <td valign="top"> Premarin family(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">213</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td></tr> <tr> <td valign="top"> Zosyn/Tazocin(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">184</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td></tr> <tr> <td valign="top"> BeneFIX(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">98</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td></tr> <tr> <td valign="top"> ReFacto/Xyntha(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">47</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td></tr> <tr> <td valign="top"> All Other(d)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">8,575</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,528</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,499</td></tr> <tr> <td valign="top"> Alliance revenues (Enbrel (in the U.S. and Canada)(a), Aricept, Exforge, Rebif and Spiriva)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,925</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,251</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,789</td></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="top"> Total Biopharmaceutical products</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">45,448</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">44,174</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">44,424</td></tr> <tr> <td valign="top"> Diversified products:</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/></tr> <tr> <td valign="top"> Animal health products(d)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,764</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,825</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,639</td></tr> <tr> <td valign="top"> Consumer healthcare products(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">494</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td></tr> <tr> <td valign="top"> Capsugel(e)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">740</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">767</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">685</td></tr> <tr> <td valign="top"> Nutrition products(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">191</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="top"> Total Diversified products</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">4,189</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right">3,592</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right">3,324</td></tr> <tr> <td valign="top"> Corporate/Other</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">372</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">530</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">670</td></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> Total revenues</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">50,009</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right">48,296</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" align="right">48,418</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="11"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Legacy Wyeth products and operations. In accordance with Pfizer’s domestic and international year-ends, includes approximately two-and-a-half months of Wyeth’s U.S. operations and approximately one-and-a-half months of Wyeth’s international operations in 2009. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Represents direct sales under license agreement with Eisai. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> Outside the U.S. and Canada. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d)</td> <td valign="top" align="left"> Includes legacy Pfizer and legacy Wyeth products in 2009. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(e)</td> <td valign="top" align="left"> Prior-period amounts for Capsugel, which were previously classified in Corporate/Other are now classified in Diversified. </td></tr></table>

19. Legal Proceedings and Contingencies We and certain of our subsidiaries are involved in various patent, product liability, consumer, commercial, securities, environmental and tax litigations and claims; government investigations; and other legal proceedings that arise from time to time in the ordinary course of our business. We do not believe any of them will have a material adverse effect on our financial position. Beginning in 2007 upon the adoption of a new accounting standard, we record accruals for income tax contingencies to the extent that we conclude that a tax position is not sustainable under a “more likely than not” standard and we record our estimate of the potential tax benefits in one tax jurisdiction that could result from the payment of income taxes in another tax jurisdiction when we conclude that the potential recovery is more likely than not (see Note 1P. Significant Accounting Policies: Income Tax Contingencies). We record accruals for all other contingencies to the extent that we conclude their occurrence is probable and the related damages are estimable, and we record anticipated recoveries under existing insurance contracts when assured of recovery. If a range of liability is probable and estimable and some amount within the range appears to be a better estima te than any other amount within the range, we accrue that amount. If a range of liability is probable and estimable and no amount within the range appears to be a better estimate than any other amount within the range, we accrue the minimum of such probable range. Many claims involve highly complex issues relating to causation, label warnings, scientific evidence, actual damages and other matters. Often these issues are subject to substantial uncertainties and, therefore, the probability of loss and an estimation of damages are difficult to ascertain. Consequently, we cannot reasonably estimate the maximum potential exposure or the range of possible loss in excess of amounts accrued for these contingencies. These assessments can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions (see Note 1C. Significant Accounting Policies: Estimates and Assumptions). Our assessments are based on estimates and assumptions that have been deemed reaso nable by management. Litigation is inherently unpredictable, and excessive verdicts do occur. Although we believe we have substantial defenses in these matters, we could in the future incur judgments or enter into settlements of claims that could have a material adverse effect on our results of operations in any particular period. Patent claims include challenges to the coverage and/or validity of our patents on various products or processes. Although we believe we have substantial defenses to these challenges with respect to all our material patents, there can be no assurance as to the outcome of these matters, and a loss in any of these cases could result in a loss of patent protection for the drug at issue, which could lead to a significant loss of sales of that drug and could materially affect future results of operations. Among the principal matters pending to which we are a party are the following: A. Patent Matters Like other pharmaceutical companies, we are involved in numerous suits relating to our patents, including but not limited to those discussed below. Most of the suits involve claims by generic drug manufacturers that patents covering our products, processes or dosage forms are invalid and/or do not cover the product of the generic manufacturer. Also, counterclaims as well as various independent actions have been filed claiming that our assertions of, or attempts to enforce, our patent rights with respect to certain products constitute unfair competition and/or violations of the antitrust laws. In addition to the challenges to the U.S. patents on a number of our products that are discussed below, we note that the patent rights to certain of our products, including without limitation Lipitor, are being challenged in various other countries. Lipitor (atorvastatin) In November 2008, Apotex Inc. (Apotex) notified us that it had filed an abbreviated new drug application with the U.S. Food and Drug Administration (FDA) seeking approval to market a generic version of Lipitor. Apotex asserts the invalidity of our enantiomer patent, which (including the six-month pediatric exclusivity period) expires in June 2011, and the non-infringement of certain later-expiring patents. In December 2008, we filed suit against Apotex in the U.S. District Court for the District of Delaware and the U.S. District Court for the Northern District of Illinois asserting the validity and infringement of the enantiomer patent. In August 2009, our action in the District of Delaware was transferred to the Northern District of Illinois and consolidated with our pending action there. In May 2009, Matrix Laboratories Limited (Matrix), a subsidiary of Mylan Inc. (Mylan), notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Lipitor. Matrix asserts the non-infringement of our patent covering the crystalline form of atorvastatin, which (including the six-month pediatric exclusivity period) expires in 2017, and the non-infringement of two formulation patents. Matrix is not challenging our enantiomer patent. In June 2009, we filed actions against Matrix, Mylan and another Mylan subsidiary in the U.S. District Court for the District of Delaware and the U.S. District Court for the Northern District of West Virginia asserting the infringement of the crystalline patent and two process patents that expire in 2016. In November 2009, our action in the Northern District of West Virginia was transferred t o the District of Delaware and consolidated with our pending action there. In October 2009, Dr. Reddy’s Laboratories Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively, Dr. Reddy’s) and KUDCO Ireland, Ltd. and Kremers Urban LLC (collectively, KUDCO) notified us that they had filed abbreviated new drug applications with the FDA seeking approval to market generic versions of Lipitor. They assert the invalidity and/or non-infringement of our patent covering the crystalline form of atorvastatin and two other Lipitor patents. They are not challenging our enantiomer patent. In December 2009, we filed actions against Dr. Reddy’s and KUDCO in the U.S. District Court for the District of Delaware asserting the infringement of our crystalline patent. Caduet (atorvastatin/amlodipine combination) In August 2009, Sandoz Inc., a division of Novartis AG (Sandoz), notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Caduet. In that filing and in a declaratory judgment action brought by Sandoz in October 2009 in the U.S. District Court for the District of Colorado, collectively, Sandoz asserts the invalidity of our patent covering the atorvastatin/amlodipine combination, which expires in 2018, and the invalidity and non-infringement of three patents for Lipitor, which (including the six-month pediatric exclusivity period) expire between 2013 and 2017. Sandoz is not challenging our enantiomer patent for Lipitor. In October 2009, we filed suit against Sandoz in the U.S. District Court for the District of Delaware and the U.S. District Court for the District of Colorado asserting the infringement of the atorvastatin/amlodipine combinati on patent. In December 2009, Mylan Pharmaceuticals, Inc. notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Caduet. Mylan asserts the invalidity of our patent covering the atorvastatin/ amlodipine combination and the non-infringement of three patents for Lipitor, which (including the six-month pediatric exclusivity period) expire between 2013 and 2017. Mylan Pharmaceuticals, Inc. is not challenging our enantiomer patent for Lipitor. In February 2010, we filed suit against Mylan Pharmaceuticals, Inc. in the U.S. District Court for the District of Delaware asserting the infringement of the atorvastatin/amlodipine combination patent. Detrol (tolterodine) In March 2004, we brought a patent infringement suit in the U.S. District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva USA), which had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Detrol. In January 2007, Teva USA withdrew its challenge to our patent, and the patent infringement suit was dismissed. Also in January 2007, Ivax Pharmaceuticals, Inc. (Ivax), a wholly owned subsidiary of Teva USA, amended its previously filed abbreviated new drug application for tolterodine to challenge our basic patent for Detrol, and we brought a patent infringement action against Ivax in the U.S. District Court for the District of New Jersey. The basic patent (including the six-month pediatric exclusivity period) expires in September 2012. In January 2010, the court issued a decision in our favor, upholding the basic patent. The court entered an order preventing the FDA from approving Ivax’s abbreviated new drug application for Detrol before the expiration of the basic patent in September 2012. Ivax and Teva have filed a notice of appeal. Detrol LA (tolterodine) In October 2007 and January 2008, respectively, Teva USA and Impax Laboratories, Inc. notified us that they had filed abbreviated new drug applications with the FDA challenging on various grounds four patents relating to Detrol LA, an extended-release formulation of Detrol (tolterodine), and seeking approval to market their generic versions of Detrol LA. We filed suit against each of them in the U.S. District Court for the Southern District of New York asserting the infringement of three of the patents relating to Detrol LA., which (including the six-month pediatric exclusivity period) expire between 2012 (the basic patent) and 2020. Each of these actions subsequently was transferred to the U.S. District Court for the District of New Jersey. Vfend (voriconazole) In October 2009, we settled a challenge by Matrix and Mylan to four of our patents relating to Vfend by entering into an agreement granting Matrix and another subsidiary of Mylan the right to market voriconazole tablets in the U.S. beginning in the first quarter of 2011. Lyrica (pregabalin) In March and April 2009, several generic manufacturers notified us that they had filed abbreviated new drug applications with the FDA seeking approval to market generic versions of Lyrica. Each of the generic manufacturers is challenging one or more of three patents for Lyrica: the basic patent, which expires in 2018, and two other patents, which expire in 2013 and 2018. Each of the generic manufacturers asserts the invalidity and/or the non-infringement of the patents subject to challenge. In April 2009, we filed an action against each of the generic manufacturers in the U.S. District Court for the District of Delaware asserting the infringement and validity of our patents for Lyrica. In October 2009, all of these cases were consolidated in the District of Delaware. Zyvox (linezolid) In December 2009, Teva Parenteral Medicines Inc. (Teva Parenteral) notified us that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Zyvox. Teva Parenteral asserts the invalidity and non-infringement of the basic Zyvox patent, which (including the six-month pediatric exclusivity period) expires in 2015, and another patent that expires in 2021. In January 2010, we filed suit against Teva Parenteral in the U.S. District Court for the District of Delaware asserting the infringement of the basic patent. Aricept (donepezil hydrochloride) In October 2005, Teva USA notified Eisai Co., Ltd. (Eisai) that Teva USA had filed an abbreviated new drug application with the FDA challenging on various grounds Eisai’s basic patent for Aricept, which expires in November 2010, and seeking approval to market a generic version of Aricept. In December 2005, Eisai filed suit against Teva USA in the U.S. District Court for the District of New Jersey asserting infringement of that patent. While Teva USA has received final approval from the FDA for its generic product, it is subject to a preliminary injunction prohibiting the marketing of its product pending the outcome of Eisai’s patent infringement action. We co-promote Aricept with Eisai in the U.S. but are not a party to Eisai’s patent infringement action. Neurontin (gabapentin) In August 2005, the U.S. District Court for the District of New Jersey held that the generic gabapentin (Neurontin) products of a number of generic manufacturers did not infringe our gabapentin low-lactam patent, which expires in 2017, and it granted summary judgment in their favor. Several generic manufacturers launched their gabapentin products in 2004 and 2005. In September 2007, the U.S. Court of Appeals for the Federal Circuit reversed the District Court’s summary judgment decision and remanded the case to the District Court for trial on the patent infringement issue. If successful at trial, we intend to seek compensation from the generic manufacturers for damages resulting from their at-risk launches of generic gabapentin. Protonix (pantoprazole sodium) Wyeth has an exclusive license to market Protonix in the U.S. from Nycomed GmbH (Nycomed), which owns the patents relating to Protonix. The basic patent (including the six-month pediatric exclusivity period) for Protonix expires in January 2011. Following their respective filings of abbreviated new drug applications with the FDA, Teva USA and Teva Pharmaceutical Industries, Ltd. (Teva Industries), Sun Pharmaceutical Advanced Research Centre Ltd. and Sun Pharmaceutical Industries Ltd. (collectively, Sun) and KUDCO Ireland, Ltd. (KUDCO Ireland) received final FDA approval to market their generic versions of Protonix 20 mg and 40 mg delayed release tablets. Wyeth and Nycomed filed actions against Teva USA and Teva Industries, Sun and KUDCO Ireland in the U.S. District Court for the District of New Jersey, which subsequently were consolidated into a single proceeding, alleging infringement of the basic patent and seeking declaratory and injunctive relief. Following the court’s denial of a preliminary injunction sought by Wyeth and Nycomed, Teva USA and Teva Industries and Sun launched their generic versions of Protonix tablets at risk in Decemb er 2007 and January 2008, respectively. Wyeth launched its own generic version of Protonix tablets in January 2008, and Wyeth and Nycomed filed amended complaints in the pending patent infringement action seeking to recover lost profits and other damages resulting from Teva USA’s and Teva Industries’ and Sun’s at-risk launches. To Wyeth’s knowledge, KUDCO Ireland has not launched its generic product to date. In July 2009, Apotex notified Wyeth that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Protonix 20 mg and 40 mg delayed release tablets and asserting the invalidity of the basic patent for Protonix. In August 2009, Wyeth and Nycomed filed suit against Apotex in the U.S. District Court for the Northern District of Illinois alleging infringement of the basic patent. Wyeth and Nycomed are defendants in purported class actions brought by direct and indirect purchasers of Protonix in the U.S. District Court for the District of New Jersey. Plaintiffs seek damages, on behalf of the respective putative classes, for the alleged violation of antitrust laws in connection with the procurement and enforcement of the patents for Protonix. These purported class actions have been stayed pending resolution of the underlying patent litigation in the U.S. District Court for the District of New Jersey. Effexor XR (venlafaxine HCl (extended release capsules)) In 2005, Wyeth entered into a settlement of patent litigation against Teva USA and Teva Industries pursuant to which they are permitted to launch generic versions of Effexor XR (extended release capsules) in the U.S. beginning on July 1, 2010, subject to possible earlier launch based on specified market conditions or developments regarding the applicable patent rights, including the outcome of other generic challenges to such patent rights. Since the settlement with Teva USA and Teva Industries, Wyeth has settled patent suits against certain other generic companies that generally grant licenses permitting the generic companies to launch generic versions of Effexor XR (extended release capsules) in the U.S. on or after June 1, 2011, subject to possible earlier launch in limited circumstances but in no event earlier than January 1, 2011. Wyeth has patent infringement actions pending a gainst several other generic companies that have filed abbreviated new drug applications with the FDA seeking approval to market generic versions of Effexor XR (extended release capsules) in the U.S. ReFacto and Xyntha In February 2008, Novartis Vaccines and Diagnostics, Inc. (Novartis) filed suit against Wyeth and a subsidiary of Wyeth in the U.S. District Court for the Eastern District of Texas alleging that Wyeth’s ReFacto and Xyntha products infringe two Novartis patents. Novartis’ complaint seeks damages, including treble damages, for alleged willful infringement. Wyeth and its subsidiary assert, among other things, the invalidity and non-infringement of the Novartis patents. In November 2009, Novartis added a third patent to its infringement claim against Wyeth and its subsidiary. In May 2008, a subsidiary of Wyeth filed suit in the U.S. District Court for the District of Delaware against Novartis seeking a declaration that the two Novartis patents initially asserted against Wyeth and its subsidiary in the action referred to in the preceding paragraph are invalid on the ground that the Wyeth subsidiary was the first to invent the subject matter. Tygacil (tigecycline) In October 2009, Sandoz notified Wyeth that it had filed an abbreviated new drug application with the FDA seeking approval to market a generic version of Tygacil. Sandoz asserts the invalidity and non-infringement of two of Wyeth’s patents relating to Tygacil, including the basic patent, which expires in 2016. In December 2009, Wyeth filed suit against Sandoz in the U.S. District Court for the District of Delaware asserting infringement of the basic patent. B. Product Litigation Like other pharmaceutical companies, we are defendants in numerous cases, including but not limited to those discussed below, related to our pharmaceutical and other products. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. Asbestos   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Quigley </td></tr></table> Quigley Company, Inc. (Quigley), a wholly owned subsidiary, was acquired by Pfizer in 1968 and sold small amounts of products containing asbestos until the early 1970s. In September 2004, Pfizer and Quigley took steps that were intended to resolve all pending and future claims against Pfizer and Quigley in which the claimants allege personal injury from exposure to Quigley products containing asbestos, silica or mixed dust. We recorded a charge of $369 million before-tax ($229 million after-tax) in the third quarter of 2004 in connection with these matters. In September 2004, Quigley filed a petition in the U.S. Bankruptcy Court for the Southern District of New York seeking reorganization under Chapter 11 of the U.S. Bankruptcy Code. In March 2005, Quigley filed a reorganization plan in the Bankruptcy Court that needed the approval of both the Bankruptcy Court and the U.S. District Court for the Southern District of New York after receipt of the vote of 75% of the claimants. In connection with that filing, Pfizer entered into settlement agreements with lawyers representing more than 80% of the individuals with claims related to Quigley products against Quigley and Pfizer. The agreements provide for a total of $430 million in payments, of which $215 million became due in December 2005 and is being paid to claimants upon receipt by the Company of certain required documentation from each of the claimants. The reorganization plan provided for the establishment of a Trust (the Trust) for the payment of all remaining pending claims as well as any future claims alleging injury from exposure to Quigley products. As certified by the balloting agent in May 2006, more than 75% of Quigley’s claimants holding claims that represented more than two-thirds in value of claims against Quigley voted to accept Quigley’s plan of reorganization. In August 2006, in reviewing the voting tabulation methodology, the Bankruptcy Court ruled that certain votes that accepted the plan were not predicated upon the actual value of the claim. As a result, the reorganization plan was not accepted. In June 2007, Quigley filed an amended plan of reorganization that was intended to address the Bankruptcy Court’s concerns regarding the voting tabulation methodology. In February 2008, the Bankruptcy Court authorized Quigley to solicit its amended reorganization plan for acceptance by claimants. According to the official report filed with the court by the balloting agent in July 2008, the requisite number of votes was cast in favor of the amended plan of reorganization. The Bankruptcy Court held a confirmation hearing, which concluded in December 2009, at which objections to the plan’s confirmation were presented. Briefing on legal issues related to the confirmation hearing will conclude in February 2010, and thereafter the Bankruptcy Court will determine whether to approve the plan. If approved by the claimants and the courts, the amended reorganization plan will result in a permanent in junction directing all pending and future claims alleging personal injury from exposure to Quigley products to the Trust. Under the amended reorganization plan, Pfizer will contribute to the Trust $405 million through a note as well as approximately $100 million in cash and insurance, and will forgive a $76 million secured loan to Quigley. In addition, Pfizer entered into an agreement with the representative of future claimants that provides for the contribution to the Trust of an additional amount with a present value of $88.4 million. In a separately negotiated transaction with an insurance company in August 2004, we agreed to a settlement related to certain insurance coverage that provides for payments to us over a 10-year period of amounts totaling $405 million.   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Other Matters </td></tr></table> Between 1967 and 1982, Warner-Lambert owned American Optical Corporation (American Optical), which manufactured and sold respiratory protective devices and asbestos safety clothing. In connection with the sale of American Optical in 1982, Warner-Lambert agreed to indemnify the purchaser for certain liabilities, including certain asbestos-related and other claims. As of December 31, 2009, approximately 100,000 claims naming American Optical and numerous other defendants were pending in various federal and state courts seeking damages for alleged personal injury from exposure to asbestos and other allegedly hazardous materials. Warner-Lambert is actively engaged in the defense of, and will continue to explore various means to resolve, these claims. Several of the insurance carriers that provided coverage for the American Optical asbestos and other allegedly hazardous materials claims have denied covera ge. Warner-Lambert believes that these carriers’ position is without merit and is pursuing legal proceedings against such carriers. Numerous lawsuits are pending against Pfizer in various federal and state courts seeking damages for alleged personal injury from exposure to products containing asbestos and other allegedly hazardous materials sold by Gibsonburg Lime Products Company (Gibsonburg). Gibsonburg was acquired by Pfizer in the 1960s and sold small amounts of products containing asbestos until the early 1970s. There also is a small number of lawsuits pending in various federal and state courts seeking damages for alleged exposure to asbestos in facilities owned or formerly owned by Pfizer or its subsidiaries. Celebrex and Bextra   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Securities and ERISA Actions </td></tr></table> Beginning in late 2004, actions, including purported class actions, have been filed in various federal and state courts against Pfizer, Pharmacia and certain current and former officers, directors and employees of Pfizer and Pharmacia. These actions include (i) purported class actions alleging that Pfizer and certain current and former officers of Pfizer violated federal securities laws by misrepresenting the safety of Celebrex and Bextra and (ii) purported class actions filed by persons who claim to be participants in the Pfizer or Pharmacia Savings Plan alleging that Pfizer and certain current and former officers, directors and employees of Pfizer or, where applicable, Pharmacia and certain former officers, directors and employees of Pharmacia, violated certain provisions of the Employee Retirement Income Security Act of 1974 (ERISA) by selecting and maintaining Pfizer stock as an investme nt alternative when it allegedly no longer was a suitable or prudent investment option. In June 2005, the federal securities and ERISA actions were transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Pfizer Inc. Securities, Derivative and “ERISA” Litigation MDL-1688) in the U.S. District Court for the Southern District of New York.   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Securities Action in New Jersey </td></tr></table> In 2003, several purported class action complaints were filed in the U.S. District Court for the District of New Jersey against Pharmacia, Pfizer and certain former officers of Pharmacia. The complaints allege that the defendants violated federal securities laws by misrepresenting the data from a study concerning the gastrointestinal effects of Celebrex. These cases were consolidated for pre-trial proceedings in the District of New Jersey (Alaska Electrical Pension Fund et al. v. Pharmacia Corporation et al.). In January 2007, the court certified a class consisting of all persons who purchased Pharmacia securities from April 17, 2000 through February 6, 2001 and were damaged as a result of the decline in the price of Pharmacia’s securities allegedly attributable to the misrepresentations. Plaintiffs seek damages in an unspecified amount. In October 2007, the cour t granted defendants’ motion for summary judgment and dismissed the plaintiffs’ claims. In November 2007, the plaintiffs appealed the decision to the U.S. Court of Appeals for the Third Circuit. In January 2009, the Third Circuit vacated the District Court’s grant of summary judgment in favor of defendants and remanded the case to the District Court for further proceedings. The Third Circuit also held that the District Court erred in determining that the class period ended on February 6, 2001, and directed that the class period end on August 5, 2001. In June 2009, the District Court stayed proceedings in the case pending a determination by the U.S. Supreme Court with regard to defendants’ petition for certiorari seeking reversal of the Third Circuit’s decision, as well as the decision by the U.S. Supreme Court in a case involving another company that presents questions of law and fact that are similar to those in this case.   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Other </td></tr></table> Pfizer and several predecessor and affiliated companies, including Monsanto Company (Monsanto), are defendants in an action brought by Brigham Young University (BYU) and a BYU professor in the U.S. District Court for the District of Utah alleging, among other things, breach by Monsanto of a 1991 research agreement with BYU. Plaintiffs claim that research under that agreement led to the discovery of Celebrex and that, as a result, they are entitled to a share of the profits from Celebrex sales. Plaintiffs seek, among other things, compensatory and punitive damages. Bextra and Certain Other Drugs Beginning in September 2009, a number of shareholder derivative actions were filed in the U.S. District Court for the Southern District of New York and in the Supreme Court of the State of New York, County of New York, against certain current and former Pfizer officers and directors. Pfizer is named as a nominal defendant. These actions allege that the individual defendants breached fiduciary duties by causing or allowing Pfizer to engage in off-label promotion of certain drugs, including Bextra. Damages in unspecified amounts are sought on behalf of Pfizer. In November 2009, the federal cases were consolidated in the Southern District of New York (In re Pfizer Inc. Shareholder Derivative Litigation). Various Drugs In September 2009, a number of purported nationwide class actions were filed against us in the U.S. District Court for the District of Massachusetts and the U.S. District Court for the Eastern District of Pennsylvania alleging off-label promotion of certain drugs. In each case, the plaintiffs seek monetary and injunctive relief on behalf of the purported class, including the recovery of amounts paid for the drugs, treble damages and punitive damages. Hormone-Replacement Therapy Pfizer and certain wholly owned subsidiaries and limited liability companies, including Wyeth, along with several other pharmaceutical manufacturers, have been named as defendants in numerous lawsuits in various federal and state courts alleging personal injury resulting from the use of certain estrogen and progestin medications primarily prescribed for women to treat the symptoms of menopause. Plaintiffs in these suits allege a variety of personal injuries, including breast cancer, ovarian cancer, stroke and heart disease. Certain co-defendants in some of these actions have asserted indemnification rights against Pfizer and its affiliated companies. The cases against Pfizer and its affiliated companies involve one or more of the following products, all of which remain approved by the FDA: femhrt (which Pfizer divested in 2003); Activella and Vagifem (which are Novo Nordisk products that were marketed by a Pf izer affiliate from 2000 to 2004); Premarin, Prempro, Aygestin, Cycrin and Premphase (which are legacy Wyeth products); and Provera, Ogen, Depo-Estradiol, Estring and generic MPA (which are legacy Pharmacia & Upjohn products). The federal cases have been transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Prempro Products Liability Litigation MDL-1507) in the U.S. District Court for the Eastern District of Arkansas. Certain of the federal cases have been remanded to their respective District Courts for further proceedings, including, if necessary, trial. This litigation originally included both individual actions as well as various purported nationwide and statewide class actions. However, as a result of the denial of class certification by the courts in certain actions, the voluntary dismissal by the plaintiffs of certain purported class actions and the withdrawal of the class action allegations by the plaintiffs in certain other actions, this litigation now consists of individual actions, a few purported statewide class actions and a purported nationwide class action in Canada. Pfizer and its affiliated companies, including Wyeth, have prevailed in many of the hormone-replacement therapy actions that have been resolved to date, whether by voluntary dismissal by the plaintiffs, summary judgment, defense verdict or judgment notwithstanding the verdict; a number of these cases have been appealed by the plaintiffs. Certain other hormone-replacement therapy actions have resulted in verdicts for the plaintiffs and have included the award of compensatory and, in some instances, punitive damages; each of these cases has been appealed by Pfizer and/or its affiliated companies. Some of the cases that had been appealed by Pfizer and/or its affiliated companies or by the plaintiffs have been sent back by the appellate courts to their respective trial courts for further proceedings, and certain other cases have been settled by the parties in advance of trial. Trials of additional hormone-replace ment therapy actions are scheduled for 2010. Pfizer and/or its affiliated companies also have received inquiries from various federal and state agencies and officials relating to the marketing of their hormone-replacement products. In November 2008, the State of Nevada filed an action against Pfizer, Pharmacia & Upjohn Company and Wyeth in state court in Nevada alleging that they had engaged in deceptive marketing of their respective hormone-replacement therapy medications in Nevada in violation of the Nevada Deceptive Trade Practices Act. The action seeks monetary relief, including civil penalties and treble damages. Viagra A number of lawsuits, including purported class actions, have been filed against us in various federal and state courts alleging that Viagra causes certain types of visual injuries. The plaintiffs in the purported class actions seek to represent nationwide and certain statewide classes of Viagra users. All of the actions seek damages for personal injury, and the purported class actions also seek medical monitoring. In January 2006, the federal cases were transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Viagra Products Liability Litigation MDL-1724) in the U.S. District Court for the District of Minnesota. Zoloft and Effexor A number of individual lawsuits, as well as a multi-plaintiff lawsuit with respect to Effexor, have been filed against us and/or our subsidiaries in various federal and state courts alleging personal injury as a result of the purported ingesting of Zoloft or Effexor. Neurontin A number of lawsuits, including purported class actions, have been filed against us in various federal and state courts alleging claims arising from the promotion and sale of Neurontin. The plaintiffs in the purported class actions seek to represent nationwide and certain statewide classes consisting of persons, including individuals, health insurers, employee benefit plans and other third-party payers, who purchased or reimbursed patients for the purchase of Neurontin that allegedly was used for indications other than those included in the product labeling approved by the FDA. In October 2004, many of the suits pending in federal courts, including individual actions as well as purported class actions, were transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Neurontin Marketing, Sales Practices and Product Liability Litigation MDL-1629) in the U.S. Distr ict Court for the District of Massachusetts. Purported class actions also have been filed against us in various Canadian provincial courts alleging claims arising from the promotion and sale of Neurontin and generic gabapentin. In the Multi-District Litigation, in August 2007, the court denied without prejudice plaintiffs’ motion to certify a nationwide class of all consumers and third-party payers who allegedly purchased or reimbursed patients for the purchase of Neurontin for off-label uses from 1994 through 2004. In December 2007, plaintiffs filed a renewed motion for class certification. In May 2009, the court denied plaintiffs’ renewed motion for class certification. Plaintiffs have filed a motion for reconsideration. In June 2007, a Pennsylvania state court certified a class of all individuals in Pennsylvania who allegedly purchased Neurontin for off-label uses since 1995. The court subsequently expanded the class to include purchasers of generic gabapentin. However, in February 2009, the court determined that class certification was not appropriate and entered an order decertifying the class. The plaintiffs appealed and, in January 2010, the appellate court affirmed the trial court’s order decertifying the class. Other plaintiffs are seeking certification of statewide classes of Neurontin purchasers in actions pending in California, Illinois, Indiana, Missouri and Oklahoma. State courts in New York and New Mexico have declined to certify statewide classes of Neurontin purchasers. A number of individual lawsuits have been filed against us in various U.S. federal and state courts and in certain other countries alleging suicide, attempted suicide and other personal injuries as a result of the purported ingesting of Neurontin. Certain of the U.S. federal actions have been transferred for consolidated pre-trial proceedings to the same Multi-District Litigation referred to in the first paragraph of this section. Lipitor In 2006, a purported class action was filed against us alleging, among other things, violation of the federal Racketeer Influenced and Corrupt Organizations (RICO) Act and certain state consumer fraud statutes primarily related to the promotion of Lipitor. In 2008, the action was transferred to the U.S. District Court for the Southern District of New York. In September 2009, the court dismissed the action, but granted the plaintiffs leave to amend certain of their claims. In November 2009, the plaintiffs filed a voluntary dismissal of the action, with prejudice. In 2004, a former employee filed a whistleblower action against us in the U.S. District Court for the Eastern District of New York. The complaint remained under seal until September 2007, at which time the U.S. Attorney for the Eastern District of New York declined to intervene in the case. We were served with the complaint in December 2007. Plaintiff alleges that, through patient and medical education programs, written materials and other actions aimed at doctors, consumers, payers and investors, the Company promoted Lipitor for use by certain patients contrary to national cholesterol guidelines that plaintiff claims are a part of the labeled indications for the product. Plaintiff alleges violations of the Federal Civil False Claims Act and the false claims acts of certain states and seeks treble damages and civil penalties on behalf of the federal government and the specified states as the result of their p urchase, or reimbursement of patients for the purchase, of Lipitor allegedly for such off-label uses. Plaintiff also seeks compensation as a whistleblower under those federal and state statutes. In addition, plaintiff alleges that he was wrongfully terminated, in violation of the anti-retaliation provisions of the Federal Civil False Claims Act, the Civil Rights Act of 1964 and applicable New York law, for raising concerns about the alleged off-label promotion of Lipitor and about alleged instances of sexual harassment in the workplace, and he seeks damages and the reinstatement of his employment. In May 2009, the court dismissed without prejudice the claims alleging violations of the Federal Civil False Claims Act and the false claims acts of certain states. In February 2010, plaintiff filed an amended complaint containing allegations concerning violations of the Federal Civil False Claims Act and false claims acts of certain states that are substantially similar to the allegations in the original complaint . Chantix/Champix A number of individual lawsuits have been filed against us in various federal and state courts alleging suicide, attempted suicide and other personal injuries as a result of the purported ingesting of Chantix, as well as economic loss. Plaintiffs in these actions seek compensatory and punitive damages and the disgorgement of profits resulting from the sale of Chantix. In October 2009, the federal cases were transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Chantix (Varenicline) Products Liability Litigation MDL-2092) in the U.S. District Court for the Northern District of Alabama. In December 2008, a purported class action was filed against us in the Ontario Superior Court of Justice (Toronto Region) on behalf of all individuals and third-party payers in Canada who have purchased and ingested Champix or reimbursed patients for the purchase of Champix. This action asserts claims under Canadian product liability law, including with respect to the safety and efficacy of Champix, and, on behalf of the putative class, seeks monetary relief, including punitive damages. In April and October 2009 and February 2010, respectively, substantially similar purported class actions were filed against us in the Superior Court of Quebec (District of Montreal), the Court of Queen’s Bench of Alberta, Judicial District of Calgary, and the Superior Court of British Columbia (Vancouver Registry). Zosyn In April 2006, Wyeth filed a citizen petition with the FDA asking it to refrain from approving any application for a generic product that references Zosyn (piperacillin and tazobactam) unless the generic product complies with the U.S. Pharmacopeia standards on particulate matter in injectable drugs and exhibits the same compatibility profile as Zosyn. Wyeth further requested that, in the event the FDA chose to approve a generic product that did not exhibit the same compatibility profile as Zosyn, the FDA condition such approval upon the applicant’s implementation of a risk-minimization action plan to address the confusion that would necessarily arise as a result of such difference. In September 2009, the FDA denied the principal requests in Wyeth’s citizen petition and approved applications by Orchid Healthcare for a generic piperacillin/tazobactam product that does not exhibit the same compatibility profile as Zosyn. Following the FDA’s decision, in September 2009, Wyeth brought suit in the U.S. District Court for the District of Columbia against the FDA and its parent agency, the U.S. Department of Health and Human Services, seeking to overturn the FDA’s ruling on Wyeth’s citizen petition and to have the generic approvals suspended and/or withdrawn. Orchid Healthcare and its U.S. marketing partner, Apotex Corp., intervened in the case. In September 2009, the court denied Wyeth’s motion for a temporary restraining order. Pending action by the courts, the generic approvals granted by the FDA in September remain in effect. Wyeth understan ds that generic piperacillin/tazobactam is currently being marketed in the U.S. pursuant to those approvals. Thimerosal Wyeth is a defendant in a number of suits by or on behalf of vaccine recipients alleging that exposure through vaccines to cumulative doses of thimerosal, a preservative used in certain childhood vaccines formerly manufactured and distributed by Wyeth and other vaccine manufacturers, causes severe neurological damage and/or autism in children. While several suits were filed as purported nationwide or statewide class actions, all but one of the purported class actions have been dismissed, either by the courts or voluntarily by plaintiffs. In the one remaining purported class action, the U.S. District Court for the Eastern District of Kentucky dismissed all claims except plaintiffs’ fraud claim, which has been stayed. In addition to the suits alleging injury from exposure to thimerosal, certain of the cases were brought by parents in their individual capacities for, among other things, loss of service s and loss of consortium of the injured child. The National Childhood Vaccine Injury Act (the Vaccine Act) requires that plaintiffs alleging injury from childhood vaccines first bring a claim under the Vaccine Act in the U.S. Court of Federal Claims. At the conclusion of that proceeding, plaintiffs may bring a lawsuit against the manufacturer in federal or state court, provided that they have satisfied certain procedural requirements. Also under the terms of the Vaccine Act, if a claim has not been adjudicated by the U.S. Court of Federal Claims within a specified time period after filing, the claimant may opt out of the proceeding and pursue a lawsuit against the manufacturer by following certain procedures. Some of the vaccine recipients who have sued Wyeth to date may not have satisfied the conditions to filing a lawsuit that are mandated by the Vaccine Act. The claims brought by parents for, among other things, loss of services and loss of consortium of the injured child are not covered by the Vaccine Act. In July 2002, the U.S. Court of Federal Claims established an Omnibus Autism Proceeding with jurisdiction over petitions in which vaccine recipients claim to suffer from autism or autism spectrum disorder as a result of receiving thimerosal-containing childhood vaccines or the measles, mumps and rubella (MMR) vaccine. There currently are several thousand petitions pending in the Omnibus Autism Proceeding. The court heard six test cases on claimants’ theories that either thimerosal-containing vaccines in combination with the MMR vaccine or thimerosal-containing vaccines alone can cause autism or autism spectrum disorder. In February 2009, the court rejected the three cases brought on the theory that a combination of MMR and thimerosal-containing vaccines caused claimants’ conditions. The court in each case found that the scientific evidence against a connection between the vaccines and auti sm was significantly stronger than the evidence presented by the claimants. Two of these cases have been appealed by the plaintiffs to the U.S. Court of Appeals for the Federal Circuit. Decisions on the three test cases involving thimerosal-containing vaccines alone are pending. Pristiq In late 2007 and early 2008, the following actions were filed in various federal courts and remain pending: (i) a purported class action alleging that Wyeth and certain former officers of Wyeth violated federal securities laws by misrepresenting the safety of Pristiq during the period before the FDA’s issuance on July 24, 2007 of an “approvable” letter for Pristiq for the treatment of vasomotor symptoms, which allegedly caused a decline in the price of Wyeth stock; (ii) a shareholder derivative action alleging that certain former officers of Wyeth and certain former directors of Wyeth, two of whom are now directors of Pfizer, breached fiduciary duties and violated federal securities laws by virtue of the aforementioned alleged misrepresentation; and (iii) a purported class action against Wyeth, the Wyeth Savings Plan Committee, the Wyeth Saving s Plan-Puerto Rico Committee, the Wyeth Retirement Committee and certain former Wyeth officers and committee members alleging that they violated certain provisions of ERISA by maintaining Wyeth stock as an investment alternative under certain Wyeth plans notwithstanding their alleged knowledge of the aforementioned alleged misrepresentation. C. Commercial and Other Matters Acquisition of Wyeth Beginning in late January 2009, several purported class action complaints were filed by Wyeth shareholders challenging Wyeth’s proposed merger with Pfizer. The actions were filed in federal court in New Jersey (the Federal Action) and in state courts in New Jersey and Delaware. Subsequently, the actions filed in state court in New Jersey were consolidated (the New Jersey Action), and the actions filed in state court in Delaware were consolidated (the Delaware Action). The complaints in all of the actions name as defendants Wyeth and the individuals who served as the members of Wyeth’s Board of Directors prior to the consummation of the merger, two of whom are now directors of Pfizer. The complaints in the Federal Action and the Delaware Action also name Pfizer as a defendant. The plaintiffs allege that (i) each of the members of Wyeth’s pre-merger Board of Directors breached his or her fiduciary duties to Wyeth and its shareholders by authorizing the sale of Wyeth to Pfizer for what plaintiffs deem “inadequate” consideration; (ii) Wyeth directly breached and/or aided and abetted the other defendants’ alleged breaches of fiduciary duties; and (iii) in the actions in which Pfizer is a defendant, Pfizer aided and abetted the alleged breaches of fiduciary duties by Wyeth and its pre-merger directors. The plaintiffs sought, among other things, to enjoin the defendants from consummating the merger on the agreed-upon terms. On June 10, 2009, Wyeth, Wyeth’s directors and Pfizer entered into a memorandum of understanding with the plaintiffs in the Delaware Action reflecting an agreement-in-principle to settle the Delaware Action based on their agreement to include in the Pfizer/Wyeth registration statement/proxy statement on Form S-4 certain additional disclosures relating to the transaction. Wyeth, Wyeth’s pre-merger directors and Pfizer each have denied that they committed or aided and abetted in the commission of any violation of law or engaged in any of the wrongful acts alleged in the Delaware Action and expressly maintain that they diligently and scrupulously complied with their fiduciary and other legal duties. If the settlement is consummated, the Delaware Action will be dismissed with prejudice, and the defendants will receive—from or on behalf of all persons who were Wyeth shareholders at any time between the announcement of the merger agreement on January 26, 2009 and the closing of the merger—a release of all claims related to the merger, including the claims asserted in the Federal Action and the New Jersey Action. Members of the purported plaintiff class will be sent notice of the proposed settlement, and a hearing before the Delaware Court of Chancery will be scheduled regarding approval of the proposed settlement. Separately, in August 2009, a number of retail pharmacies in California brought an action against Pfizer and Wyeth in the U.S. District Court for the Northern District of California. The plaintiffs allege, among other things, that our acquisition of Wyeth violates various federal antitrust laws by creating a monopoly in the manufacture, distribution and sale of prescription drugs in the U.S. The plaintiffs’ request for a temporary restraining order preventing consummation of the acquisition was denied, and the court granted our motion to dismiss the case, on October 14, 2009. On the day following the consummation of the acquisition, October 16, 2009, the plaintiffs filed an amended complaint containing allegations substantially similar to those in the original complaint and renewing the request for a temporary restraining order. In December 2009, the court granted our motion to dis miss the amended complaint and denied the plaintiffs’ renewed request for a temporary restraining order. In January 2010, the plaintiffs filed a second amended complaint containing allegations substantially similar to those in the original complaint. Average Wholesale Price Litigation A number of states, as well as most counties in New York, have sued Pharmacia, Pfizer and other pharmaceutical manufacturers alleging that they provided average wholesale price (AWP) information for certain of their products that was higher than the actual prices at which those products were sold. The AWP is used to determine reimbursement levels under Medicare Part B and Medicaid and in many private-sector insurance policies and medical plans. The plaintiffs claim that the alleged spread between the AWPs at which purchasers were reimbursed and the actual sale prices was promoted by the defendants as an incentive to purchase certain of their products. In addition to suing on their own behalf, many of the plaintiff states seek to recover on behalf of individual Medicare Part B co-payers and private-sector insurance companies and medical plans in their states. These various actions generally assert fraud claims , as well as claims under state deceptive trade practice laws, and seek monetary and other relief, including civil penalties and treble damages. Several of the suits also allege that Pharmacia and/or Pfizer did not report to the states their best price for certain products under the Medicaid program. In addition, Pharmacia, Pfizer and other pharmaceutical manufacturers are defendants in a number of purported class action suits in various federal and state courts brought by employee benefit plans and other third-party payers that assert claims similar to those in the state and county actions. These suits allege, among other things, fraud, unfair competition and unfair trade practices and seek monetary and other relief, including civil penalties and treble damages. All of these state, county and purported class action suits were transferred for consolidated pre-trial proceedings to a Multi-District Litigation (In re Pharmaceutical Industry Average Wholesale Price Litigation MDL-1456) in the U.S. District Court for the District of Massachusetts. Certain of the state and private suits have been remanded to their respective state courts. In November 2006, the claims against Pfizer in the Multi-District Litigation were dismissed with prejudice; the claims against Pharmacia are still pending. In April 2008, the court in the Multi-District Litigation granted preliminary approval with respect to the fairness of a proposed settlement of the claims against 11 defendants, including Pharmacia, for a total of $125 million. It is expected that the court will schedule a hearing for later this year to consider final approval of the settlement. If the settlement is approved, Pharmacia’s contribution would be immaterial. In addition, Wyeth is a defendant in AWP actions brought by certain states, which are not included in the Multi-District Litigation, as well as AWP actions brought by most counties in New York, almost all of which are included in the Multi-District Litigation. Wyeth also is a defendant in a purported class action in state court in New Jersey brought by a third-party payer. These actions against Wyeth would not be included in the proposed settlement referred to in the previous paragraph. Monsanto-Related Matters In 1997, Monsanto Company (Former Monsanto) contributed certain chemical manufacturing operations and facilities to a newly formed corporation, Solutia Inc. (Solutia), and spun off the shares of Solutia. In 2000, Former Monsanto merged with Pharmacia & Upjohn Company to form Pharmacia Corporation (Pharmacia). Pharmacia then transferred its agricultural operations to a newly created subsidiary, named Monsanto Company (New Monsanto), which it spun off in a two-stage process that was completed in 2002. Pharmacia was acquired by Pfizer in 2003 and is now a wholly owned subsidiary of Pfizer. In connection with its spin-off that was completed in 2002, New Monsanto assumed, and agreed to indemnify Pharmacia for, any liabilities related to Pharmacia’s former agricultural business. New Monsanto is defending and indemnifying Pharmacia for various claims and litigation arising out of, or related to, the agricultural business. In connection with its spin-off in 1997, Solutia assumed, and agreed to indemnify Pharmacia for, liabilities related to Former Monsanto’s chemical businesses. As the result of its reorganization under Chapter 11 of the U.S. Bankruptcy Code, Solutia’s indemnification obligations related to Former Monsanto’s chemical businesses are limited to sites that Solutia has owned or operated. In addition, in connection with its spin-off that was completed in 2002, New Monsanto assumed, and agreed to indemnify Pharmacia for, any liabilities primarily related to Former Monsanto’s chemical businesses, including, but not limited to, any such liabilities that Solutia assumed. Solutia’s and New Monsanto’s assumption of and agreement to indemnify Pharmacia for these liabilities apply to pending actions and any future actions related to Former Monsanto’s chem ical businesses in which Pharmacia is named as a defendant, including, without limitation, actions asserting environmental claims, including alleged exposure to polychlorinated biphenyls. Pharmacia Cash Balance Pension Plan In 2006, several current and former employees of Pharmacia Corporation filed a purported class action in the U.S. District Court for the Southern District of Illinois against the Pharmacia Cash Balance Pension Plan (the Plan), Pharmacia Corporation, Pharmacia & Upjohn Company and Pfizer Inc. Plaintiffs seek monetary and injunctive relief on behalf of a class consisting of certain current and former participants in the Plan who accrued a benefit in the Monsanto Company Pension Plan prior to its conversion to a cash balance plan in 1997. In January 2002, after various corporate reorganizations, certain of the assets and liabilities of the Monsanto Company Pension Plan were transferred to the Plan. Plaintiffs claim that the Plan violates the age-discrimination provisions of ERISA by providing certain credits to such participants only to age 55. This action has been consolidated in the U.S. Distr ict Court for the Southern District of Illinois (Walker, et al., v. The Monsanto Company Pension Plan et al.) with purported class actions pending in that court that make largely similar claims against substantially similar cash balance plans sponsored by Monsanto Company and Solutia, each of which was spun off by Pharmacia Corporation or a predecessor of Pharmacia Corporation. In May 2008, at the request of the parties, the court issued an order permitting the case to proceed as a class action. In June 2009, the court granted our motion for summary judgment and dismissed the claims against the Plan, Pfizer and the two Pfizer subsidiaries. In October 2009, the plaintiffs filed a notice of appeal to the U.S. Court of Appeals for the Seventh Circuit. Trade Secrets Action in California In 2004, Ischemia Research and Education Foundation (IREF) and its chief executive officer brought an action in California Superior Court, Santa Clara County, against a former IREF employee and Pfizer. Plaintiffs allege that defendants conspired to misappropriate certain information from IREF’s allegedly proprietary database in order to assist Pfizer in designing and executing a clinical study of a Pfizer drug. In December 2008, the jury returned a verdict for compensatory damages of approximately $38.7 million. In March 2009, the court awarded prejudgment interest but declined to award punitive damages. In July 2009, the court granted our motion for a new trial and vacated the jury verdict. Trimegestone Aventis filed a breach of contract action against Wyeth in the Commercial Court of Nanterre in France arising out of the December 2003 termination by Wyeth of an October 2000 agreement between Wyeth and Aventis relating to the development of hormone-therapy drugs utilizing Aventis’ trimegestone (TMG) progestin. Aventis alleges that the termination was improper and seeks monetary damages and injunctive relief. In January 2009, a three-judge tribunal rendered its decision in favor of Wyeth, denying all of the relief sought by Aventis. Aventis has filed an appeal from the Commercial Court’s decision. Environmental Matters   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> Remediation Matters </td></tr></table> In 2009, we submitted to the U.S. Environmental Protection Agency a corrective measures study report with regard to Pharmacia Corporation’s discontinued industrial chemical facility in North Haven, Connecticut, and a revised site-wide feasibility study with regard to Wyeth’s discontinued industrial chemical facility in Bound Brook, New Jersey. We are a party to a number of other proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended (CERCLA or Superfund), and other state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">•</td> <td valign="top" width="1%"> </td> <td valign="top" align="left"> MPA Matter </td></tr></table> In 2006, Wyeth’s Wyeth Medica Ireland (WMI) subsidiary was served with criminal summonses charging it with violations of the Ireland Waste Management Act and WMI’s Integrated Pollution Prevention and Control License in connection with five shipments from WMI’s Newbridge, Ireland facility of sugar waste water allegedly contaminated with medroxyprogesterone acetate (MPA). This matter remains pending. D. Government Investigations Like other pharmaceutical companies, we are subject to extensive regulation by national, state and local government agencies in the U.S. and in the other countries in which we operate. As a result, we have interactions with government agencies on an ongoing basis. Among the investigations by government agencies are those discussed below. It is possible that criminal charges and substantial fines and/or civil penalties could result from government investigations, including but not limited to those discussed below. The Company has voluntarily provided the DOJ and the SEC with information concerning potentially improper payments made in connection with certain sales activities outside the U.S. We have been exploring with the DOJ and SEC various ways to resolve this matter. In addition, certain potentially improper payments and other matters are the subject of investigations by government authorities in certain foreign countries, including a civil and criminal investigation in Germany with respect to certain tax matters relating to a wholly owned subsidiary of Pfizer. The DOJ is conducting civil and criminal investigations regarding Wyeth’s promotional practices with respect to Protonix and its practices relating to the pricing for Protonix and Premarin for Medicaid rebate purposes. In connection with the pricing investigation, in May 2009, the DOJ filed a civil complaint in intervention in two qui tam actions that had been filed under seal in the U.S. District Court for the District of Massachusetts. The complaint alleges that Wyeth’s practices relating to the pricing for Protonix for Medicaid rebate purposes between 2001 and 2006 violated the Federal Civil False Claims Act and federal common law. The two qui tam actions have been unsealed, and the complaints include substantially similar allegations. In addition, in June 2009, several states and the District of Columbia filed a complaint under the same docket number asserting violations of various sta te laws based on allegations substantially similar to those set forth in the civil complaint filed by the DOJ. The U.S. Attorney’s Office for the Western District of Oklahoma is conducting a criminal investigation with respect to Wyeth’s promotional practices relating to Rapamune. E. Guarantees and Indemnifications In the ordinary course of business and in connection with the sale of assets and businesses, we often indemnify our counterparties against certain liabilities that may arise in connection with the transaction or related to activities prior to the transaction. These indemnifications typically pertain to environmental, tax, employee and/or product-related matters and patent infringement claims. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, we would be required to reimburse the loss. These indemnifications are generally subject to threshold amounts, specified claim periods and other restrictions and limitations. Historically, we have not paid significant amounts under these provisions and, as of December 31, 2009, recorded amounts for the estimated fair value of these indemnifications were not significant.

Quarterly Consolidated Financial Data (Unaudited) Pfizer Inc. and Subsidiary Companies       <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="56%"/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#ffffff">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="14" bgcolor="#ffffff">QUARTER</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#ffffff"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS, EXCEPT PER COMMON SHARE DATA)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">FIRST</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">SECOND</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">THIRD</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" colspan="2" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">FOURTH(a)</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td></tr> <tr> <td valign="top"> 2009</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td valign="top"> Revenues</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">10,867</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">   </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">10,984</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">   </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">11,621</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">   </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">16,537</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td valign="top"> Costs and expenses</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">6,510</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">7,456</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">7,457</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">13,354</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td valign="top"> Acquisition-related in-process research and development charges</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">20</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">48</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Restructuring charges and certain acquisition-related costs(b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">554</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">459</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">193</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">3,131</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td valign="top"> Income from continuing operations before provision for taxes on income</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">3,803</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">3,049</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">3,971</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">4</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Provision/(benefit) for taxes on income</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">1,074</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">786</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">1,092</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">(755</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td valign="top"> Income from continuing operations</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">2,729</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">2,263</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">2,879</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">759</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Discontinued operations—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">1</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">3</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">2</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">8</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td valign="top"> Net income before allocation to noncontrolling interests</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">2,730</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">2,266</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">2,881</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td align="right" bgcolor="#bfbfbf" valign="bottom">767</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Less: Net income attributable to noncontrolling interests</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">1</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">5</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">3</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Net income attributable to Pfizer Inc.</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">2,729</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">2,261</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">2,878</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">767</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td valign="top"> Earnings per common share—basic(c):</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td valign="top"> Income from continuing operations attributable to Pfizer Inc. common shareholders</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">0.41</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">0.34</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">0.43</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">0.10</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Discontinued operations—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Net income attributable to Pfizer Inc. common shareholders</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.41</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.34</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.43</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.10</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td valign="top"> Earnings per common share—diluted(c):</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td valign="top"> Income from continuing operations attributable to Pfizer Inc. common shareholders</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">0.41</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">0.34</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">0.43</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">0.10</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Discontinued operations—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Net income attributable to Pfizer Inc. common shareholders</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.41</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.34</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.43</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.10</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Cash dividends paid per common share</td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.32</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.16</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.16</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" align="right" bgcolor="#bfbfbf" valign="bottom">0.16</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" bgcolor="#bfbfbf" valign="bottom"> </td></tr> <tr> <td valign="top"> Stock prices</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"/> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td valign="top"> High</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">18.48</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">15.60</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">16.98</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">18.99</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr> <td valign="top"> Low</td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">11.62</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">12.75</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">14.11</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom">$</td> <td align="right" bgcolor="#bfbfbf" valign="bottom">16.07</td> <td nowrap="nowrap" bgcolor="#bfbfbf" valign="bottom">  </td> <td bgcolor="#bfbfbf" valign="bottom"> </td> <td bgcolor="#bfbfbf" valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" colspan="19" valign="bottom"> </td></tr></table>   <table cellspacing="0" style="BORDER-COLLAPSE: collapse" cellpadding="0" width="100%" border="0"> <tr> <td align="left" width="1%" valign="top">(a) </td> <td align="left" valign="top"> In accordance with our domestic and international fiscal year-ends, approximately two-and-a-half months of Wyeth’s U.S. operations and approximately one-and-a-half months of Wyeth’s international operations are included in our consolidated financial statements for the quarter ended December 31, 2009. For additional information, see Note 2. Acquisition of Wyeth. The increase in revenues and costs and expenses in the fourth quarter of 2009 primarily reflects the results of Wyeth’s operations as well as higher purchase accounting charges resulting from the Wyeth acquisition. </td></tr></table> <table cellspacing="0" style="BORDER-COLLAPSE: collapse" cellpadding="0" width="100%" border="0"> <tr> <td align="left" width="1%" valign="top">(b) </td> <td align="left" valign="top"> Restructuring charges and certain acquisition-related costs includes restructuring charges recorded in the fourth quarter of 2009 related to our acquisition of Wyeth. </td></tr></table> <table cellspacing="0" style="BORDER-COLLAPSE: collapse" cellpadding="0" width="100%" border="0"> <tr> <td align="left" width="1%" valign="top">(c) </td> <td align="left" valign="top"> Earnings per share in fourth-quarter 2009 was impacted by the increased number of shares outstanding in comparison with prior 2009 quarters, resulting primarily from shares issued to partially fund the Wyeth acquisition. </td></tr></table> Basic and diluted EPS are computed independently for each of the periods presented. Accordingly, the sum of the quarterly EPS amounts may not agree to the total for the year. As of January 31, 2010, there were 239,543 holders of record of our common stock (New York Stock Exchange symbol PFE). <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="62%"/> <td valign="bottom" width="4%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="4%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="14">QUARTER</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS, EXCEPT PER COMMON SHARE DATA)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap" colspan="2">FIRST</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap" colspan="2">SECOND</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap" colspan="2">THIRD</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" nowrap="nowrap" colspan="2">FOURTH</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> 2008</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Revenues</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,848</td> <td valign="bottom" nowrap="nowrap">     </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,129</td> <td valign="bottom" nowrap="nowrap">     </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,973</td> <td valign="bottom" nowrap="nowrap">     </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,346</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Costs and expenses</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,715</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,614</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,872</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,093</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Acquisition-related in-process research and development charges</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">398</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">156</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">66</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Restructuring charges and certain acquisition-related costs</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">178</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">569</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">366</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,562</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Income from continuing operations before provision for taxes on income</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,557</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,790</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,722</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">625</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Provision for taxes on income</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">763</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">25</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">463</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">394</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Income from continuing operations</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,794</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,765</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,259</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">231</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Discontinued operations—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(4</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">17</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">25</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">40</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Net income before allocation to noncontrolling interests</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,790</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,782</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,284</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">271</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Less: Net income attributable to noncontrolling interests</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">6</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">6</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">6</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">5</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Net income attributable to Pfizer Inc.</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,784</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,776</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,278</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">266</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Earnings per common share—basic:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Income from continuing operations attributable to Pfizer Inc. common shareholders</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.41</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.41</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.34</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.03</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Discontinued operations—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.01</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Net income attributable to Pfizer Inc. common shareholders</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.41</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.41</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.34</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.04</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Earnings per common share—diluted:</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Income from continuing operations attributable to Pfizer Inc. common shareholders</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.41</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.41</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.33</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.03</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Discontinued operations—net of tax</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.01</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.01</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Net income attributable to Pfizer Inc. common shareholders</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.41</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.41</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.34</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.04</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Cash dividends paid per common share</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.32</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.32</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.32</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">0.32</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Stock prices</td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> High</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24.24</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21.60</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">20.13</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">19.39</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Low</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">20.19</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17.12</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17.16</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14.26</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="18"> </td></tr></table> Basic and diluted EPS are computed independently for each of the periods presented. Accordingly, the sum of the quarterly EPS amounts may not agree to the total for the year. Revenues include a reduction of $217 million recorded in the third quarter of 2008 to adjust our prior years’ liabilities for product returns. Costs and expenses includes a charge of $2.3 billion recorded in the fourth quarter of 2008 related to the resolution of certain investigations concerning Bextra and various other products, and charges of $900 million recorded in the third quarter of 2008 associated with the resolution of certain litigation involving our NSAID pain medicines. Acquisition-related in-process research and development charges primarily includes amounts incurred in connection with our acquisitions of Serenex, Encysive, CovX, Coley and a number of animal health product lines in Europe from Schering-Plough, as well as two smaller acquisitions also related to animal health.

4. Cost-Reduction Initiatives and Acquisition-Related Costs We have incurred significant costs in connection with our cost-reduction initiatives (several programs initiated since 2005) and our acquisition of Wyeth on October 15, 2009. Since the acquisition of Wyeth, our cost-reduction initiatives that were announced on January 26, 2009 have been incorporated into a comprehensive plan to integrate Wyeth’s operations, generate cost savings and capture synergies across the combined company. We are focusing our efforts on achieving an appropriate cost structure for the combined company. We incurred the following costs in connection with our cost-reduction initiatives and the Wyeth acquisition:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="73%"/> <td valign="bottom" width="4%"/> <td/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="11">YEAR ENDED DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td></tr> <tr> <td valign="top"> Transaction costs(a)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">768</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">   </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">—</td></tr> <tr> <td valign="top"> Integration costs and other(b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">569</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Restructuring charges(c) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">3,000</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,626</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,523</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Restructuring charges and certain acquisition-related costs</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">4,337</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,675</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2,534</td></tr> <tr> <td valign="top"> Additional depreciation—asset restructuring(d)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">241</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">786</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">788</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Implementation costs(e) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">250</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">819</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">601</td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,828</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,280</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3,923</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="13"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Transaction costs represent external costs directly related to effecting the acquisition of Wyeth and primarily include expenditures for banking, legal, accounting and other similar services. Substantially all of the costs incurred are fees related to a $22.5 billion bridge term loan credit agreement entered into with certain financial institutions on March 12, 2009 to partially fund our acquisition of Wyeth. The bridge term loan credit agreement was terminated in June 2009 as a result of our issuance of approximately $24.0 billion of senior unsecured notes in the first half of 2009. All bridge term loan commitment fees have been expensed, and we no longer are subject to the covenants under that agreement (see Note 9D: Financial Instruments: Long-Term Debt). </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Integration costs represent external, incremental costs directly related to integrating acquired businesses and primarily include expenditures for consulting and systems integration. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> Restructuring charges include the following: </td></tr></table>   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="44%"/> <td valign="bottom" width="3%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td valign="bottom" width="2%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom" colspan="2">  </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">ACTIVITY</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">ACCRUAL</td></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="16">COSTS INCURRED</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">THROUGH DECEMBER 31,</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">AS OF DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" nowrap="nowrap" colspan="2">2005-2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009(1)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009(2)</td></tr> <tr> <td valign="top"> Employee termination costs</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,571</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">   </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,004</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,034</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,721</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,488</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3,233</td></tr> <tr> <td valign="top"> Asset impairments</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">159</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">543</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">260</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,452</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,452</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">270</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">79</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">229</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">710</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">577</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">133</td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3,000</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,626</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,523</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,883</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">6,517</td> <td valign="bottom"> </td> <td valign="bottom"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">3,366</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="26"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(1)</td> <td valign="top" align="left"> Includes adjustments for foreign currency translation. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(2)</td> <td valign="top" align="left"> Included in Current deferred tax liabilities and other current liabilities ($2.5 billion) and Other noncurrent liabilities ($846 million). </td></tr></table> From the beginning of our cost-reduction and transformation initiatives in 2005 through December 31, 2009, Employee termination costs represent the expected reduction of the workforce by approximately 40,000 employees, mainly in manufacturing, sales and research of which approximately 25,700 employees have been terminated as of December 31, 2009. Employee termination costs are generally recorded when the actions are probable and estimable and include accrued severance benefits, pension and postretirement benefits, many of which may be paid out during periods after termination. Asset impairments primarily include charges to write down property, plant and equipment to fair value. Other primarily includes costs to exit certain assets and activities.   <table cellpadding="0" style="BORDER-COLLAPSE: collapse" cellspacing="0" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d)</td> <td valign="top" align="left"> Additional depreciation—asset restructuring represents the impact of changes in the estimated useful lives of assets involved in restructuring actions and are included in our consolidated statements of income as follows: </td></tr></table>   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="82%"/> <td valign="bottom" width="2%"/> <td/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/> <td valign="bottom" width="2%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="9">YEAR ENDED DECEMBER 31,</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#cccccc"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2" bgcolor="#cccccc">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#cccccc"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">2007</td></tr> <tr> <td valign="top"> Cost of sales</td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" bgcolor="#cccccc">$</td> <td valign="bottom" align="right" bgcolor="#cccccc">   133</td> <td valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">596</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">   571</td></tr> <tr> <td valign="top"> Selling, informational and administrative expenses</td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" align="right" bgcolor="#cccccc">53</td> <td valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1</td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Research and development expenses</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#cccccc"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#cccccc"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#cccccc">55</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">171</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">216</td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" bgcolor="#cccccc">$</td> <td valign="bottom" align="right" bgcolor="#cccccc">241</td> <td valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">   786</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">788</td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="11"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(e)</td> <td valign="top" align="left"> Implementation costs represent external, incremental costs directly related to implementing cost-reduction initiatives and primarily include expenditures related to system and process standardization and the expansion of shared services. Implementation costs relate to costs incurred for our cost-reduction initiatives prior to our acquisition of Wyeth on October 15, 2009. Costs related to our cost-reduction initiatives incurred after the Wyeth acquisition, other than additional depreciation––asset restructuring, are included in Restructuring charges and certain acquisition-related costs. Implementation costs are included in our consolidated statements of income as follows: </td></tr></table>   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="81%"/> <td valign="bottom" width="3%"/> <td/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="9">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#cccccc"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2" bgcolor="#cccccc">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#cccccc"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Cost of sales</td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" bgcolor="#cccccc">$</td> <td valign="bottom" align="right" bgcolor="#cccccc">42</td> <td valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">   149</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">   129</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Selling, informational and administrative expenses</td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" align="right" bgcolor="#cccccc">   166</td> <td valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">394</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">333</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Research and development expenses</td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" align="right" bgcolor="#cccccc">36</td> <td valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">262</td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">200</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other (income)/deductions—net</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#cccccc"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#cccccc"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#cccccc">6</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">14</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(61</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Total</td> <td valign="bottom" bgcolor="#cccccc"> </td> <td valign="bottom" bgcolor="#cccccc">$</td> <td valign="bottom" align="right" bgcolor="#cccccc">250</td> <td valign="bottom" nowrap="nowrap" bgcolor="#cccccc">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">819</td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">601</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="11"> </td></tr></table>

7. Taxes on Income A. Taxes on Income Income from continuing operations before provision for taxes on income, and income attributable to noncontrolling interests consist of the following:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="71%"/> <td valign="bottom" width="4%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/> <td/> <td valign="bottom" width="3%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> United States</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(3,632</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(1,760</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">242</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> International</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">14,459</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">11,454</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">9,036</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Total income from continuing operations before provision for taxes on income</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">10,827</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,694</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right"> 9,278</td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="14"> </td></tr></table> The decrease in domestic income from continuing operations before taxes in 2009 compared to 2008 was due primarily to an increase in certain expenses incurred in connection with the Wyeth acquisition, which was partially offset by the non-recurrence of charges of $2.3 billion recorded in 2008 resulting from an agreement-in-principle with the DOJ to resolve the previously reported investigations regarding past off-label promotional practices concerning Bextra and certain other investigations, as well as other litigation-related charges recorded in 2008 of approximately $900 million associated with the resolution of certain litigation involving our NSAID pain medicines. The decrease in domestic income from continuing operations before taxes in 2008 compared to 2007 was due primarily to the aforementioned charges and an increase in restructuring charges in 2008 compared to 2007, partially offset by the charges a ssociated with Exubera in 2007. The increase in international income from continuing operations before taxes in 2009 compared to 2008 was due primarily to the gain in connection with the formation of ViiV, the decrease in international restructuring charges and the non-recurrence of acquired IPR&D, partially offset by an increase in amortization expenses incurred in connection with the Wyeth acquisition. The increase in international income from continuing operations before taxes in 2008 compared to 2007 was due primarily to the charges associated with Exubera in 2007. For additional information on all of these charges, see Note 3. Other Significant Transactions and Events. Provision for taxes on income consists of the following:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="69%"/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/> <td/> <td/> <td valign="bottom" width="4%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="10">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> United States:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Taxes currently payable:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Federal</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">10,169</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">     </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">707</td> <td valign="bottom" nowrap="nowrap">     </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,393</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> State and local</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">71</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">154</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">243</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Deferred income taxes:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Federal</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(10,002</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">106</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,774</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> State and local</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(93</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(136</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(212</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total U.S. tax (benefit)/provision(a), (b)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">145</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">831</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(350</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> International:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Taxes currently payable</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,539</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,115</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,175</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Deferred income taxes</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">513</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(1,301</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(802</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Total international tax provision</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2,052</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">814</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">1,373</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Total provision for taxes on income(c)</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,197</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,645</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,023</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="15"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a) </td> <td valign="top" align="left"> The increase in Federal current tax payable in 2009 was due to increased tax costs associated with certain business decisions executed to finance the Wyeth acquisition. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b) </td> <td valign="top" align="left"> The decrease in Federal deferred income taxes was due to a reduction of deferred tax liabilities recorded in connection with our acquisition of Wyeth. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c) </td> <td valign="top" align="left"> Excludes federal, state and international net tax liabilities assumed or established on the date of the acquisition of Wyeth (see Note 2. Acquisition of Wyeth for additional details) and $4 million in 2008 and $1 million in 2007 primarily related to the resolution of certain tax positions related to Pharmacia Corporation (Pharmacia), which were debited or credited to Goodwill, as appropriate. </td></tr></table> A tax benefit of $174 million was recorded in the third quarter of 2009 related to the final resolution of an agreement-in-principle with the DOJ to settle investigations of past promotional practices concerning Bextra and certain other investigations. This resulted in the receipt of information that raised our assessment of the likelihood of prevailing on the technical merits of our tax position. In 2009 and 2008, we sold two of our biopharmaceutical companies, Vicuron Pharmaceuticals, Inc. (Vicuron) and Esperion Therapeutics, Inc. (Esperion), respectively. Both sales, for nominal consideration, resulted in a loss for tax purposes that reduced our U.S. tax expense by $556 million in 2009 and $426 million in 2008. These tax benefits are a result of the significant initial investment in these entities at the time of acquisition, primarily reported as an income statement charge for IPR&D at acquisition date. These tax benefits were offset by certain costs associated with the Wyeth acquisition that are not deductible. In 2008, we effectively settled certain issues common among multinational corporations with various foreign tax authorities primarily relating to years 2000 through 2005. As a result, in 2008 we recognized $305 million in tax benefits. 2008 also reflects the impact of the third-quarter 2008 provision for the proposed resolution of certain Bextra and Celebrex civil litigation and the impact of the fourth-quarter 2008 provision for the proposed resolution of certain investigations, which were either not deductible or deductible at lower tax rates. Amounts reflected in the preceding tables are based on the location of the taxing authorities. B. Tax Rate Reconciliation Reconciliation of the U.S. statutory income tax rate to our effective tax rate for income from continuing operations follows:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="70%"/> <td valign="bottom" width="9%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/> <td valign="bottom" width="8%"/> <td/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="7">YEAR ENDED DECEMBER 31,</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">2009</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2008</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">2007</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> U.S. statutory income tax rate</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">35.0</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">35.0</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">35.0</td> <td valign="bottom" nowrap="nowrap">% </td></tr> <tr> <td valign="top"> Earnings taxed at other than U.S. statutory rate</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(9.3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">)     </td> <td valign="bottom">    </td> <td valign="bottom" align="right">(20.2</td> <td valign="bottom" nowrap="nowrap">)     </td> <td valign="bottom">    </td> <td valign="bottom" align="right">(21.6</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Sales of biopharmaceutical companies</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(5.1</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">    </td> <td valign="bottom" align="right">(4.3</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">    </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Resolution of certain tax positions</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">(3.1</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">    </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> U.S. research tax credit and manufacturing deduction</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(1.3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">    </td> <td valign="bottom" align="right">(1.2</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">    </td> <td valign="bottom" align="right">(1.5</td> <td valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Legal settlements</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(1.6</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">    </td> <td valign="bottom" align="right">9.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Acquired IPR&D</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">0.2</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">2.1</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">1.1</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td valign="top"> Costs associated with Wyeth acquisition</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2.4</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> All other—net</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(0.3</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(2.0</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td></tr> <tr> <td valign="top"> Effective tax rate for income from continuing operations</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">20.3</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">17.0</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom">    </td> <td valign="bottom" align="right">11.0</td> <td valign="bottom" nowrap="nowrap">% </td></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="9"> </td> <td> </td></tr></table> For earnings taxed at other than the U.S. statutory rate, this rate impact reflects the fact that we operate manufacturing subsidiaries in Puerto Rico, Ireland and Singapore. We benefit from Puerto Rican incentive grants that expire between 2013 and 2029. Under the grants, we are partially exempt from income, property and municipal taxes. In Ireland, we benefit from an incentive tax rate effective through 2010 on income from manufacturing operations. In Singapore, we benefit from incentive tax rates effective through 2031 on income from manufacturing operations. In 2008 and 2009, the rate impact also reflects the jurisdictional location of earnings and the costs of certain repatriation decisions. In 2008, the rate impact also reflects the realization of approximately $711 million (tax effect) in net operating losses. For a discussion about the sales of the biopharmaceutical companies, legal settlements and costs associated with the Wyeth acquisition, see the “Taxes on Income” section above. For a discussion about the resolution of certain tax positions, see the “Tax Contingencies” section below. On October 3, 2008, the Tax Extenders and Alternative Minimum Tax Relief Act (the Extenders Act) extended the R&D tax credit from January 1, 2008, through December 31, 2009. As of December 31, 2009, the credit has expired. The charges for acquired IPR&D in 2009, 2008 and 2007 are primarily not deductible. C. Deferred Taxes Deferred taxes arise as a result of basis differentials between financial statement accounting and tax amounts. The tax effect of the major items recorded as deferred tax assets and liabilities, shown before jurisdictional netting, as of December 31 is as follows:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="52%"/> <td valign="bottom" width="7%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="6%"/> <td/> <td/> <td/> <td valign="bottom" width="7%"/> <td/> <td/> <td/> <td valign="bottom" width="5%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6" bgcolor="#bfbfbf">2009 DEFERRED TAX</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="6">2008 DEFERRED TAX</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">ASSETS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">(LIABILITIES)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">ASSETS</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">(LIABILITIES)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom"> Prepaid/deferred items</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,330</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(60</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(152</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Inventories</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">437</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(859</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">102</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(43</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Intangibles</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">949</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(19,802</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">872</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(5,727</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Property, plant and equipment</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">715</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(2,014</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">205</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(996</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Employee benefits</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,786</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(66</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,414</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(585</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Restructurings and other charges</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">884</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(8</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">841</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(5</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Legal and product liability reserves</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,010</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">703</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(104</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Net operating loss/credit carryforwards</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">4,658</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,065</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Unremitted earnings</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(7,057</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,471</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> State and local tax adjustments</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">747</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">585</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> All other</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">744</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(187</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">905</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(389</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom"> Subtotal</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">16,260</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(30,053</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">)     </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,692</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(12,472</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Valuation allowance</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(353</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">)     </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">—</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(194</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Total deferred taxes</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">15,907</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(30,053</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">11,498</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">$</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(12,472</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom"> Net deferred tax liability</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(14,146</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">  </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(974</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="19"> </td></tr></table> Classified in our Consolidated Balance Sheet as follows:   <table cellpadding="0" cellspacing="0" align="center" border="0" width="100%"> <tr> <td width="49%"/> <td valign="bottom" width="16%"/> <td/> <td/> <td/> <td valign="bottom" width="16%"/> <td/> <td/> <td/> <td valign="bottom" width="10%"/> <td/></tr> <tr> <td valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2" bgcolor="#bfbfbf"> DEFERRED TAX ASSET/ (LIABILITY)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center" colspan="2"> DEFERRED TAX ASSET/ (LIABILITY)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="bottom">Current:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Current deferred tax assets and other current assets</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">2,591</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,143</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Current deferred tax liabilities and other current liabilities</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(226</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(414</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom">Noncurrent:</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom" bgcolor="#bfbfbf"/> <td valign="bottom">    </td> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"/> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="bottom"> Noncurrent deferred tax assets and other noncurrent assets</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">1,328</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom">    </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,256</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> Noncurrent deferred tax liabilities</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(17,839</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom">    </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(2,959</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="bottom">Net deferred tax liability</td> <td valign="bottom" bgcolor="#bfbfbf">    </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(14,146</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom">    </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(974</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="11"> </td></tr></table> The increase in the net deferred tax liability position in 2009 compared to 2008 was primarily due to the noncurrent deferred tax liabilities related to identifiable intangible assets established in connection with our acquisition of Wyeth as well as the increase in noncurrent deferred tax liabilities on unremitted earnings, partially offset by the net deferred tax assets acquired, and net deferred tax assets established as a result of various restructuring charges incurred in connection with our acquisition of Wyeth. We have carryforwards, primarily related to foreign tax credit carryovers and net operating loss carryovers, which are available to reduce future U.S. federal and state, as well as international income taxes payable with either an indefinite life or expiring at various times between 2010 and 2028. Certain of our U.S. net operating losses are subject to limitations under Internal Revenue Code Section 382. Valuation allowances are provided when we believe that our deferred tax assets are not recoverable based on an assessment of estimated future taxable income that incorporates ongoing, prudent, feasible tax planning strategies. As of December 31, 2009, we have not made a U.S. tax provision on approximately $42.5 billion of unremitted earnings of our international subsidiaries. As of December 31, 2009, these earnings are intended to be permanently reinvested overseas; as such, it is not practical to compute the estimated deferred tax liability on these permanently reinvested earnings. D. Tax Contingencies Unrecognized tax benefits represent liabilities that we have recorded for the difference between the estimated tax benefits recognized in our financial statements and tax positions taken or expected to be taken on our tax returns. These unrecognized tax benefits are recorded due to the uncertainty of the ultimate outcome of tax positions taken on our tax returns. Because tax laws and regulations are subject to interpretation and tax litigation inherently is uncertain, these evaluations can involve a series of complex judgments about future events and can rely heavily on estimates and assumptions. Our evaluations are based on estimates and assumptions that have been deemed reasonable by management. However, if our estimates and assumptions are not representative of actual outcomes, our results could be materially impacted. For a description of our accounting policies associated with accounting for income tax c ontingencies, see Note 1P. Significant Accounting Policies: Income Tax Contingencies and Note 1C. Significant Accounting Policies: Estimates and Assumptions. Tax assets associated with uncertain tax positions represent our estimate of the potential tax benefits in one tax jurisdiction that could result from the payment of income taxes in another tax jurisdiction. These potential benefits generally result from cooperative efforts among taxing authorities, as required by tax treaties to minimize double taxation, commonly referred to as the competent authority process. The recoverability of these assets, which we believe to be more likely than not, is dependent upon the actual payment of taxes in one tax jurisdiction and, in some cases, the successful petition for recovery in another tax jurisdiction. The United States is one of our major tax jurisdictions. We currently are appealing two issues related to the Internal Revenue Service’s (IRS) audits of the Pfizer Inc. tax returns for the years 2002 through 2005. The 2006, 2007 and 2008 tax years currently are under audit. The 2009 tax year is not yet under audit. All other tax years in the U.S. for Pfizer Inc. are closed under the statute of limitations. With respect to Pharmacia, the IRS currently is conducting an audit for the year 2003 through the date of merger with Pfizer (April 16, 2003). With respect to Wyeth, the years 2002 through 2005 currently are under IRS audit, and tax years 2006 through the Wyeth acquisition date (October 15, 2009) have not been audited yet. In addition to the open audit years in the U.S., we have open audit years in other major tax jurisdictions, such as Canada (1998-2009), Japan (2006-2009), Europe (1997-2009, pri marily reflecting Ireland, the United Kingdom, France, Italy, Spain and Germany) and Puerto Rico (2003-2009). Finalizing audits with the relevant taxing authorities can include formal administrative and legal proceedings, and, as a result, it is difficult to estimate the timing and range of possible change to our uncertain tax positions. If our estimates and assumptions are not representative of actual outcomes, any change could have a significant impact. In 2008, we effectively settled certain issues common among multinational corporations with various foreign tax authorities primarily relating to tax years 2000 to 2005. As a result, we recognized $305 million in tax benefits. Tax liabilities associated with uncertain tax positions represent unrecognized tax benefits, which arise when the estimated benefit recorded in our financial statements differs from the amounts taken or expected to be taken in a tax return because of the uncertainties described above. These unrecognized tax benefits relate primarily to issues common among multinational corporations. Substantially all of these unrecognized tax benefits, if recognized, would impact our effective income tax rate. A reconciliation of the beginning and ending amounts of gross unrecognized tax benefits is as follows:   <table cellspacing="0" cellpadding="0" align="center" border="0" width="100%"> <tr> <td width="84%"/> <td valign="bottom" width="3%"/> <td/> <td/> <td/> <td valign="bottom" width="3%"/> <td/> <td/> <td/> <td valign="bottom" width="3%"/> <td/></tr> <tr> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">(MILLIONS OF DOLLARS)</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2" bgcolor="#bfbfbf">2009</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" colspan="2">2008</td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-TOP: #000000 1px solid; BORDER-BOTTOM: #000000 1px solid" valign="bottom">  </td></tr> <tr> <td valign="top"> Balance, January 1</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(5,372</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">)   </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(5,466</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Acquisition of Wyeth</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(1,785</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Decreases based on tax positions taken during a prior period(a) </td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">38</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">880</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Increases based on tax positions taken during the current period(b)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(941</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(990</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Decreases based on tax positions taken during the current period(c)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">712</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td valign="top"> Impact of foreign exchange</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf"> </td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(284</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">211</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid" valign="top"> Other, net(d)</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" bgcolor="#bfbfbf"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right" bgcolor="#bfbfbf">(25</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="right">(7</td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" nowrap="nowrap">) </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"> </td></tr> <tr> <td valign="top"> Balance, December 31(e)</td> <td valign="bottom" bgcolor="#bfbfbf">  </td> <td valign="bottom" bgcolor="#bfbfbf">$</td> <td valign="bottom" align="right" bgcolor="#bfbfbf">(7,657</td> <td valign="bottom" nowrap="nowrap" bgcolor="#bfbfbf">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(5,372</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"/></tr> <tr style="FONT-SIZE: 1px"> <td style="BORDER-TOP: #000000 3px double" valign="bottom" colspan="11"> </td></tr></table>   <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(a)</td> <td valign="top" align="left"> Decreases are primarily a result of effectively settling certain issues with various foreign tax authorities. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(b)</td> <td valign="top" align="left"> Primarily included in Provision for taxes on income. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(c)</td> <td valign="top" align="left"> Primarily included in Income taxes payable. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(d)</td> <td valign="top" align="left"> Includes increases based on tax positions taken during a prior period, decreases due to settlements with taxing authorities primarily resulting in cash payments and decreases as a result of a lapse of applicable statutes of limitations. </td></tr></table> <table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE: collapse" border="0" width="100%"> <tr> <td valign="top" align="left" width="1%">(e)</td> <td valign="top" align="left"> In 2009, included in Income taxes payable ($144 million), Current deferred tax assets and other current assets ($78 million), Noncurrent deferred tax liabilities ($208 million) and Other taxes payable ($7.2 billion). In 2008, included in Income taxes payable ($85 million), Current deferred tax assets and other current assets ($44 million) and Other taxes payable ($5.2 billion). </td></tr></table> Interest expense related to our unrecognized tax benefits is recorded in Provision for taxes on income in our consolidated statements of income and totaled $191 million in 2009, $106 million in 2008 and $214 million in 2007. Gross accrued interest totaled $1.9 billion as of December 31, 2009 (including $300 million recorded upon the acquisition of Wyeth) and $1.3 billion as of December 31, 2008. In 2009, these amounts were included in Income taxes payable ($90 million), Current deferred tax assets and other current assets ($55 million) and Other taxes payable ($1.8 billion). In 2008, these amounts were primarily included in Other taxes payable. Accrued penalties are not significant. Any settlements or statute of limitations expirations would likely result in a significant decrease in our uncertain tax positions. We estimate that within the next 12 months, our gross uncertain tax positions, exclusive of interest could decrease by as much as $900 million, as a result of settlements with taxing authorities or the expiration of the statute of limitations. Our estimates of unrecognized tax benefits and potential tax benefits may not be representative of actual outcomes, and variation from such estimates could materially affect our financial statements in the period of settlement or when the statutes of limitations expire, as we treat these events as discrete items in the period of resolution. Finalizing audits with the relevant taxing authorities can include formal administrative and legal proceedings, and, as a result, it is difficult to estimate the timing and range of possible ch ange related to our uncertain tax positions and such changes could be significant.

0 0 0

11000000

9994000000

-20000000

-5775000000

-7913000000

-7235000000

Exclusive of amortization of intangible assets except as disclosed in Note 1L. Significant Accounting Policies: Amortization of Intangible Assets, Depreciation and Certain Long-Lived Assets.